rfhg_156500.1

Basic information about the TSS

---

TSS ID: rfhg_156500.1 TSS ID(Version3): hg_133338.1 Species: human Chr: chr12		Start: 112409550 End: 112409653 Strand: -
Source datasets	FANTOM5|EPD|DBTSS|DRA000914|ENCODE|RAMPAGE|PRJNA615891 |PRJNA401781|PRJNA548673|PRJDB5282|PRJNA4843412|DRA013844 |PRJNA597322
Protocol	CAGE|TSS_database|TSS-seq|RAMPAGE|TIF-seq2|oligo_capping |ReCappable-seq|SLIC_CAGE|C1CAGE|NETCAGE|STRIPE-seq
TSS cluster detected*	17

  * The number of TSS cluster called data-sets (maximum 17)

cCREs annotation

---

Description:	PLS,CTCF-bound (EH38D2608212,EH38E1645151)
Category:	PLS

  * cCREs are candidates for cis regulatory elements generated from the subset of representative DNase hypersensitivity sites supported by either histone modifications or CTCF-binding data. Find more details here.

Gene and protein annotation

---

Nearest transcript id and distance: ENST00000202773.14:0 ENST00000424576.6:0 ENST00000546368.2:0 ENST00000551041.6:0 ENST00000552455.5:0 ENST00000550566.6:0 ENST00000553213.2:0 ENST00000549562.1:0 AK299470:0 BC020679:0 BC031009:0 BC004138:0 BC022444:0 AF261087:0 D17554:0 X69391:0 BC070195:0 BC104824:0 BC104826:0 AK311863:0 AK308469:0 AK308680:0 GeneID: 6128 HGNC/MGI_ID: HGNC:10362 UniProt_ID: A0A024RBK3 B2R4K7 B4DRX3 F8VWR1 Q8N5Z7 Q8TBK5 Q9HBB3 U3KQR5 Nearer transcript ids and distances: ENST00000549847.5:239 NM_001320140.2:265 NM_001320138.2:265 NM_001320139.2:265 view more...

Gene_name: ribosomal protein L6 Gene_symbol: RPL6 Gene_synonyms: L6 TAXREB107 Gene_source: HGNC:10362

TATA-Box annotation

---

Distance to TSS:	13
Nearest PromoterID:	NM_001320137
Entrez ID:	6128
Nearest Unigene:	Hs.528668
Nearest Refseq:	NM_000970
Nearest Ensembl:	ENSG00000089009
Gene Name:	ribosomal protein L6
Gene Alias:	L6|SHUJUN-2|TAXREB107|TXREB1
Gene Type:	protein-coding
CpG%:	0.048544
GC%:	0.500000
TATA-Box(TBP)/Promoter/Homer Distance From Peak(sequence,strand,conservation):	18(GCTTATAGACCG,+,0.00)

TSS expression

Sample Category  All in vivo cell sample cell line sample tissue sample human bronchial epithelial cell sample CD19-positive B cell sample CD8-positive T cell sample CD4-positive T cell sample common myeloid progenitor sample human monocyte immature derived dendritic cell sample human endothelial cell of the aorta sample human cardiac fibroblast sample human dermal fibroblast sample human fibroblast of gingiva sample human fibroblast of periodontium sample granulocyte macrophage progenitor cell sample human hepatocyte sample human mesenchymal stem cell of umbilical cord-Sciencell sample human mesenchymal stem cell of adipose sample human mesenchymal stem cell of bone marrow sample mouse sample mouse granule cell sample mouse hepatocyte sample human neutrophil sample human osteoblast-Sciencell sample human osteoblast-Cell applications sample human renal glomerular endothelial cell sample human retinal pigment epithelial cell sample human skeletal muscle cell sample human aortic smooth muscle cell sample human smooth muscle cell of umbilical artery sample human urothelial cell sample cerebellar granule cell sample human sample mast cell- heparinase treated sample human mature adipocyte sample human cardiac mesenchymal precursor cell sample human mesenchymal precursor cell- ovarian cancer-left ovary sample human mesenchymal precursor cell- ovarian cancer-metastasis sample human mesenchymal precursor cell- ovarian cancer-right ovary sample human whole blood sample control treatment sample human adipose tissue - adult sample human brain - adult sample human parietal lobe - adult sample hippocampus - adult sample human CD14-CD16-positive Monocytes sample mouse cerebellum- embryo E13 sample mouse cerebellum- embryo E15 sample mouse cerebellum- embryo E18 sample human Monocyte-derived macrophages 0h after mock infection sample human Monocyte-derived macrophages 0h after udorn influenza infection sample human Monocyte-derived macrophages 2h after udorn influenza infection sample human Monocyte-derived macrophages 7h after udorn influenza infection sample human Monocyte-derived macrophages 24h after udorn influenza infection sample human Monocyte-derived macrophages 24h after mock infection sample mouse whole body- embryo E17.5 sample adenocarcinoma cell line sample small cell lung cancer cell sample carcinoma cell line sample teratocarcinoma cell line sample sarcoma cell line sample K-562 cell sample embryonic cell line sample epithelial cell line sample THP-1 cell sample gastrointestinal cancer cell sample acute myeloid leukemia cell line sample cervical cancer cell line sample squamous cell carcinoma cell line sample mesothelioma cell line sample NCI cell sample human nasal epithelial cell sample macrophage, TB infection sample iPS differentiation to neuron, control sample iPS differentiation to neuron, down-syndrome donor sample myoblast differentiation to myotubes, control sample H1 embryonic stem cells differentiation to CD34+ HSC sample 293SLAM rinderpest infection sample COBL-a rinderpest infection sample partial hepatectomy sample sham operation sample ES-OS25 embryonic stem cells sample ES-OS25 embryonic stem cells, untreated sample ES-46C embryonic stem cells, neuronal differentiation sample ES-OS25 embryonic stem cells, KD for exosomal component EXOSC3, biol_rep1 sample ARPE-19 EMT induced with TGF-beta and TNF-alpha sample hIPS sample

		Promoter select All p1@RPL6 p2@RPL6 p3@RPL6 p4@RPL6 p5@RPL6 p6@RPL6 p7@RPL6
Sample		p1@RPL6	p2@RPL6	p3@RPL6	p4@RPL6	p5@RPL6	p6@RPL6	p7@RPL6
293SLAM rinderpest infection, 00hr, biol_rep1	13541-145H4	220.32	2.34	2.92	11.69	1.17	0.39	3.51
293SLAM rinderpest infection, 00hr, biol_rep2	13542-145H5	205.76	3.03	1.21	8.90	0.20	0.00	1.62
293SLAM rinderpest infection, 00hr, biol_rep3	13543-145H6	237.46	2.12	1.74	11.19	0.96	0.19	3.86
293SLAM rinderpest infection, 06hr, biol_rep1	13544-145H7	206.25	3.95	2.91	13.10	1.25	0.62	2.29
293SLAM rinderpest infection, 06hr, biol_rep2	13545-145H8	215.74	5.85	1.57	13.27	1.35	0.22	1.35
293SLAM rinderpest infection, 06hr, biol_rep3	13546-145H9	239.94	4.26	1.16	12.40	0.58	0.00	1.16
293SLAM rinderpest infection, 12hr, biol_rep1	13547-145I1	357.76	5.66	1.53	20.48	1.53	0.00	2.40
293SLAM rinderpest infection, 12hr, biol_rep2	13548-145I2	281.70	4.12	1.21	17.20	0.00	0.00	3.39
293SLAM rinderpest infection, 12hr, biol_rep3	13549-145I3	253.04	3.21	2.78	8.55	0.64	0.00	2.78
293SLAM rinderpest infection, 24hr, biol_rep1	13550-145I4	170.99	4.06	2.32	5.22	0.00	0.00	1.16
293SLAM rinderpest infection, 24hr, biol_rep2	13551-145I5	168.57	3.64	2.83	6.87	2.83	0.00	0.40
293SLAM rinderpest infection, 24hr, biol_rep3	13552-145I6	137.41	1.22	2.85	6.10	0.41	0.00	1.22
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep1	13625-146H7	31.59	1.93	0.81	0.00	0.16	0.00	0.81
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep2	13626-146H8	38.49	2.26	0.90	0.00	0.45	0.00	0.30
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep3	13627-146H9	35.79	2.20	1.10	0.00	0.66	0.00	0.66
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep1	13628-146I1	31.44	2.26	1.51	0.00	0.25	0.25	0.50
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep2	13629-146I2	38.44	1.31	0.66	0.00	0.00	0.00	0.87
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep3	13630-146I3	28.26	2.53	0.42	0.00	0.00	0.00	0.84
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep1	13631-146I4	28.79	1.07	0.00	0.00	0.53	0.00	1.07
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep2	13632-146I5	28.58	1.65	1.35	0.00	0.45	0.00	0.60
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep3	13633-146I6	35.28	0.67	1.87	0.00	0.00	0.13	0.53
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep1	13634-146I7	37.80	2.07	0.86	0.35	0.17	0.35	1.21
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep2	13635-146I8	35.42	1.29	0.65	0.39	0.39	0.13	0.65
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep3	13636-146I9	34.46	2.18	0.24	0.00	0.00	0.24	0.97
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep1	13637-147A1	42.31	1.03	1.29	0.00	0.00	0.26	0.26
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep2	13638-147A2	33.23	1.58	0.95	0.32	0.32	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep3	13639-147A3	33.52	1.10	0.00	0.00	0.55	0.55	1.65
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep1	13640-147A4	43.85	0.94	1.18	0.00	0.00	0.00	0.94
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep2	13641-147A5	30.04	1.94	1.45	0.16	0.16	0.32	0.48
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep3	13642-147A6	43.61	1.45	1.63	0.18	0.00	0.36	0.18
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep1	13643-147A7	41.45	1.26	1.47	0.42	0.00	0.42	1.26
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep2	13644-147A8	39.86	1.76	1.56	0.20	0.20	0.00	0.20
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep3	13645-147A9	36.30	2.95	0.63	0.42	0.42	0.00	0.63
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep1	13646-147B1	70.26	1.65	0.33	0.49	0.49	0.33	0.82
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep2	13647-147B2	47.12	1.50	1.31	0.00	0.00	0.00	1.31
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep3	13648-147B3	36.79	2.49	1.34	0.00	0.19	0.19	0.19
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep1	13649-147B4	43.74	1.84	0.61	0.61	0.00	0.82	0.41
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep2	13650-147B5	48.56	1.01	1.61	0.00	0.40	0.00	1.21
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep3	13651-147B6	45.65	2.43	1.62	0.54	0.27	0.00	0.81
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep1	13652-147B7	51.37	2.16	0.96	0.24	0.00	0.24	0.96
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep2	13653-147B8	40.46	2.35	1.18	0.24	0.24	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep3	13654-147B9	55.78	2.05	0.44	0.73	0.15	0.15	0.88
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep1	13655-147C1	44.08	1.69	0.63	0.84	0.00	0.21	1.27
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep2	13656-147C2	42.66	2.27	1.40	0.52	0.00	0.17	0.70
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep3	13657-147C3	48.19	2.41	2.81	0.60	0.40	0.20	0.40
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep1	13658-147C4	46.06	1.40	1.63	0.93	0.00	0.00	0.93
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep2	13659-147C5	45.58	3.12	0.48	0.72	0.00	0.00	0.96
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep3	13660-147C6	49.18	2.09	0.60	0.89	0.00	0.00	0.89
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep1	13661-147C7	43.33	1.68	1.44	0.48	0.24	0.00	0.96
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep2	13662-147C8	39.63	1.62	0.61	0.40	0.00	0.00	0.81
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep3	13663-147C9	38.12	0.61	1.84	0.61	0.41	0.00	2.05
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep1	13664-147D1	40.03	2.22	0.89	0.89	0.22	0.22	1.33
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep2	13665-147D2	503.72	13.99	0.00	13.99	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep3	13666-147D3	29.45	1.77	1.06	0.35	0.35	0.00	1.06
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep1	13667-147D4	35.79	1.33	1.99	0.00	0.00	0.00	1.66
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep2	13668-147D5	182.05	3.36	0.84	0.00	0.00	1.68	9.23
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep3	13669-147D6	65.21	2.76	0.92	0.92	0.00	0.00	2.30
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep1	13670-147D7	29.49	0.65	2.92	0.00	0.00	0.00	1.62
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep2	13671-147D8	28.58	0.64	2.89	0.32	0.00	0.64	1.28
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep3	13672-147D9	63.18	2.20	0.94	1.57	0.63	0.31	4.09
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep2	13674-147E2	31.02	0.71	0.71	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep3	13675-147E3	34.21	1.68	1.68	0.56	0.56	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep1	13676-147E4	56.53	1.59	1.59	0.80	0.00	0.80	6.37
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep2	13677-147E5	38.39	2.38	1.02	0.00	0.00	0.34	1.70
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep3	13678-147E6	27.94	0.65	0.97	0.00	0.00	0.00	0.65
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep1	13679-147E7	26.27	1.06	1.06	0.00	0.00	0.00	1.06
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep2	13680-147E8	274.79	0.00	16.16	0.00	0.00	0.00	16.16
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep3	13681-147E9	426.46	0.00	0.00	0.00	7.90	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep1	13682-147F1	32.66	2.44	3.41	0.00	0.00	0.00	0.98
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep2	13683-147F2	38.18	1.49	3.47	0.00	0.00	0.00	1.49
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep3	13684-147F3	32.37	0.47	1.88	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep1	13685-147F4	37.09	2.65	0.00	0.00	0.00	0.00	0.66
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep2	13686-147F5	27.84	1.86	2.17	0.00	0.00	0.31	0.62
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep3	13687-147F6	26.29	1.83	1.83	0.00	0.00	0.00	0.92
Adipocyte - breast, donor1	11376-118A8	43.56	4.12	0.16	0.32	0.16	0.16	0.48
Adipocyte - breast, donor2	11327-117E4	36.26	1.60	0.96	0.48	0.16	0.00	1.12
Adipocyte - omental, donor1	11473-119C6	53.44	3.18	0.13	0.25	0.38	0.00	0.51
Adipocyte - omental, donor2	11474-119C7	32.14	0.75	0.00	0.75	0.00	0.00	2.24
Adipocyte - omental, donor3	11475-119C8	34.83	2.34	0.67	0.00	0.00	0.00	2.34
Adipocyte - perirenal, donor1	11476-119C9	40.19	2.55	3.19	0.00	0.00	0.00	0.00
Adipocyte - subcutaneous, donor1	11259-116F8	27.49	0.00	1.10	0.00	0.00	0.00	3.30
Adipocyte - subcutaneous, donor2	11336-117F4	93.49	1.35	0.00	0.00	0.00	0.90	0.90
Adipocyte - subcutaneous, donor3	11408-118E4	30.93	0.35	0.70	0.00	0.00	0.17	0.70
Adipocyte differentiation, day04, donor1	13019-139D4	48.31	1.17	0.59	0.00	0.20	0.00	0.59
Adipocyte differentiation, day04, donor2	13022-139D7	36.55	1.54	0.77	0.00	0.26	0.26	0.77
Adipocyte differentiation, day04, donor3	13025-139E1	37.91	1.12	1.12	0.00	0.28	0.00	0.28
Adipocyte differentiation, day04, donor4	13028-139E4	28.21	2.35	0.00	0.59	0.00	0.00	0.00
Adipocyte differentiation, day08, donor1	13020-139D5	61.21	1.77	0.24	0.32	0.32	0.08	0.08
Adipocyte differentiation, day08, donor2	13023-139D8	31.63	1.61	1.29	0.32	0.32	0.00	1.29
Adipocyte differentiation, day08, donor3	13026-139E2	32.52	0.00	0.00	0.53	0.00	0.00	2.67
Adipocyte differentiation, day08, donor4	13029-139E5	26.15	0.56	1.11	0.00	0.00	0.00	1.67
Adipocyte differentiation, day12, donor1	13021-139D6	28.70	1.25	0.83	0.00	0.00	0.00	0.42
Adipocyte differentiation, day12, donor2	13024-139D9	21.35	0.00	0.75	0.00	0.25	0.00	0.75
Adipocyte differentiation, day12, donor3	13027-139E3	24.22	0.00	1.31	0.00	0.33	0.00	0.33
Adipocyte differentiation, day12, donor4	13030-139E6	25.27	1.22	0.30	0.00	0.00	0.00	0.61
Alveolar Epithelial Cells, donor1	11510-119G7	70.50	0.66	0.44	1.10	0.22	0.00	0.00
Alveolar Epithelial Cells, donor2	11590-120G6	11.12	0.00	1.43	0.36	0.00	0.00	0.00
Alveolar Epithelial Cells, donor3	11671-122G6	4.79	0.00	0.00	0.00	0.00	0.00	0.00
Amniotic Epithelial Cells, donor1	11533-120A3	24.47	0.54	0.36	0.36	0.00	0.18	0.18
Amniotic Epithelial Cells, donor2	11613-122A2	6.69	0.00	1.67	0.00	0.00	0.00	1.67
Amniotic Epithelial Cells, donor3	11694-123A2	15.82	0.62	0.21	0.00	0.21	0.00	0.00
Anulus Pulposus Cell, donor1	11248-116E6	43.71	3.43	0.11	0.23	0.57	0.57	0.57
Anulus Pulposus Cell, donor2	11463-119B5	27.92	1.71	0.49	0.00	0.24	0.00	2.94
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep1 (LK1)	12642-134G5	66.05	0.90	0.00	1.35	0.00	0.00	1.80
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep2 (LK2)	12740-135I4	53.83	0.43	0.00	0.87	0.00	0.43	1.30
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep3 (LK3)	12838-137B3	55.65	0.00	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep1 (LK4)	12643-134G6	63.07	1.49	0.00	1.49	0.00	0.00	4.48
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep2 (LK5)	12741-135I5	88.53	0.00	0.00	2.53	0.00	0.00	3.79
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep3 (LK6)	12839-137B4	41.58	0.66	0.66	1.32	0.66	0.00	1.32
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep1 (LK7)	12644-134G7	54.26	1.30	0.32	0.97	0.65	0.00	1.30
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep2 (LK8)	12742-135I6	65.05	1.46	0.00	0.00	0.49	0.49	1.46
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep3 (LK9)	12840-137B5	56.42	2.97	0.59	0.59	0.00	0.00	1.78
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep1 (LK10)	12645-134G8	74.20	1.13	0.38	0.75	0.00	0.00	4.90
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep2 (LK11)	12743-135I7	68.94	0.73	0.00	0.73	0.00	0.00	0.73
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep3 (LK12)	12841-137B6	55.17	0.00	0.00	1.25	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep1 (LK13)	12646-134G9	68.70	1.81	0.82	0.99	0.16	0.00	0.33
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep2 (LK14)	12744-135I8	42.31	0.00	0.00	1.36	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep3 (LK15)	12842-137B7	52.78	1.81	0.30	0.90	0.45	0.00	0.30
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep1 (LK16)	12647-134H1	53.58	0.54	0.00	1.61	0.00	0.54	1.07
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep2 (LK17)	12745-135I9	57.44	1.13	0.19	0.76	0.00	0.38	0.94
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep3 (LK18)	12843-137B8	59.34	1.34	0.00	0.00	0.27	0.27	1.34
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep1 (LK19)	12648-134H2	51.70	0.98	0.98	0.98	0.00	0.00	1.95
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep2 (LK20)	12746-136A1	59.38	1.33	0.50	1.00	0.00	0.50	0.83
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep3 (LK21)	12844-137B9	39.62	0.00	1.20	1.20	0.00	0.00	1.20
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep1 (LK22)	12649-134H3	35.40	0.00	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep2 (LK23)	12747-136A2	59.86	0.86	0.51	0.69	0.00	0.34	0.17
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep3 (LK24)	12845-137C1	62.92	0.00	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep1 (LK25)	12650-134H4	61.65	0.49	0.00	0.97	0.00	0.00	4.37
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep2 (LK26)	12748-136A3	64.89	0.38	0.00	0.38	0.00	0.00	2.28
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep3 (LK27)	12846-137C2	47.24	1.21	1.21	1.21	1.21	0.00	3.63
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep1 (LK28)	12651-134H5	56.43	2.85	0.00	1.71	0.57	0.57	0.00
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep2 (LK29)	12749-136A4	45.75	1.28	0.21	1.71	0.00	0.21	1.28
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep3 (LK30)	12847-137C3	46.97	1.55	0.00	0.52	0.26	0.00	1.03
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep1 (LK31)	12652-134H6	64.75	0.94	0.47	0.00	0.00	0.47	0.94
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep2 (LK32)	12750-136A5	49.84	0.32	0.32	0.96	0.00	0.00	1.93
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep3 (LK33)	12848-137C4	52.80	0.71	0.00	2.85	0.00	0.00	2.85
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep1 (LK34)	12653-134H7	53.82	0.00	0.00	1.17	0.00	0.00	1.17
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep2 (LK35)	12751-136A6	54.49	1.81	0.00	0.30	0.00	0.30	0.90
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep3 (LK36)	12849-137C5	43.96	1.19	0.00	0.00	1.19	0.00	1.19
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep1 (LK37)	12654-134H8	89.51	1.53	0.51	2.03	0.00	0.00	4.58
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep2 (LK38)	12752-136A7	66.98	1.78	0.51	0.25	0.51	0.25	2.29
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep3 (LK39)	12850-137C6	50.83	0.64	1.27	0.00	0.00	0.00	1.91
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep1 (LK40)	12655-134H9	65.16	0.86	0.00	0.00	0.00	0.00	2.59
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep2 (LK41)	12753-136A8	65.41	0.64	0.42	1.48	0.42	0.64	0.21
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep3 (LK42)	12851-137C7	57.42	1.16	0.29	0.00	0.29	0.00	2.32
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep1 (LK43)	12656-134I1	50.07	0.94	0.00	1.89	0.00	0.94	0.94
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep2 (LK44)	12754-136A9	58.66	1.19	0.51	1.02	0.00	0.00	1.19
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep3 (LK45)	12852-137C8	44.01	2.32	0.00	0.00	0.00	0.00	2.32
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep1 (LK46)	12657-134I2	54.93	0.00	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep2 (LK47)	12755-136B1	54.68	0.86	0.00	0.86	0.00	0.00	1.07
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep3 (LK48)	12853-137C9	48.73	0.60	0.00	1.20	0.00	0.00	1.20
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep1 (LK49)	12658-134I3	57.59	0.00	0.00	0.73	0.00	0.00	3.64
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep2 (LK50)	12756-136B2	66.67	1.61	0.00	0.69	0.46	0.69	2.30
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep3 (LK51)	12854-137D1	35.70	0.00	0.00	2.55	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep1 (LK52)	12659-134I4	66.10	2.03	0.51	1.27	0.00	0.00	0.25
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep2 (LK53)	12757-136B3	55.95	0.83	0.41	0.41	0.21	0.21	0.83
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep3 (LK54)	12855-137D2	46.82	0.61	0.31	1.22	0.31	0.31	0.92
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep1 (LK55)	12660-134I5	74.09	0.96	0.96	0.48	0.00	0.48	2.39
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep2 (LK56)	12758-136B4	56.99	0.67	0.89	0.44	0.00	0.22	1.33
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep3 (LK57)	12856-137D3	48.83	1.53	1.53	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep1 (LK58)	12661-134I6	53.73	0.00	0.00	0.55	0.00	0.00	1.11
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep2 (LK59)	12759-136B5	51.37	0.79	0.53	0.26	0.26	0.26	1.06
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep3 (LK60)	12857-137D4	55.61	0.36	0.00	0.73	0.00	0.00	1.45
Astrocyte - cerebellum, donor1	11500-119F6	41.39	1.47	0.74	0.12	0.00	0.12	0.25
Astrocyte - cerebellum, donor2	11580-120F5	21.22	0.51	0.68	0.00	0.00	0.00	0.00
Astrocyte - cerebellum, donor3	11661-122F5	9.44	0.00	0.21	0.21	0.00	0.00	0.00
Astrocyte - cerebral cortex, donor1	11235-116D2	85.40	1.74	1.05	0.00	0.70	0.35	0.00
Astrocyte - cerebral cortex, donor2	11316-117D2	108.06	1.29	1.29	1.13	0.32	0.00	1.62
Astrocyte - cerebral cortex, donor3	11392-118C6	65.78	1.34	0.75	0.45	0.60	0.15	0.60
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep1	10821-111C2	133.38	10.67	2.52	0.80	0.57	0.69	0.92
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep2	10822-111C3	165.50	14.03	2.88	1.88	0.75	0.25	0.50
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep3	10823-111C4	166.71	10.01	2.28	2.39	1.48	0.34	0.91
Basophils, donor1	12241-129G9	12.03	0.52	4.45	0.00	0.00	0.52	0.00
Basophils, donor2	12242-129H1	24.89	1.80	2.16	0.00	0.00	0.00	0.36
Basophils, donor3	12243-129H2	17.49	0.88	3.09	0.00	0.00	0.00	0.15
Bronchial Epithelial Cell, donor1	11511-119G8	15.95	0.22	0.00	0.00	0.00	0.00	0.22
Bronchial Epithelial Cell, donor2	11591-120G7	4.57	0.46	2.29	0.00	0.00	0.00	0.00
Bronchial Epithelial Cell, donor3	11672-122G7	43.04	0.00	0.00	0.00	0.00	0.00	0.00
Bronchial Epithelial Cell, donor4	11453-119A4	101.68	0.63	5.65	0.63	0.00	0.00	1.26
Bronchial Epithelial Cell, donor5	11457-119A8	55.52	2.08	2.29	0.83	0.00	0.21	0.00
Bronchial Epithelial Cell, donor6	11461-119B3	53.43	1.15	1.38	0.00	0.23	0.00	1.61
Bronchial Epithelial Cell, donor7	11769-123I5	55.42	0.72	0.18	0.18	0.00	0.18	2.16
Burkitt's lymphoma cell line:DAUDI	10422-106C8	151.59	7.52	1.75	2.68	1.03	0.41	0.10
Burkitt's lymphoma cell line:RAJI	10476-106I8	182.83	4.43	1.40	2.33	0.47	0.47	0.47
CD133+ stem cells - adult bone marrow derived, pool1	12224-129F1	66.83	6.08	3.52	0.32	0.64	0.00	2.24
CD133+ stem cells - cord blood derived, pool1	12223-129E9	113.76	0.00	0.00	0.00	0.00	0.00	0.00
CD14+ Monocytes, donor1	11224-116B9	12.96	1.13	1.69	0.00	0.00	0.00	0.00
CD14+ Monocytes, donor2	11305-117B9	11.51	0.19	4.27	0.00	0.00	0.19	0.37
CD14+ Monocytes, donor3	11381-118B4	8.12	0.22	7.46	0.22	0.00	0.00	0.44
CD14+ monocyte derived endothelial progenitor cells, donor1	11229-116C5	17.83	3.40	1.42	0.00	0.28	0.28	0.00
CD14+ monocyte derived endothelial progenitor cells, donor2	11310-117C5	19.71	4.17	0.00	0.00	0.00	0.00	0.38
CD14+ monocyte derived endothelial progenitor cells, donor3	11386-118B9	16.44	4.60	0.99	0.00	0.00	0.33	0.66
CD14+ monocytes - mock treated, donor1	11863-125A9	15.76	1.01	1.73	0.00	0.14	0.00	1.01
CD14+ monocytes - mock treated, donor2	11873-125C1	17.80	1.51	1.21	0.00	0.00	0.00	0.30
CD14+ monocytes - mock treated, donor3	11883-125D2	14.92	1.18	1.66	0.00	0.00	0.00	2.13
CD14+ monocytes - treated with B-glucan, donor1	11869-125B6	13.89	1.34	1.00	0.00	0.00	0.00	0.00
CD14+ monocytes - treated with B-glucan, donor2	11879-125C7	10.76	0.28	1.10	0.55	0.00	0.00	0.83
CD14+ monocytes - treated with B-glucan, donor3	11889-125D8	15.37	1.24	0.99	0.74	0.00	0.25	0.25
CD14+ monocytes - treated with BCG, donor1	11860-125A6	13.71	0.39	3.13	0.00	0.00	0.00	0.39
CD14+ monocytes - treated with BCG, donor2	11870-125B7	11.75	0.89	2.49	0.00	0.00	0.00	0.53
CD14+ monocytes - treated with BCG, donor3	11880-125C8	23.29	1.96	5.22	0.00	0.00	0.00	1.09
CD14+ monocytes - treated with Candida, donor1	11868-125B5	11.00	1.40	1.40	0.00	0.00	0.00	0.00
CD14+ monocytes - treated with Candida, donor2	11878-125C6	13.20	0.00	2.64	0.00	0.00	0.00	1.58
CD14+ monocytes - treated with Candida, donor3	11888-125D7	14.42	2.22	4.44	0.00	0.00	0.00	0.00
CD14+ monocytes - treated with Cryptococcus, donor1	11867-125B4	11.01	1.64	0.59	0.15	0.00	0.15	0.89
CD14+ monocytes - treated with Cryptococcus, donor2	11877-125C5	15.17	0.40	0.80	0.40	0.20	0.60	1.60
CD14+ monocytes - treated with Cryptococcus, donor3	11887-125D6	31.02	2.08	0.62	0.00	0.00	0.00	2.08
CD14+ monocytes - treated with Group A streptococci, donor1	11864-125B1	10.52	0.46	1.14	0.00	0.00	0.00	1.37
CD14+ monocytes - treated with Group A streptococci, donor2	11874-125C2	14.48	0.45	1.81	0.00	0.00	0.00	1.58
CD14+ monocytes - treated with Group A streptococci, donor3	11884-125D3	13.53	1.31	1.75	0.00	0.44	0.00	0.00
CD14+ monocytes - treated with IFN + N-hexane, donor1	11861-125A7	13.18	1.34	1.08	0.00	0.27	0.00	0.27
CD14+ monocytes - treated with IFN + N-hexane, donor2	11871-125B8	15.00	1.22	1.05	0.00	0.00	0.35	0.70
CD14+ monocytes - treated with IFN + N-hexane, donor3	11881-125C9	15.99	0.84	2.10	0.00	0.00	0.42	1.68
CD14+ monocytes - treated with Salmonella, donor1	11866-125B3	11.02	1.10	2.94	0.00	0.00	0.00	0.55
CD14+ monocytes - treated with Salmonella, donor2	11876-125C4	11.27	0.35	2.11	0.00	0.00	0.00	1.76
CD14+ monocytes - treated with Salmonella, donor3	11886-125D5	17.55	0.44	3.07	0.44	0.00	0.00	0.88
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor1	11862-125A8	9.59	0.87	2.44	0.00	0.00	0.35	0.87
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor2	11872-125B9	8.55	1.86	1.86	0.00	0.00	0.00	1.12
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor3	11882-125D1	21.77	1.94	3.02	0.00	0.00	0.22	1.51
CD14+ monocytes - treated with lipopolysaccharide, donor1	11865-125B2	9.83	1.23	1.64	0.00	0.00	0.00	0.41
CD14+ monocytes - treated with lipopolysaccharide, donor2	11875-125C3	12.98	1.39	1.62	0.23	0.00	0.00	0.70
CD14+ monocytes - treated with lipopolysaccharide, donor3	11885-125D4	19.95	2.09	1.16	0.23	0.00	0.23	0.46
CD14+CD16+ Monocytes, donor1	11789-124B7	30.08	1.74	2.83	0.00	0.00	0.00	1.09
CD14+CD16+ Monocytes, donor2	11801-124D1	29.11	0.46	2.31	0.00	0.00	0.00	0.69
CD14+CD16+ Monocytes, donor3	11912-125G4	29.89	1.08	4.55	0.00	0.00	0.43	0.87
CD14+CD16- Monocytes, donor1	11788-124B6	28.19	0.78	3.74	0.16	0.31	0.00	0.47
CD14+CD16- Monocytes, donor2	11799-124C8	25.85	1.05	1.92	0.00	0.00	0.35	0.87
CD14+CD16- Monocytes, donor3	11910-125G2	25.64	0.67	0.45	0.00	0.00	0.00	0.89
CD14-CD16+ Monocytes, donor1	11790-124B8	28.83	1.79	3.32	0.00	0.00	0.00	0.26
CD14-CD16+ Monocytes, donor2	11800-124C9	29.42	0.88	3.51	0.22	0.00	0.00	0.22
CD14-CD16+ Monocytes, donor3	11911-125G3	22.74	1.26	2.95	0.00	0.00	0.00	0.42
CD19+ B Cells (pluriselect), donor090309, donation1	12189-129B2	50.81	4.06	0.00	0.00	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090309, donation2	12194-129B7	44.75	2.71	2.03	0.00	0.00	0.68	2.71
CD19+ B Cells (pluriselect), donor090309, donation3	12199-129C3	42.46	1.04	1.04	0.00	0.00	1.04	0.00
CD19+ B Cells (pluriselect), donor090325, donation1	12151-128F9	37.31	1.60	3.20	0.00	0.00	0.00	0.53
CD19+ B Cells (pluriselect), donor090325, donation2	12174-128I5	52.53	2.14	2.68	0.00	0.00	0.00	1.61
CD19+ B Cells (pluriselect), donor090612, donation1	12204-129C8	49.14	2.11	4.21	0.00	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090612, donation2	12209-129D4	39.22	3.14	3.14	0.78	0.00	0.00	0.78
CD19+ B Cells (pluriselect), donor090612, donation3	12214-129D9	55.37	0.00	5.27	0.00	0.00	0.00	0.00
CD19+ B Cells, donor1	11544-120B5	17.26	0.00	5.75	0.00	0.00	0.00	2.47
CD19+ B Cells, donor2	11624-122B4	14.51	0.00	6.53	0.00	0.00	0.00	1.45
CD19+ B Cells, donor3	11705-123B4	14.14	0.50	3.53	0.50	0.00	0.50	1.01
CD34 cells differentiated to erythrocyte lineage, biol_ rep1	11931-125I5	130.91	2.83	2.02	0.81	0.40	0.40	0.81
CD34 cells differentiated to erythrocyte lineage, biol_ rep2	11932-125I6	112.26	3.20	2.80	1.20	0.00	0.00	0.00
CD34+ Progenitors, donor1	11545-120B6	22.09	2.01	4.02	0.00	0.00	0.00	1.00
CD34+ Progenitors, donor2	11625-122B5	37.08	2.81	3.37	0.00	0.00	0.56	2.25
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep1	12225-129F2	87.18	10.52	2.63	0.38	0.75	0.38	0.38
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep2	12225-129F2	92.90	7.89	2.03	0.45	0.90	0.45	0.90
CD4+ T Cells, donor1	11225-116C1	39.28	0.71	7.86	0.00	0.00	0.71	0.36
CD4+ T Cells, donor2	11306-117C1	31.23	0.61	11.02	0.00	0.00	0.00	3.06
CD4+ T Cells, donor3	11382-118B5	18.60	0.30	8.54	0.30	0.00	0.00	2.74
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor1	11793-124C2	41.09	1.28	4.85	0.00	0.00	0.00	1.02
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor2	11915-125G7	39.08	1.35	6.29	0.00	0.00	0.22	0.90
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor3	11919-125H2	32.77	0.86	5.46	0.00	0.00	0.00	0.86
CD4+CD25+CD45RA+ naive regulatory T cells, donor1	11780-124A7	47.88	0.47	12.80	0.00	0.00	0.00	1.42
CD4+CD25+CD45RA+ naive regulatory T cells, donor2	11796-124C5	49.86	0.70	18.26	0.00	0.00	0.00	1.40
CD4+CD25+CD45RA+ naive regulatory T cells, donor3	11907-125F8	19.78	0.00	3.30	0.00	0.00	0.00	0.00
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor1	11794-124C3	36.42	2.46	3.03	0.00	0.14	0.14	0.29
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor2	11916-125G8	31.18	1.36	6.78	0.00	0.00	0.00	0.85
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor3	11920-125H3	27.08	1.77	5.32	0.00	0.00	0.00	0.48
CD4+CD25+CD45RA- memory regulatory T cells, donor1	11782-124A9	36.31	2.24	7.62	0.00	0.00	0.00	0.90
CD4+CD25+CD45RA- memory regulatory T cells, donor2	11797-124C6	42.63	0.70	5.94	0.00	0.00	0.00	1.75
CD4+CD25+CD45RA- memory regulatory T cells, donor3	11908-125F9	30.36	2.20	4.84	0.00	0.00	0.88	0.00
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor1	11791-124B9	35.84	1.26	0.42	0.00	0.00	0.00	0.00
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor2	11913-125G5	23.89	1.04	3.12	0.00	0.00	0.00	1.25
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor3	11917-125G9	24.06	2.00	8.02	0.00	0.00	0.00	0.67
CD4+CD25-CD45RA+ naive conventional T cells, donor1	11784-124B2	58.74	1.36	11.15	0.00	0.00	0.00	1.36
CD4+CD25-CD45RA+ naive conventional T cells, donor2	11795-124C4	44.48	0.54	5.36	0.00	0.00	0.00	2.14
CD4+CD25-CD45RA+ naive conventional T cells, donor3	11906-125F7	44.83	0.00	1.79	0.00	0.00	0.00	3.59
CD4+CD25-CD45RA- memory conventional T cells expanded, donor1	11792-124C1	54.52	2.78	3.71	0.00	0.00	0.19	0.56
CD4+CD25-CD45RA- memory conventional T cells expanded, donor2	11914-125G6	40.94	1.73	4.98	0.00	0.00	0.00	0.65
CD4+CD25-CD45RA- memory conventional T cells expanded, donor3	11918-125H1	34.89	2.10	7.36	0.00	0.00	0.21	1.05
CD4+CD25-CD45RA- memory conventional T cells, donor1	11786-124B4	44.49	2.53	10.62	0.00	0.00	0.00	1.52
CD4+CD25-CD45RA- memory conventional T cells, donor2	11798-124C7	50.26	1.30	8.67	0.00	0.00	0.43	2.17
CD4+CD25-CD45RA- memory conventional T cells, donor3	11909-125G1	42.27	0.44	2.61	0.00	0.00	0.00	1.31
CD8+ T Cells (pluriselect), donor090309, donation1	12186-129A8	52.95	2.47	4.95	0.00	0.00	0.49	0.49
CD8+ T Cells (pluriselect), donor090309, donation2	12191-129B4	76.62	0.92	1.85	0.00	0.00	0.00	3.69
CD8+ T Cells (pluriselect), donor090309, donation3	12196-129B9	47.46	4.19	1.40	0.00	0.00	1.40	1.40
CD8+ T Cells (pluriselect), donor090325, donation1	12148-128F6	55.39	1.94	4.15	0.00	0.00	0.00	2.77
CD8+ T Cells (pluriselect), donor090325, donation2	12171-128I2	56.19	1.96	1.96	0.00	0.00	0.00	2.70
CD8+ T Cells (pluriselect), donor090612, donation1	12201-129C5	41.58	1.54	4.62	0.00	0.00	0.00	1.54
CD8+ T Cells (pluriselect), donor090612, donation2	12206-129D1	47.99	1.79	1.43	0.00	0.00	0.00	2.51
CD8+ T Cells (pluriselect), donor090612, donation3	12211-129D6	63.71	1.38	2.77	0.00	0.00	1.38	1.38
CD8+ T Cells, donor1	11226-116C2	33.72	1.64	10.48	0.00	0.00	0.00	0.33
CD8+ T Cells, donor2	11307-117C2	25.90	0.75	11.64	0.00	0.00	0.00	1.13
CD8+ T Cells, donor3	11383-118B6	26.76	1.51	11.36	0.00	0.00	0.50	1.01
COBL-a rinderpest infection, 00hr, biol_rep1	13553-145I7	59.18	1.84	0.92	0.92	0.00	0.00	0.69
COBL-a rinderpest infection, 00hr, biol_rep2	13554-145I8	60.39	0.72	1.68	0.24	0.24	0.00	0.96
COBL-a rinderpest infection, 00hr, biol_rep3	13555-145I9	66.21	1.09	1.64	0.55	0.27	0.00	0.00
COBL-a rinderpest infection, 06hr, biol_rep1	13556-146A1	96.07	1.50	0.90	1.50	0.30	0.00	1.80
COBL-a rinderpest infection, 06hr, biol_rep2	13557-146A2	52.56	0.24	1.92	0.96	0.00	0.00	0.72
COBL-a rinderpest infection, 06hr, biol_rep3	13558-146A3	63.90	0.23	1.36	0.45	0.00	0.00	0.45
COBL-a rinderpest infection, 12hr, biol_rep1	13559-146A4	98.43	0.43	0.87	0.43	0.00	0.00	0.87
COBL-a rinderpest infection, 12hr, biol_rep2	13560-146A5	91.07	0.79	2.37	0.26	0.00	0.26	0.53
COBL-a rinderpest infection, 12hr, biol_rep3	13561-146A6	83.02	1.88	0.70	0.23	0.23	0.00	1.41
COBL-a rinderpest infection, 24hr, biol_rep1	13562-146A7	93.88	2.72	1.51	0.60	0.00	0.30	0.91
COBL-a rinderpest infection, 24hr, biol_rep2	13563-146A8	85.70	3.20	0.58	1.16	0.00	0.00	0.58
COBL-a rinderpest infection, 24hr, biol_rep3	13564-146A9	92.19	2.40	0.27	0.80	0.27	0.00	0.80
COBL-a rinderpest infection, 48hr, biol_rep1	13565-146B1	28.45	0.88	2.63	0.00	0.44	0.00	1.31
COBL-a rinderpest infection, 48hr, biol_rep2	13566-146B2	37.35	0.46	1.82	0.00	0.00	0.00	0.91
COBL-a rinderpest infection, 48hr, biol_rep3	13567-146B3	36.55	2.24	1.49	0.00	0.00	0.00	0.75
COBL-a rinderpest(-C) infection, 06hr, biol_rep1	13568-146B4	59.07	0.36	0.00	0.00	0.00	0.00	1.08
COBL-a rinderpest(-C) infection, 06hr, biol_rep2	13569-146B5	59.56	0.86	1.15	0.58	0.00	0.29	0.29
COBL-a rinderpest(-C) infection, 06hr, biol_rep3	13570-146B6	56.80	0.71	0.94	0.24	0.00	0.00	0.47
COBL-a rinderpest(-C) infection, 12hr, biol_rep1	13571-146B7	108.06	1.58	1.27	0.32	0.32	0.32	1.27
COBL-a rinderpest(-C) infection, 12hr, biol_rep2	13572-146B8	79.04	0.00	0.92	0.92	0.31	0.00	0.92
COBL-a rinderpest(-C) infection, 12hr, biol_rep3	13573-146B9	83.35	0.96	1.28	0.96	0.00	0.00	0.32
COBL-a rinderpest(-C) infection, 24hr, biol_rep1	13574-146C1	81.47	1.53	0.76	0.00	0.00	0.38	0.76
COBL-a rinderpest(-C) infection, 24hr, biol_rep2	13575-146C2	78.03	0.79	0.79	0.79	0.00	0.39	1.18
COBL-a rinderpest(-C) infection, 24hr, biol_rep3	13576-146C3	82.45	3.03	1.51	0.76	0.00	0.00	0.76
COBL-a rinderpest(-C) infection, 48hr, biol_rep1	13577-146C4	26.50	0.00	4.01	0.00	0.00	0.00	1.61
COBL-a rinderpest(-C) infection, 48hr, biol_rep2	13578-146C5	33.57	0.00	1.40	0.00	0.00	0.00	1.40
COBL-a rinderpest(-C) infection, 48hr, biol_rep3	13579-146C6	34.06	0.00	3.01	0.00	0.00	0.00	0.00
Cardiac Myocyte, donor1	11525-119I4	23.76	0.00	0.00	0.00	0.00	0.00	0.00
Cardiac Myocyte, donor2	11605-120I3	67.69	1.48	0.99	0.99	0.49	0.00	1.48
Cardiac Myocyte, donor3	11686-122I3	78.08	3.05	0.00	0.84	0.21	0.11	0.21
Chondrocyte - de diff, donor1	11261-116G1	61.71	0.00	0.35	0.00	0.00	0.00	0.35
Chondrocyte - de diff, donor2	11338-117F6	26.30	1.07	0.00	0.00	0.36	0.00	0.36
Chondrocyte - de diff, donor3	11410-118E6	34.59	1.48	0.23	0.34	0.23	0.11	0.80
Chondrocyte - re diff, donor2	11339-117F7	68.93	2.69	0.00	0.00	0.90	0.00	0.90
Chondrocyte - re diff, donor3	11411-118E7	20.62	1.21	1.62	0.00	0.00	0.40	0.40
Ciliary Epithelial Cells, donor1	11242-116D9	97.20	2.64	0.57	0.46	0.23	0.00	0.46
Ciliary Epithelial Cells, donor2	11323-117D9	71.83	1.07	0.43	0.43	0.43	0.00	2.14
Ciliary Epithelial Cells, donor3	11399-118D4	67.35	2.21	0.44	0.53	0.18	0.00	1.06
Clontech Human Universal Reference Total RNA, pool1	10000-101A1	19.44	4.31	2.93	0.00	0.28	0.83	0.09
Corneal Epithelial Cells, donor1	11526-119I5	17.35	0.22	0.44	0.00	0.00	0.00	0.00
Corneal Epithelial Cells, donor2	11606-120I4	27.30	1.14	1.14	1.14	0.00	0.00	0.00
Corneal Epithelial Cells, donor3	11687-122I4	36.30	0.51	0.00	0.51	0.00	0.00	0.00
Dendritic Cells - monocyte immature derived, donor1, rep2	11227-116C3	12.88	16.84	0.00	0.17	0.33	0.33	0.00
Dendritic Cells - monocyte immature derived, donor1, tech_rep1	11227-116C3	16.09	20.19	0.00	0.00	0.00	0.32	0.32
Dendritic Cells - monocyte immature derived, donor2	11308-117C3	10.35	13.80	0.00	0.00	3.45	0.00	0.00
Dendritic Cells - monocyte immature derived, donor3	11384-118B7	11.12	10.47	0.43	0.00	0.11	0.65	0.32
Dendritic Cells - plasmacytoid, donor1	11228-116C4	28.36	3.76	2.73	0.00	0.00	0.68	0.34
Dendritic Cells - plasmacytoid, donor2	11309-117C4	33.95	2.61	3.92	0.00	0.00	0.65	0.00
Dendritic Cells - plasmacytoid, donor3	11385-118B8	28.07	5.81	7.74	0.00	0.00	0.48	2.42
Endothelial Cells - Aortic, donor0	11207-116A1	64.04	3.17	0.33	0.83	0.17	0.00	0.33
Endothelial Cells - Aortic, donor1	11263-116G3	44.01	1.76	0.59	1.17	0.00	0.00	0.00
Endothelial Cells - Aortic, donor2	11340-117F8	53.17	2.26	0.57	0.85	0.28	0.00	0.00
Endothelial Cells - Aortic, donor3	11412-118E8	38.93	3.93	0.79	0.79	0.00	0.00	0.39
Endothelial Cells - Artery, donor1	11264-116G4	42.47	2.04	0.58	0.58	0.00	0.00	0.00
Endothelial Cells - Artery, donor2	11341-117F9	84.70	1.65	0.24	0.71	0.00	0.47	0.47
Endothelial Cells - Artery, donor3	11413-118E9	51.01	1.75	0.53	0.70	0.53	0.53	0.18
Endothelial Cells - Lymphatic, donor1	11236-116D3	39.23	0.66	0.44	0.00	0.00	0.00	0.00
Endothelial Cells - Lymphatic, donor2	11317-117D3	37.42	2.13	0.00	0.00	0.00	0.30	0.30
Endothelial Cells - Lymphatic, donor3	11393-118C7	28.75	1.69	0.00	0.00	0.00	0.00	0.56
Endothelial Cells - Microvascular, donor1	11265-116G5	45.16	2.38	0.30	0.59	0.30	0.59	0.00
Endothelial Cells - Microvascular, donor2	11342-117G1	54.67	2.08	1.04	0.52	0.00	0.00	0.00
Endothelial Cells - Microvascular, donor3	11414-118F1	14.32	0.57	0.14	0.00	0.14	0.00	0.14
Endothelial Cells - Thoracic, donor1	11266-116G6	136.04	6.40	0.00	0.80	0.00	0.40	1.20
Endothelial Cells - Thoracic, donor2	11343-117G2	31.45	1.05	0.00	0.00	0.00	0.00	0.52
Endothelial Cells - Umbilical vein, donor1	11243-116E1	115.30	3.85	0.37	1.74	0.00	0.37	0.50
Endothelial Cells - Umbilical vein, donor2	11324-117E1	58.44	3.04	0.00	0.65	0.00	0.22	0.43
Endothelial Cells - Umbilical vein, donor3	11400-118D5	73.15	1.83	0.73	0.61	0.37	0.37	0.37
Endothelial Cells - Vein, donor1	11267-116G7	48.91	2.28	2.28	1.14	0.00	0.00	0.00
Endothelial Cells - Vein, donor2	11344-117G3	39.81	1.40	0.00	0.70	0.00	0.00	0.70
Endothelial Cells - Vein, donor3	11416-118F3	47.57	2.36	0.16	0.47	0.47	0.16	0.31
Eosinophils, donor1	12244-129H3	0.00	0.00	0.00	0.00	0.00	0.00	15.25
Eosinophils, donor2	12245-129H4	23.10	3.30	4.95	0.00	0.00	0.00	0.00
Eosinophils, donor3	12246-129H5	17.83	0.00	0.00	0.00	0.00	0.00	0.00
Esophageal Epithelial Cells, donor1	11507-119G4	16.61	0.24	0.24	0.24	0.00	0.00	0.24
Esophageal Epithelial Cells, donor2	11587-120G3	6.24	2.08	0.00	0.00	0.00	0.00	0.00
Esophageal Epithelial Cells, donor3	11668-122G3	65.08	0.00	0.00	0.00	0.00	0.00	0.00
Ewing's sarcoma cell line:Hs 863.T	10705-109H3	36.54	2.87	0.00	0.00	0.41	0.41	0.41
Fibroblast - Aortic Adventitial donor2 (cytoplasmic fraction)	14331-155F2	42.37	0.33	0.22	0.66	0.44	0.11	2.08
Fibroblast - Aortic Adventitial donor3 (cytoplasmic fraction)	14310-155C8	54.49	3.14	0.22	0.22	0.22	0.22	2.38
Fibroblast - Aortic Adventitial, donor1	11245-116E3	113.28	4.61	0.12	0.73	0.73	0.24	0.24
Fibroblast - Aortic Adventitial, donor2 (nuclear fraction)	14332-155F3	91.57	1.50	1.36	1.77	0.27	0.14	0.00
Fibroblast - Aortic Adventitial, donor2	11326-117E3	43.66	1.69	0.32	0.21	0.42	0.00	0.84
Fibroblast - Aortic Adventitial, donor3 (nuclear fraction)	14311-155C9	49.54	0.26	0.00	0.53	0.26	0.00	0.00
Fibroblast - Aortic Adventitial, donor3	11401-118D6	70.76	1.66	0.33	0.33	0.00	0.33	0.00
Fibroblast - Cardiac, donor1	11268-116G8	57.61	1.36	0.45	0.45	0.91	0.45	1.81
Fibroblast - Cardiac, donor2	11345-117G4	40.17	0.00	3.03	0.00	0.00	0.00	0.76
Fibroblast - Cardiac, donor3	11417-118F4	42.90	1.26	0.47	0.47	0.47	0.00	1.58
Fibroblast - Cardiac, donor4	11452-119A3	53.35	1.21	0.00	0.00	0.61	0.30	0.00
Fibroblast - Cardiac, donor5	11456-119A7	72.21	2.03	0.51	0.51	0.13	0.38	1.65
Fibroblast - Cardiac, donor6	11460-119B2	84.59	4.40	0.76	1.21	0.15	0.30	1.82
Fibroblast - Choroid Plexus, donor1	11492-119E7	29.34	0.94	0.27	0.13	0.00	0.00	0.00
Fibroblast - Choroid Plexus, donor2	11572-120E6	37.10	2.59	0.00	0.00	0.00	0.00	0.00
Fibroblast - Choroid Plexus, donor3	11653-122E6	95.21	5.86	0.00	0.00	0.00	0.00	1.46
Fibroblast - Conjunctival, donor1	11531-120A1	35.29	0.69	0.46	0.00	0.00	0.00	0.00
Fibroblast - Conjunctival, donor3	11692-122I9	28.32	2.04	0.00	0.17	0.34	0.17	0.17
Fibroblast - Dermal, donor1	11269-116G9	104.24	0.47	0.23	0.94	0.23	0.00	1.88
Fibroblast - Dermal, donor2	11346-117G5	105.18	2.83	0.94	0.00	0.00	0.47	0.00
Fibroblast - Dermal, donor3	11418-118F5	68.06	1.21	0.73	0.85	0.48	0.24	0.60
Fibroblast - Dermal, donor4	11450-119A1	109.31	2.26	1.02	1.13	0.34	0.23	1.92
Fibroblast - Dermal, donor5	11454-119A5	139.56	1.05	1.05	0.17	0.70	0.00	1.57
Fibroblast - Dermal, donor6	11458-119A9	159.50	2.92	1.30	0.97	0.16	0.16	1.62
Fibroblast - Gingival, donor1	11237-116D4	92.45	1.67	0.83	0.62	0.21	0.00	0.21
Fibroblast - Gingival, donor10 (periodontitis)	11928-125I2	44.54	2.10	0.79	0.26	0.26	0.00	0.26
Fibroblast - Gingival, donor2	11318-117D4	94.09	1.45	0.66	0.40	0.53	0.40	1.05
Fibroblast - Gingival, donor3	11394-118C8	41.29	0.87	0.39	0.00	0.10	0.10	0.58
Fibroblast - Gingival, donor4 (GFH2)	11222-116B7	34.28	1.04	0.00	0.00	0.00	0.00	1.04
Fibroblast - Gingival, donor5 (GFH3)	11303-117B7	22.55	0.88	0.35	0.18	0.18	0.18	0.53
Fibroblast - Gingival, donor6 (aggressive periodontitis)	11921-125H4	75.30	1.87	1.09	0.78	0.31	0.16	0.16
Fibroblast - Gingival, donor6 (control)	11922-125H5	63.15	2.16	0.54	0.68	0.41	0.14	0.68
Fibroblast - Gingival, donor7 (aggressive periodontitis)	11923-125H6	19.41	0.35	0.71	0.00	0.35	0.00	0.00
Fibroblast - Gingival, donor7 (control)	11924-125H7	56.74	2.19	0.88	0.15	0.44	0.15	0.73
Fibroblast - Gingival, donor8 (chronic periodontitis)	11925-125H8	63.95	1.77	0.14	0.27	0.14	0.00	0.14
Fibroblast - Gingival, donor8 (control)	11926-125H9	92.25	1.97	1.10	0.33	0.33	0.11	0.77
Fibroblast - Gingival, donor9 (control)	11927-125I1	22.60	0.88	0.44	0.00	0.00	0.00	0.73
Fibroblast - Lung, donor1	11270-116H1	32.62	1.36	0.00	0.00	0.00	0.00	0.00
Fibroblast - Lung, donor2	11347-117G6	71.62	2.98	0.00	0.00	0.00	0.00	0.00
Fibroblast - Lung, donor3	11419-118F6	60.36	1.90	0.42	0.63	0.21	0.63	0.63
Fibroblast - Lymphatic, donor1	11506-119G3	22.49	0.00	0.00	0.00	0.00	0.00	0.00
Fibroblast - Lymphatic, donor2	11586-120G2	23.78	0.00	0.00	0.00	0.00	0.00	0.00
Fibroblast - Lymphatic, donor3	11667-122G2	5.04	0.00	0.28	0.28	0.00	0.00	0.00
Fibroblast - Mammary, donor1	11540-120B1	38.57	0.81	0.41	0.00	0.00	0.00	0.00
Fibroblast - Mammary, donor2	11620-122A9	23.97	3.99	0.00	0.00	0.00	0.00	0.00
Fibroblast - Mammary, donor3	11701-123A9	17.87	0.00	0.00	0.00	0.00	0.00	0.00
Fibroblast - Periodontal Ligament, donor1	11238-116D5	123.37	3.69	0.58	0.19	0.39	0.78	0.39
Fibroblast - Periodontal Ligament, donor2	11319-117D5	90.25	1.97	1.37	0.30	0.30	0.00	1.52
Fibroblast - Periodontal Ligament, donor3	11395-118C9	103.73	1.22	0.61	0.31	0.61	0.31	0.00
Fibroblast - Periodontal Ligament, donor4 (PL29)	11223-116B8	36.25	1.91	0.76	0.00	0.00	0.00	0.76
Fibroblast - Periodontal Ligament, donor5 (PL30)	11304-117B8	47.25	1.08	0.27	0.27	0.00	0.00	1.62
Fibroblast - Periodontal Ligament, donor6 (PLH3)	11380-118B3	21.92	0.58	0.23	0.00	0.12	0.00	0.58
Fibroblast - Pulmonary Artery, donor1	11250-116E8	151.65	3.09	0.44	2.43	0.11	0.22	0.33
Fibroblast - Villous Mesenchymal, donor1	11535-120A5	30.88	0.20	0.00	0.00	0.00	0.00	0.00
Fibroblast - Villous Mesenchymal, donor2	11615-122A4	22.05	0.00	0.00	0.00	0.00	0.00	0.00
Fibroblast - Villous Mesenchymal, donor3	11696-123A4	49.82	1.19	0.40	0.40	0.40	0.00	1.19
Fibroblast - skin dystrophia myotonica, donor1 (nuclear fraction)	14329-155E9	59.34	1.39	0.40	0.79	0.40	0.00	0.20
Fibroblast - skin dystrophia myotonica, donor1	11556-120C8	37.48	1.42	0.18	0.18	0.18	0.18	0.00
Fibroblast - skin dystrophia myotonica, donor2	11557-120C9	55.97	1.97	0.00	0.20	0.59	0.39	0.59
Fibroblast - skin dystrophia myotonica, donor3 (nuclear fraction)	14308-155C6	80.63	1.50	1.81	0.30	0.00	0.00	0.30
Fibroblast - skin dystrophia myotonica, donor3	11560-120D3	78.59	3.89	0.32	0.43	0.11	0.32	0.97
Fibroblast - skin normal, donor1 (nuclear fraction)	14323-155E3	53.90	0.25	0.76	0.25	0.76	0.00	0.51
Fibroblast - skin normal, donor1	11553-120C5	43.81	2.13	0.33	0.00	0.33	0.49	0.49
Fibroblast - skin normal, donor2 (nuclear fraction)	14302-155B9	95.64	2.01	1.60	0.80	0.40	0.20	0.00
Fibroblast - skin normal, donor2	11561-120D4	76.45	2.61	0.30	0.20	0.10	0.30	0.60
Fibroblast - skin spinal muscular atrophy, donor1 (nuclear fraction)	14326-155E6	81.60	1.81	2.42	0.60	0.30	0.00	0.00
Fibroblast - skin spinal muscular atrophy, donor1	11555-120C7	40.10	2.40	0.66	0.25	0.17	0.17	0.66
Fibroblast - skin spinal muscular atrophy, donor2	11558-120D1	52.99	1.71	0.34	0.17	0.17	0.34	1.37
Fibroblast - skin spinal muscular atrophy, donor3 (nuclear fraction)	14305-155C3	40.40	1.97	1.31	0.66	0.33	0.00	0.33
Fibroblast - skin spinal muscular atrophy, donor3	11559-120D2	91.82	2.13	0.43	0.43	0.64	0.75	0.85
Fibroblast - skin walker warburg, donor1	11554-120C6	76.92	3.04	0.34	0.00	0.34	0.17	0.34
Fibroblast - skin, normal donor1 (cytoplasmic fraction)	14322-155E2	59.12	2.67	0.16	0.16	0.78	0.31	2.51
Fibroblast - skin, normal donor2 (cytoplasmic fraction)	14301-155B8	1019.35	0.00	0.00	22.16	0.00	0.00	0.00
Fingernail (including nail plate, eponychium and hyponychium), donor2	10301-104H4	30.50	2.61	0.00	0.00	1.74	0.00	1.74
Gingival epithelial cells, donor1 (GEA11)	11221-116B6	89.80	2.95	0.69	0.87	0.00	0.17	0.17
Gingival epithelial cells, donor2 (GEA14)	11302-117B6	110.34	2.08	0.52	1.56	0.00	0.00	0.00
Gingival epithelial cells, donor3 (GEA15)	11379-118B2	104.76	3.32	0.00	1.53	0.26	0.26	0.51
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep1	13523-145F4	193.68	6.89	0.77	6.89	3.06	0.00	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep2	13524-145F5	360.51	8.93	1.28	10.21	8.93	0.64	3.19
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep3	13525-145F6	344.31	6.28	1.71	14.55	6.28	0.57	1.71
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep1	13526-145F7	76.66	0.83	5.79	0.00	0.28	0.00	2.48
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep2	13527-145F8	75.58	1.83	6.39	1.14	1.14	0.23	1.14
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep3	13528-145F9	201.89	4.36	1.19	4.16	4.16	0.00	1.78
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep1	13529-145G1	87.23	1.32	5.02	0.79	1.32	0.26	1.59
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep2	13530-145G2	61.97	1.30	10.76	0.00	1.30	1.30	0.65
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep3	13531-145G3	281.25	6.19	1.77	11.94	9.29	0.00	2.65
H9 Embryoid body cells, melanocytic induction, day00, biol_rep1 (H9EB-1 d0)	12627-134E8	185.13	3.67	0.57	2.83	2.54	0.00	0.57
H9 Embryoid body cells, melanocytic induction, day00, biol_rep2 (H9EB-2 d0)	12725-135G7	107.63	3.32	1.60	1.97	2.09	0.12	1.60
H9 Embryoid body cells, melanocytic induction, day00, biol_rep3 (H9EB-3 d0)	12823-136I6	187.50	3.49	0.54	2.69	2.15	0.00	0.27
H9 Embryoid body cells, melanocytic induction, day01, biol_rep1 (H9EB-1 d1)	12628-134E9	89.20	2.85	1.24	0.50	1.61	0.12	0.62
H9 Embryoid body cells, melanocytic induction, day01, biol_rep2 (H9EB-2 d1)	12726-135G8	123.61	3.60	1.11	2.08	1.25	0.28	1.66
H9 Embryoid body cells, melanocytic induction, day01, biol_rep3 (H9EB-3 d1)	12824-136I7	162.64	6.10	0.81	4.07	2.24	0.41	1.02
H9 Embryoid body cells, melanocytic induction, day03, biol_rep1 (H9EB-1 d3)	12629-134F1	70.28	2.97	0.46	0.46	0.68	0.68	0.68
H9 Embryoid body cells, melanocytic induction, day03, biol_rep2 (H9EB-2 d3)	12727-135G9	73.24	3.24	0.50	0.62	1.00	0.12	0.87
H9 Embryoid body cells, melanocytic induction, day03, biol_rep3 (H9EB-3 d3)	12825-136I8	64.48	1.53	1.31	0.22	2.19	0.00	0.22
H9 Embryoid body cells, melanocytic induction, day06, biol_rep1 (H9EB-1 d6)	12630-134F2	67.37	3.25	0.89	0.30	0.30	0.00	2.07
H9 Embryoid body cells, melanocytic induction, day06, biol_rep2 (H9EB-2 d6)	12728-135H1	72.01	1.59	0.95	0.48	0.95	0.00	1.59
H9 Embryoid body cells, melanocytic induction, day06, biol_rep3 (H9EB-3 d6)	12826-136I9	75.29	2.68	1.12	0.45	1.56	0.45	0.45
H9 Embryoid body cells, melanocytic induction, day09, biol_rep1 (H9EB-1 d9)	12631-134F3	62.71	1.41	0.20	0.20	0.40	0.00	0.81
H9 Embryoid body cells, melanocytic induction, day09, biol_rep2 (H9EB-2 d9)	12729-135H2	87.87	4.41	0.51	1.70	0.17	0.34	2.21
H9 Embryoid body cells, melanocytic induction, day09, biol_rep3 (H9EB-3 d9)	12827-137A1	119.09	3.81	0.35	0.89	1.51	0.18	0.62
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	69.51	2.60	0.73	0.21	0.52	0.21	0.31
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	66.43	3.24	0.34	0.17	1.20	0.00	0.17
H9 Embryoid body cells, melanocytic induction, day12, biol_rep2 (H9EB-2 d12)	12730-135H3	58.98	2.21	0.55	0.00	0.44	0.33	0.66
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	97.09	3.91	0.50	0.50	1.08	0.17	0.17
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	91.47	2.65	0.41	0.41	0.61	0.00	0.82
H9 Embryoid body cells, melanocytic induction, day15, biol_rep1 (H9EB-1 d15)	12633-134F5	56.94	1.65	0.21	0.00	0.21	0.21	0.41
H9 Embryoid body cells, melanocytic induction, day15, biol_rep2 (H9EB-2 d15)	12731-135H4	47.50	3.00	0.58	0.00	0.46	0.00	0.46
H9 Embryoid body cells, melanocytic induction, day15, biol_rep3 (H9EB-3 d15)	12829-137A3	72.71	3.67	0.50	0.67	0.50	0.17	0.83
H9 Embryoid body cells, melanocytic induction, day18, biol_rep1 (H9EB-1 d18)	12634-134F6	41.88	0.66	0.22	0.00	1.54	0.00	1.10
H9 Embryoid body cells, melanocytic induction, day18, biol_rep2 (H9EB-2 d18)	12732-135H5	54.61	1.84	0.61	0.25	0.25	0.12	1.48
H9 Embryoid body cells, melanocytic induction, day18, biol_rep3 (H9EB-3 d18)	12830-137A4	69.05	2.27	0.49	0.32	0.32	0.49	1.30
H9 Embryoid body cells, melanocytic induction, day21, biol_rep1 (H9EB-1 d21)	12635-134F7	36.56	1.28	0.00	0.32	0.64	0.00	1.28
H9 Embryoid body cells, melanocytic induction, day21, biol_rep2 (H9EB-2 d21)	12733-135H6	44.53	1.80	0.57	0.19	0.19	0.00	1.04
H9 Embryoid body cells, melanocytic induction, day21, biol_rep3 (H9EB-3 d21)	12831-137A5	58.68	1.58	0.16	0.16	1.27	0.00	0.79
H9 Embryoid body cells, melanocytic induction, day24, biol_rep1 (H9EB-1 d24)	12636-134F8	49.87	3.65	0.00	0.00	0.30	0.30	0.91
H9 Embryoid body cells, melanocytic induction, day24, biol_rep2 (H9EB-2 d24)	12734-135H7	55.82	3.45	1.05	0.42	0.21	0.31	0.84
H9 Embryoid body cells, melanocytic induction, day24, biol_rep3 (H9EB-3 d24)	12832-137A6	46.33	2.42	0.88	0.00	0.22	0.44	1.32
H9 Embryoid body cells, melanocytic induction, day27, biol_rep1 (H9EB-1 d27)	12637-134F9	43.49	2.81	1.12	0.00	0.56	0.00	0.56
H9 Embryoid body cells, melanocytic induction, day27, biol_rep2 (H9EB-2 d27)	12735-135H8	49.44	2.87	0.37	0.46	0.46	0.19	0.37
H9 Embryoid body cells, melanocytic induction, day27, biol_rep3 (H9EB-3 d27)	12833-137A7	80.76	4.55	0.27	1.34	0.27	0.27	1.07
H9 Embryoid body cells, melanocytic induction, day30, biol_rep1 (H9EB-1 d30)	12638-134G1	72.52	3.37	0.31	0.00	0.31	0.31	0.77
H9 Embryoid body cells, melanocytic induction, day30, biol_rep2 (H9EB-2 d30)	12736-135H9	63.21	2.59	0.65	1.17	0.00	0.26	0.91
H9 Embryoid body cells, melanocytic induction, day30, biol_rep3 (H9EB-3 d30)	12834-137A8	48.79	4.34	0.81	0.27	0.81	0.27	0.27
H9 Embryoid body cells, melanocytic induction, day34, biol_rep1 (H9EB-1 d34)	12639-134G2	47.75	2.40	0.18	0.00	0.18	0.18	0.74
H9 Embryoid body cells, melanocytic induction, day34, biol_rep2 (H9EB-2 d34)	12737-135I1	36.41	2.41	0.44	0.22	0.44	0.00	0.44
H9 Embryoid body cells, melanocytic induction, day34, biol_rep3 (H9EB-3 d34)	12835-137A9	24.79	3.97	0.99	0.00	0.00	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day41, biol_rep1 (H9EB-1 d41)	12640-134G3	40.50	2.11	0.26	0.13	0.00	0.13	0.40
H9 Embryoid body cells, melanocytic induction, day41, biol_rep2 (H9EB-2 d41)	12738-135I2	31.47	1.01	0.40	0.20	0.00	0.40	0.81
H9 Embryoid body cells, melanocytic induction, day41, biol_rep3 (H9EB-3 d41)	12836-137B1	18.55	2.03	0.00	0.00	0.00	0.25	0.00
H9 Embryonic Stem cells, biol_rep1 (H9ES-1)	12626-134E7	312.92	5.57	1.00	6.37	7.56	0.40	2.79
H9 Embryonic Stem cells, biol_rep2 (H9ES-2)	12724-135G6	173.80	3.70	1.23	2.16	1.85	0.31	1.54
H9 Embryonic Stem cells, biol_rep3 (H9ES-3)	12822-136I5	208.47	5.52	0.82	2.45	3.89	0.41	1.64
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep1 (UH-1)	13364-143F7	246.59	5.63	1.25	5.95	3.13	0.63	0.31
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep2 (UH-2)	13365-143F8	256.84	6.22	0.85	8.19	4.52	0.00	1.13
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep3 (UH-3)	13366-143F9	187.71	6.46	0.92	6.92	6.46	0.00	1.38
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep1	13328-143B7	227.68	4.95	4.95	7.42	2.47	0.00	7.42
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep2	13340-143D1	302.10	3.87	1.93	7.35	3.48	0.00	1.55
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep3	13352-143E4	223.02	6.42	3.21	8.02	6.42	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep1	13329-143B8	172.14	5.22	1.74	1.74	0.00	0.00	3.48
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep2	13341-143D2	207.33	3.25	1.95	4.88	4.88	0.33	4.23
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep3	13353-143E5	226.49	3.71	1.65	7.00	6.18	0.00	4.12
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep1	13330-143B9	159.95	0.00	0.00	3.33	3.33	0.00	3.33
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep2	13342-143D3	170.86	2.80	0.84	1.40	4.19	0.00	2.52
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep3	13354-143E6	173.55	4.58	1.63	2.61	2.29	0.00	2.94
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep1	13331-143C1	102.34	4.19	1.68	0.84	1.68	0.00	5.03
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep2	13343-143D4	155.54	5.09	0.95	0.64	0.95	0.00	0.64
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep3	13355-143E7	146.05	3.74	1.70	2.72	3.74	0.34	2.72
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep1	13332-143C2	200.46	4.18	2.09	2.09	2.09	2.09	4.18
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep2	13344-143D5	136.88	7.45	1.15	1.15	1.72	0.00	4.01
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep3	13356-143E8	89.98	4.14	1.48	1.78	0.59	0.89	2.37
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep1	13333-143C3	144.00	3.39	1.69	1.69	0.00	0.00	6.78
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep2	13345-143D6	167.75	7.87	2.07	2.49	2.07	0.00	5.80
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep3	13357-143E9	159.71	3.68	2.07	0.92	1.84	0.23	2.76
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep1	13334-143C4	115.91	0.00	0.00	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep2	13346-143D7	111.10	4.61	1.54	0.00	0.00	0.38	3.84
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep3	13358-143F1	103.98	3.59	1.63	1.96	0.98	0.33	1.63
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep1	13335-143C5	92.30	2.01	2.01	0.67	2.68	0.67	4.68
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep2	13347-143D8	102.10	3.47	1.54	0.77	3.47	0.77	5.01
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep3	13359-143F2	118.45	1.71	2.40	1.71	2.05	0.68	3.42
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep1	13336-143C6	69.57	2.48	12.42	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep2	13348-143D9	71.25	3.30	0.94	0.00	2.83	0.00	3.30
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep3	13360-143F3	53.71	4.22	0.60	0.00	1.21	0.60	5.43
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep1	13337-143C7	72.74	3.05	2.54	0.51	4.07	0.00	4.07
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep2	13349-143E1	89.34	3.19	2.79	0.40	3.19	0.00	3.59
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep3	13361-143F4	87.32	2.96	0.49	0.00	0.00	0.00	3.45
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep1	13338-143C8	84.99	4.72	1.18	0.00	1.18	1.18	3.54
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep2	13350-143E2	75.85	7.00	1.75	0.58	2.92	0.00	2.92
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep3	13362-143F5	61.88	2.63	3.07	0.00	2.19	0.00	3.51
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep1	13339-143C9	66.97	5.93	3.39	0.00	1.70	0.85	4.24
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep2	13351-143E3	70.44	2.98	2.39	0.00	1.19	0.00	1.79
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep3	13363-143F6	94.62	4.37	0.00	1.94	1.46	0.00	2.91
Hair Follicle Dermal Papilla Cells, donor1	11271-116H2	35.38	1.14	1.14	0.00	0.00	0.00	0.00
Hair Follicle Dermal Papilla Cells, donor2	11348-117G7	30.77	0.83	0.00	0.42	0.42	0.00	0.42
Hair Follicle Dermal Papilla Cells, donor3	11420-118F7	44.98	2.25	1.12	0.00	0.00	0.00	2.25
Hair Follicle Outer Root Sheath Cells, donor1	11504-119G1	35.20	2.85	0.32	0.00	0.00	0.32	0.95
Hair Follicle Outer Root Sheath Cells, donor2	11584-120F9	43.86	0.84	0.00	0.84	0.42	0.42	4.60
Hep-2 cells mock treated, biol_rep1	11898-125E8	122.42	1.86	0.46	1.86	0.58	0.00	0.46
Hep-2 cells mock treated, biol_rep2	11899-125E9	108.03	0.84	0.84	1.18	0.68	0.17	1.01
Hep-2 cells mock treated, biol_rep3	11900-125F1	106.70	0.68	0.00	0.91	0.46	0.23	0.46
Hep-2 cells treated with Streptococci strain 5448, biol_rep1	11890-125D9	124.07	0.98	0.44	0.98	0.66	0.11	0.66
Hep-2 cells treated with Streptococci strain 5448, biol_rep2	11891-125E1	109.18	0.86	0.21	1.93	0.21	0.00	0.43
Hep-2 cells treated with Streptococci strain 5448, biol_rep3	11892-125E2	99.89	1.72	1.29	1.08	0.86	0.22	1.08
Hep-2 cells treated with Streptococci strain JRS4, biol_rep1	11894-125E4	106.23	1.00	1.00	0.87	1.12	0.12	0.62
Hep-2 cells treated with Streptococci strain JRS4, biol_rep2	11895-125E5	94.70	0.86	0.69	1.20	0.51	0.34	0.69
Hep-2 cells treated with Streptococci strain JRS4, biol_rep3	11896-125E6	86.50	0.96	0.32	0.64	0.64	0.00	0.96
Hepatic Sinusoidal Endothelial Cells, donor1	11521-119H9	11.75	0.56	0.56	0.00	0.00	0.00	0.00
Hepatic Sinusoidal Endothelial Cells, donor2	11601-120H8	9.52	0.00	0.87	0.00	0.00	0.00	0.00
Hepatic Sinusoidal Endothelial Cells, donor3	11682-122H8	74.03	5.29	0.00	0.00	0.00	0.00	0.00
Hepatic Stellate Cells (lipocyte), donor1	11524-119I3	21.52	1.41	0.71	0.00	0.00	0.35	0.35
Hepatic Stellate Cells (lipocyte), donor2	11604-120I2	13.80	0.00	0.73	0.00	0.00	0.00	0.73
Hepatic Stellate Cells (lipocyte), donor3	11685-122I2	108.40	6.12	0.35	1.05	0.52	0.00	1.40
Hepatocyte, donor1	11523-119I2	36.32	0.00	1.21	0.00	0.00	0.00	1.21
Hepatocyte, donor2	11603-120I1	29.09	1.08	0.00	1.08	0.00	0.00	0.00
Hepatocyte, donor3	11684-122I1	28.84	0.00	0.61	0.00	0.00	0.00	0.61
Hodgkin's lymphoma cell line:HD-Mar2	10435-106E3	109.65	7.18	3.26	2.61	0.00	0.00	2.61
Intestinal epithelial cells (polarized), donor1	11246-116E4	75.68	0.52	1.22	1.22	0.00	0.17	0.35
Iris Pigment Epithelial Cells, donor1	11530-119I9	111.14	1.37	0.41	0.55	0.82	0.00	0.27
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep1	13079-140B1	76.41	3.18	6.37	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep2	13145-140I4	80.10	6.68	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep3	13211-141G7	54.17	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep1	13080-140B2	51.22	4.15	8.31	0.00	1.38	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep2	13146-140I5	47.55	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep3	13212-141G8	166.16	11.87	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep1	13081-140B3	41.01	0.00	5.13	2.56	0.00	2.56	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep2	13147-140I6	36.57	0.00	13.71	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep3	13213-141G9	73.09	3.25	9.75	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep1	13082-140B4	71.69	3.33	1.67	1.67	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep2	13148-140I7	54.46	0.00	3.63	0.00	0.00	3.63	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep3	13214-141H1	42.35	2.65	13.23	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep1	13083-140B5	88.69	1.11	5.54	2.22	1.11	1.11	1.11
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep2	13149-140I8	47.14	0.00	5.24	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep3	13215-141H2	83.14	3.78	2.52	1.26	0.63	0.00	0.63
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep1	13084-140B6	69.60	1.55	10.83	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep2	13150-140I9	14.63	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep3	13216-141H3	67.19	2.58	4.52	0.65	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep1	13085-140B7	70.84	3.22	6.44	1.61	1.61	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep2	13151-141A1	47.79	0.00	23.90	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep3	13217-141H4	65.19	1.63	6.52	0.81	0.81	1.63	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep1	13086-140B8	65.49	2.94	3.36	1.68	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep2	13152-141A2	28.74	0.00	14.37	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep3	13218-141H5	70.72	1.61	5.63	0.80	0.00	0.80	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep1	13087-140B9	65.55	0.92	5.54	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep2	13153-141A3	30.16	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep3	13219-141H6	116.59	1.89	3.30	1.42	0.94	0.00	0.47
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep1	13088-140C1	71.65	9.07	4.53	1.81	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep2	13154-141A4	0.00	0.00	29.48	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep3	13220-141H7	66.72	2.15	6.46	1.08	0.00	0.00	1.08
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep1	13089-140C2	54.63	2.54	6.35	1.27	0.00	0.00	1.27
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep2	13155-141A5	49.29	0.00	16.43	0.00	0.00	0.00	16.43
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep3	13221-141H8	53.57	1.91	7.65	0.64	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep1	13090-140C3	67.44	0.00	9.11	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep2	13156-141A6	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep3	13222-141H9	56.41	0.71	2.86	0.71	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep1	13091-140C4	43.14	0.00	13.27	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep2	13157-141A7	0.00	0.00	41.70	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep3	13223-141I1	94.76	3.40	4.94	1.54	0.00	0.62	0.93
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep1	13092-140C5	52.68	0.00	3.51	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep2	13158-141A8	47.15	0.00	3.14	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep3	13224-141I2	58.41	2.78	6.95	0.70	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep1	13093-140C6	33.20	0.00	8.85	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep2	13159-141A9	68.08	3.24	3.24	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep3	13225-141I3	34.01	0.87	4.36	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep1	13094-140C7	29.25	0.00	2.25	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep2	13160-141B1	13.94	0.00	6.97	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep3	13226-141I4	36.27	4.27	3.20	2.13	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep1	13095-140C8	59.57	0.00	4.16	1.39	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep2	13161-141B2	34.20	0.00	0.00	0.00	2.85	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep3	13227-141I5	50.62	1.84	10.12	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep1	13096-140C9	27.23	0.00	3.03	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep2	13162-141B3	12.42	0.00	6.21	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep3	13228-141I6	22.20	0.00	5.29	0.00	0.00	0.00	1.06
Keratinocyte - epidermal, donor1	11272-116H3	107.47	1.06	0.08	2.45	0.16	0.16	0.33
Keratinocyte - epidermal, donor2	11349-117G8	38.07	1.17	0.00	0.00	0.00	0.00	0.00
Keratinocyte - epidermal, donor3	11421-118F8	103.55	3.12	0.19	0.47	0.19	0.38	0.38
Keratinocyte - oral, donor1	11251-116E9	117.38	3.52	0.34	0.45	0.11	0.11	0.45
Keratocytes, donor1	11527-119I6	44.70	1.38	0.34	0.00	0.00	0.00	0.00
Keratocytes, donor2	11607-120I5	23.44	0.00	2.34	0.00	0.00	0.00	0.00
Keratocytes, donor3	11688-122I5	35.17	0.99	0.59	0.20	0.40	0.00	0.40
Krukenberg tumor cell line:HSKTC	10687-109F3	26.37	0.00	2.20	0.00	0.00	0.00	0.00
Lens Epithelial Cells, donor1	11529-119I8	76.59	1.08	1.08	2.16	1.08	1.08	1.08
Lens Epithelial Cells, donor2	11609-120I7	47.40	1.73	0.23	0.00	0.12	0.00	0.35
Lens Epithelial Cells, donor3	11690-122I7	67.31	1.01	0.00	0.91	0.71	0.00	0.10
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep1 (MM XIX - 1)	12260-130A1	51.70	2.25	0.00	0.12	0.12	0.12	0.24
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep2 (MM XIV - 1)	12382-131E6	35.72	1.95	0.00	0.28	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep3 (MM XXII - 1 )	12504-133A2	42.97	4.25	0.63	0.31	0.16	0.16	0.79
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep1 (MM XIX - 2)	12261-130A2	40.33	1.08	0.54	0.00	0.54	0.00	1.08
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep2 (MM XIV - 2)	12383-131E7	27.73	1.89	0.32	0.63	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep3 (MM XXII - 2)	12505-133A3	35.58	2.16	0.00	0.00	0.00	0.22	0.43
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep1 (MM XIX - 3)	12262-130A3	41.04	1.64	0.41	0.00	0.00	0.00	0.82
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep2 (MM XIV - 3)	12384-131E8	27.81	2.02	0.76	0.25	0.00	0.25	0.76
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep3 (MM XXII - 3)	12506-133A4	34.77	1.97	0.28	0.14	0.14	0.42	0.28
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep1 (MM XIX - 4)	12263-130A4	43.51	1.19	0.00	0.40	0.00	0.00	0.79
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep2 (MM XIV - 4)	12385-131E9	38.97	1.74	0.00	0.00	0.19	0.19	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep3 (MM XXII - 4)	12507-133A5	21.66	1.48	0.56	0.00	0.00	0.00	0.74
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep1 (MM XIX - 5)	12264-130A5	35.89	1.05	0.00	0.70	0.00	0.70	0.70
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep2 (MM XIV - 5)	12386-131F1	33.39	0.95	0.72	0.48	0.24	0.00	0.24
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep3 (MM XXII - 5)	12508-133A6	32.83	1.79	0.14	0.00	0.41	0.14	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep1 (MM XIX - 6)	12265-130A6	38.80	1.23	0.00	0.31	0.00	0.00	0.31
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep2 (MM XIV - 6)	12387-131F2	24.94	1.25	0.00	0.00	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep3 (MM XXII - 6)	12509-133A7	32.21	1.28	0.37	0.37	0.00	0.18	0.37
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep1 (MM XIX - 7)	12266-130A7	38.51	1.32	1.32	0.33	0.00	0.33	0.33
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep2 (MM XIV - 7)	12388-131F3	29.87	0.29	0.29	0.88	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep3 (MM XXII - 7)	12510-133A8	32.86	2.24	0.00	0.50	0.00	0.25	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep1 (MM XIX - 8)	12267-130A8	41.22	2.91	0.00	0.00	0.00	0.00	0.48
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep2 (MM XIV - 8)	12389-131F4	32.32	1.62	0.81	0.00	0.54	0.00	0.54
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep3 (MM XXII - 8)	12511-133A9	31.03	1.97	0.61	0.15	0.15	0.30	0.76
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep1 (MM XIX - 9)	12268-130A9	36.29	0.52	1.04	0.00	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep2 (MM XIV - 9)	12390-131F5	32.46	1.26	1.05	0.21	0.00	0.21	0.84
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep3 (MM XXII - 9)	12512-133B1	27.52	2.26	0.00	0.15	0.15	0.15	0.30
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep1 (MM XIX - 10)	12269-130B1	35.77	4.13	1.38	0.00	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep2 (MM XIV - 10)	12391-131F6	30.67	1.13	0.38	0.00	0.00	0.00	0.38
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep3 (MM XXII - 10)	12513-133B2	30.22	2.54	0.11	0.00	0.00	0.00	0.21
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep1 (MM XIX - 11)	12270-130B2	35.86	0.97	0.97	0.00	0.00	0.00	0.48
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep2 (MM XIV - 11)	12392-131F7	27.79	0.66	0.99	0.00	0.00	0.00	0.66
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep3 (MM XXII - 11)	12514-133B3	30.23	2.97	0.25	0.25	0.12	0.12	0.50
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep1 (MM XIX - 12)	12271-130B3	45.17	2.59	0.74	0.37	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep2 (MM XIV - 12)	12393-131F8	28.66	0.49	0.49	0.25	0.25	0.00	0.25
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep3 (MM XXII - 12)	12515-133B4	28.87	2.34	0.27	0.14	0.00	0.27	0.69
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep1 (MM XIX - 13)	12272-130B4	33.45	1.61	0.96	0.00	0.00	0.00	0.64
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep2 (MM XIV - 13)	12394-131F9	39.56	1.83	0.61	0.00	0.00	0.00	0.61
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep3 (MM XXII - 13)	12516-133B5	34.29	2.94	0.28	0.14	0.28	0.28	0.42
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep1 (MM XIX - 14)	12273-130B5	39.11	1.42	0.00	0.00	0.00	0.00	0.36
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep2 (MM XIV - 14)	12395-131G1	24.24	1.45	0.97	0.48	0.48	0.00	0.97
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep3 (MM XXII - 14)	12517-133B6	24.90	2.33	0.16	0.00	0.16	0.16	0.47
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep1 (MM XIX - 15)	12274-130B6	40.11	1.79	0.36	0.00	0.00	0.00	0.36
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep2 (MM XIV - 15)	12396-131G2	22.87	1.31	0.98	0.33	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep3 (MM XXII - 15)	12518-133B7	28.25	2.59	0.00	0.00	0.00	0.47	0.00
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep1 (MM XIX - 16)	12275-130B7	56.43	2.23	0.25	0.37	0.25	0.25	0.37
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep2 (MM XIV - 16)	12397-131G3	21.51	0.51	0.51	0.26	0.26	0.00	0.26
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep3 (MM XXII - 16)	12519-133B8	26.85	3.28	0.00	0.30	0.00	0.00	0.60
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep1	13031-139E7	38.52	0.00	4.53	0.00	0.00	2.27	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep2	13097-140D1	32.99	3.07	4.60	0.77	0.77	0.00	0.77
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep3	13163-141B4	40.82	0.74	4.45	0.00	0.74	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep1	13032-139E8	38.50	0.42	4.65	0.00	0.85	0.00	0.42
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep2	13098-140D2	35.17	0.70	0.70	1.41	0.00	0.00	1.41
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep3	13164-141B5	24.28	0.00	3.74	0.00	0.93	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep1	13033-139E9	41.22	1.03	4.64	1.03	0.52	0.00	1.55
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep2	13099-140D3	39.25	2.38	2.38	1.19	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep3	13165-141B6	47.27	2.04	2.94	0.45	0.00	0.45	0.23
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep1	13034-139F1	48.86	0.29	2.33	0.87	0.00	0.00	1.74
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep2	13100-140D4	58.97	0.90	4.95	0.45	0.00	0.00	0.90
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep3	13166-141B7	49.99	1.90	4.20	0.27	0.27	0.00	0.68
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep1	13035-139F2	36.97	1.54	4.11	1.03	0.51	0.00	0.51
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep2	13101-140D5	45.52	1.76	2.12	0.71	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep3	13167-141B8	41.98	0.00	1.33	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep1	13036-139F3	43.30	1.53	6.62	0.00	0.00	0.00	0.51
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep2	13102-140D6	59.50	1.60	3.20	0.27	0.80	0.00	0.53
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep3	13168-141B9	56.12	0.94	3.40	0.19	0.38	0.19	1.89
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep1	13037-139F4	47.24	0.61	7.98	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep2	13103-140D7	37.51	0.82	3.26	1.63	0.00	0.00	0.82
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep3	13169-141C1	52.06	1.04	3.33	0.21	0.21	0.42	1.46
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep1	13038-139F5	54.93	0.56	4.20	0.56	0.00	0.28	2.24
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep2	13104-140D8	46.37	5.15	4.12	0.00	0.00	0.00	1.03
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep3	13170-141C2	53.42	0.87	4.06	0.58	0.29	0.29	1.16
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep1	13039-139F6	57.99	1.79	2.39	0.30	0.00	0.00	0.30
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep2	13105-140D9	51.45	1.66	3.87	0.00	0.00	0.00	0.55
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep3	13171-141C3	38.88	1.41	6.72	0.00	0.35	0.00	0.71
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep1	13040-139F7	42.41	1.11	4.43	0.00	0.00	0.00	1.11
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep2	13106-140E1	40.29	1.15	6.91	0.00	1.15	0.00	1.15
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep3	13172-141C4	50.66	1.92	4.99	1.15	0.00	0.38	0.77
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep1	13041-139F8	49.25	2.83	6.23	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep2	13107-140E2	45.13	4.10	3.28	0.00	0.00	0.00	0.82
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep3	13173-141C5	40.22	0.00	5.42	0.45	0.00	0.45	0.90
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep1	13042-139F9	29.44	2.87	2.15	0.00	0.72	0.00	0.72
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep2	13108-140E3	53.78	2.99	3.73	0.75	0.00	0.00	0.75
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep3	13174-141C6	38.65	1.11	4.46	0.74	0.37	0.00	0.74
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep1	13043-139G1	49.97	1.72	8.18	0.43	0.43	0.00	0.43
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep2	13109-140E4	42.81	0.00	9.42	0.86	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep3	13175-141C7	48.31	2.00	7.00	0.67	0.00	0.00	1.67
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep1	13044-139G2	42.23	1.21	6.03	0.00	0.00	0.60	0.00
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep2	13110-140E5	34.84	2.13	4.98	0.71	0.00	0.00	0.71
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep3	13176-141C8	43.65	0.69	4.47	1.03	0.34	0.00	1.37
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep1	13045-139G3	44.55	0.54	5.37	0.54	0.00	0.00	2.15
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep2	13111-140E6	50.50	1.35	5.39	0.67	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep3	13177-141C9	53.71	1.48	3.70	0.00	1.11	0.00	1.11
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep1	13046-139G4	43.03	1.16	2.33	0.00	1.16	1.16	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep2	13112-140E7	37.02	2.12	7.40	2.12	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep3	13178-141D1	37.61	0.80	6.00	0.00	0.80	0.00	0.80
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep1	13048-139G6	37.80	1.45	8.72	0.00	0.73	0.00	0.73
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep2	13114-140E9	40.63	2.30	6.90	0.00	0.77	0.00	1.53
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep3	13180-141D3	44.89	1.97	4.44	0.99	0.49	0.99	0.99
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep1	13049-139G7	32.93	0.00	7.53	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep2	13115-140F1	35.20	1.51	7.54	0.50	0.00	0.00	0.50
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep3	13181-141D4	37.40	0.90	4.96	0.00	0.00	0.45	0.45
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep1	13050-139G8	34.42	0.00	1.72	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep2	13116-140F2	42.31	1.34	9.35	0.89	0.00	0.45	0.89
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep3	13182-141D5	45.36	1.96	5.87	0.39	0.00	0.39	0.39
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep1	13051-139G9	36.95	0.66	3.96	1.32	0.00	0.00	0.66
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep2	13117-140F3	43.59	2.08	7.78	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep3	13183-141D6	41.57	0.88	7.44	0.88	1.31	0.00	0.88
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep1	13052-139H1	51.44	0.00	5.59	0.00	0.56	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep2	13118-140F4	41.96	3.53	6.18	0.00	0.00	0.00	0.88
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep3	13184-141D7	50.53	1.93	3.47	1.16	0.39	0.39	0.77
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep1	13053-139H2	41.52	1.01	5.06	0.51	0.00	0.51	1.01
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep2	13119-140F5	41.33	1.44	6.73	0.00	0.00	0.48	0.00
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep3	13185-141D8	52.87	1.59	8.75	0.80	0.00	0.40	1.19
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep1	13054-139H3	48.00	1.82	6.08	0.61	0.61	0.00	0.61
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep2	13120-140F6	43.58	2.77	4.84	0.00	0.00	0.00	1.38
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep3	13186-141D9	50.16	1.90	4.56	0.00	0.76	0.38	0.38
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep1	13055-139H4	45.44	0.52	11.36	0.00	0.52	0.00	2.58
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep2	13121-140F7	35.07	2.42	7.86	0.00	0.00	0.00	1.21
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep3	13187-141E1	46.90	1.58	4.75	0.00	0.00	0.00	0.63
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep1	13056-139H5	34.65	1.60	6.40	0.00	0.00	0.00	0.53
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep2	13122-140F8	33.91	1.72	6.90	0.57	0.57	0.00	0.00
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep3	13188-141E2	47.82	0.51	6.17	0.51	0.00	0.00	0.51
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep1	13057-139H6	35.37	3.54	7.07	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep2	13123-140F9	41.43	0.57	6.24	0.57	0.00	0.00	2.27
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep3	13189-141E3	34.53	1.66	9.57	0.83	0.00	0.00	1.25
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep1	13058-139H7	47.77	0.78	6.26	0.78	0.00	0.00	0.78
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep2	13124-140G1	42.17	1.25	7.52	0.42	0.00	0.42	0.84
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep3	13190-141E4	50.18	1.86	6.50	0.46	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep1	13059-139H8	40.81	0.00	10.04	0.00	0.00	0.00	0.67
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep2	13125-140G2	54.00	1.60	6.95	0.53	0.00	0.00	0.53
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep3	13191-141E5	48.90	1.62	9.29	0.81	1.21	0.00	0.40
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep1	13060-139H9	31.20	0.92	5.51	0.92	0.00	0.00	1.84
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep2	13126-140G3	49.79	1.78	8.00	0.00	0.89	0.00	1.78
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep3	13192-141E6	45.59	0.00	6.84	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep1	13061-139I1	39.88	2.30	9.20	0.00	0.77	0.00	0.00
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep2	13127-140G4	61.83	2.19	6.57	0.55	0.55	0.00	2.19
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep3	13193-141E7	47.22	2.23	9.35	0.45	0.45	0.45	0.45
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep1	13062-139I2	67.33	1.82	4.94	0.52	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep2	13128-140G5	51.06	2.65	5.97	0.66	0.00	0.00	0.66
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep3	13194-141E8	31.18	6.24	12.47	0.00	2.08	0.00	0.00
Macrophage - monocyte derived, donor1	11232-116C8	22.11	4.79	0.23	0.00	0.00	0.00	0.00
Macrophage - monocyte derived, donor2	11313-117C8	22.20	11.56	0.00	0.00	0.18	0.18	0.73
Macrophage - monocyte derived, donor3	11389-118C3	18.48	6.03	0.52	0.13	0.13	0.00	0.52
Mallassez-derived cells, donor1 (MZH3)	12142-128E9	127.98	2.66	0.00	4.78	0.53	0.53	0.53
Mallassez-derived cells, donor2	11929-125I3	94.28	3.33	0.16	0.79	0.16	0.00	0.32
Mallassez-derived cells, donor3	11930-125I4	167.06	2.64	0.56	1.53	0.28	0.42	0.83
Mammary Epithelial Cell, donor1	11273-116H4	109.31	4.19	0.10	1.20	0.80	0.20	0.40
Mammary Epithelial Cell, donor2	11350-117G9	144.20	3.76	0.29	1.74	0.87	0.00	0.58
Mammary Epithelial Cell, donor3	11422-118F9	44.90	0.75	1.00	0.25	0.00	0.00	0.00
Mast cell - stimulated, donor1	11487-119E2	75.93	16.95	0.68	0.00	0.00	0.68	0.00
Mast cell, donor1	11563-120D6	29.74	4.54	1.08	0.00	0.11	0.11	0.11
Mast cell, donor2	11565-120D8	30.91	1.78	1.78	0.00	0.00	0.00	1.78
Mast cell, donor3	11566-120D9	32.42	1.58	3.83	0.00	0.23	0.23	0.45
Mast cell, donor4	11567-120E1	25.00	1.77	2.84	0.18	0.00	0.18	1.06
Mast cell, expanded and stimulated, donor5	11940-126A5	49.90	4.32	0.78	0.00	0.11	0.11	0.55
Mast cell, expanded and stimulated, donor8	11942-126A7	37.94	16.34	0.58	0.00	0.58	0.00	0.58
Mast cell, expanded, donor5	11939-126A4	33.73	2.98	1.15	0.00	0.00	0.11	0.69
Mast cell, expanded, donor8	11941-126A6	25.61	2.68	1.00	0.00	0.00	0.00	0.84
Melanocyte - dark, donor1	11502-119F8	52.04	3.18	0.40	0.10	0.20	0.20	0.10
Melanocyte - dark, donor2	11582-120F7	58.49	3.46	0.00	1.04	0.00	0.00	0.69
Melanocyte - dark, donor3	11663-122F7	81.21	9.42	0.80	0.58	0.43	0.58	0.00
Melanocyte - light, donor1	11274-116H5	15.75	0.94	0.00	0.00	0.00	0.47	0.24
Melanocyte - light, donor2	11351-117H1	10.92	4.09	0.68	0.00	0.00	0.00	0.68
Melanocyte - light, donor3	11423-118G1	14.74	0.00	3.47	0.00	0.00	0.00	0.87
Melanocyte, donor1 (MC+1)	12641-134G4	82.99	2.39	0.31	0.83	0.21	0.21	1.25
Melanocyte, donor2 (MC+2)	12739-135I3	55.94	3.50	0.27	0.00	0.00	0.27	0.00
Melanocyte, donor3 (MC+3)	12837-137B2	40.18	2.41	0.27	0.27	0.27	0.00	0.27
Meningeal Cells, donor1	11493-119E8	68.85	1.36	0.62	0.37	0.00	0.00	0.37
Meningeal Cells, donor2	11573-120E7	56.34	0.88	0.44	0.88	0.00	0.00	0.00
Meningeal Cells, donor3	11654-122E7	174.74	3.26	0.33	1.96	0.57	0.33	0.16
Mesenchymal Stem Cells - Vertebral, donor1	11219-116B4	125.47	5.13	0.57	0.29	0.00	0.57	1.43
Mesenchymal Stem Cells - Wharton's Jelly, donor1	11548-120B9	59.17	2.42	0.30	0.50	0.10	0.20	0.10
Mesenchymal Stem Cells - adipose, donor1	11537-120A7	5.26	0.00	0.00	0.00	0.00	0.00	0.00
Mesenchymal Stem Cells - adipose, donor2	11617-122A6	23.55	1.31	1.31	1.31	0.00	0.00	0.00
Mesenchymal Stem Cells - adipose, donor3	11698-123A6	119.12	0.72	0.00	1.44	0.00	0.00	0.72
Mesenchymal Stem Cells - amniotic membrane, donor1	11547-120B8	35.79	1.06	0.00	0.00	0.00	0.21	0.42
Mesenchymal Stem Cells - amniotic membrane, donor2	11627-122B7	42.72	1.51	0.00	0.00	0.00	1.01	0.50
Mesenchymal Stem Cells - bone marrow, donor1	11536-120A6	44.17	1.32	0.44	0.22	0.00	0.00	0.22
Mesenchymal Stem Cells - bone marrow, donor2	11616-122A5	38.72	0.73	0.73	0.73	0.00	0.00	1.46
Mesenchymal Stem Cells - bone marrow, donor3	11697-123A5	34.58	0.61	0.41	0.61	0.00	0.00	0.00
Mesenchymal Stem Cells - bone marrow, donor4	11464-119B6	64.54	2.77	0.00	0.14	0.00	0.14	1.52
Mesenchymal Stem Cells - hepatic, donor1	11538-120A8	14.87	0.37	0.37	0.00	0.00	0.00	0.00
Mesenchymal Stem Cells - hepatic, donor2	11618-122A7	47.89	2.50	0.26	0.26	0.13	0.00	0.39
Mesenchymal Stem Cells - umbilical, donor1	11539-120A9	13.06	0.30	0.00	0.00	0.30	0.00	0.00
Mesenchymal Stem Cells - umbilical, donor2	11619-122A8	0.00	0.00	2.34	0.00	0.00	0.00	0.00
Mesenchymal Stem Cells - umbilical, donor3	11700-123A8	35.86	0.64	0.64	0.00	0.00	0.00	0.64
Mesenchymal stem cells - adipose, donor0	11217-116B2	209.83	1.77	0.71	1.77	0.00	0.71	0.35
Mesenchymal stem cells - hepatic, donor0	11218-116B3	49.10	2.19	0.00	0.00	0.31	0.63	0.63
Mesenchymal stem cells - umbilical, donor0	11214-116A8	153.85	0.73	0.73	0.73	0.00	1.45	2.90
Mesothelial Cells, donor1	11247-116E5	69.74	1.06	0.00	1.33	0.00	0.27	0.00
Mesothelial Cells, donor2	12156-128G5	70.57	1.00	0.00	0.50	0.00	0.50	0.00
Mesothelial Cells, donor3	11402-118D7	37.29	1.01	0.07	0.14	0.07	0.22	0.14
Monocyte-derived macrophages response to LPS, 00hr00min, donor1 (t1 Subject1)	12698-135D7	13.50	4.05	0.00	0.00	1.35	0.00	1.35
Monocyte-derived macrophages response to LPS, 00hr00min, donor2 (t1 Subject2)	12796-136F6	22.41	6.16	0.00	0.00	0.74	0.74	0.25
Monocyte-derived macrophages response to LPS, 00hr00min, donor3 (t1 Subject3)	12894-137H5	20.32	15.31	0.29	0.00	0.29	0.00	0.29
Monocyte-derived macrophages response to LPS, 00hr15min, donor1 (t2 Subject1)	12699-135D8	6.91	3.46	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor2 (t2 Subject2)	12797-136F7	14.88	8.37	0.00	0.00	0.00	0.62	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor3 (t2 Subject3)	12895-137H6	15.14	13.07	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor1 (t3 Subject1)	12700-135D9	2.32	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor2 (t3 Subject2)	12798-136F8	21.27	6.76	1.00	0.00	0.75	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor3 (t3 Subject3)	12896-137H7	13.96	10.71	0.00	0.00	0.93	0.93	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor1 (t4 Subject1)	12701-135E1	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor2 (t4 Subject2)	12799-136F9	15.44	8.74	0.61	0.00	0.20	0.00	0.20
Monocyte-derived macrophages response to LPS, 00hr45min, donor3 (t4 Subject3)	12897-137H8	13.46	11.09	0.40	0.40	0.40	0.40	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor1 (t5 Subject1)	12702-135E2	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor2 (t5 Subject2)	12800-136G1	20.35	10.62	1.77	0.00	0.00	0.88	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor3 (t5 Subject3)	12898-137H9	20.90	11.78	0.00	0.00	0.38	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor1 (t6 Subject1)	12703-135E3	2.63	3.95	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor2 (t6 Subject2)	12801-136G2	12.52	9.34	0.21	0.00	0.21	0.00	0.42
Monocyte-derived macrophages response to LPS, 01hr20min, donor3 (t6 Subject3)	12899-137I1	4.60	5.52	0.92	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor1 (t7 Subject1)	12704-135E4	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor2 (t7 Subject2)	12802-136G3	8.35	3.87	0.60	0.00	0.30	0.30	0.30
Monocyte-derived macrophages response to LPS, 01hr40min, donor3 (t7 Subject3)	12900-137I2	6.71	10.06	1.68	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor1 (t8 Subject1)	12705-135E5	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor2 (t8 Subject2)	12803-136G4	15.81	8.03	0.50	0.25	0.50	0.25	1.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor3 (t8 Subject3)	12901-137I3	14.74	7.37	0.24	0.00	0.00	0.24	0.00
Monocyte-derived macrophages response to LPS, 02hr30min, donor1 (t9 Subject1)	12706-135E6	6.63	5.53	0.55	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr30min, donor2 (t9 Subject2)	12804-136G5	18.65	5.76	0.00	0.00	0.00	0.23	0.23
Monocyte-derived macrophages response to LPS, 02hr30min, donor3 (t9 Subject3)	12902-137I4	13.46	11.15	0.00	0.63	1.47	0.21	0.21
Monocyte-derived macrophages response to LPS, 03hr00min, donor1 (t10 Subject1)	12707-135E7	10.80	6.32	0.20	0.20	0.20	0.41	0.00
Monocyte-derived macrophages response to LPS, 03hr00min, donor2 (t10 Subject2)	12805-136G6	17.81	7.08	0.21	0.00	0.00	0.00	0.21
Monocyte-derived macrophages response to LPS, 03hr00min, donor3 (t10 Subject3)	12903-137I5	13.12	6.67	0.89	0.00	0.22	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor1 (t11 Subject1)	12708-135E8	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor2 (t11 Subject2)	12806-136G7	11.17	5.69	0.44	0.00	0.22	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor3 (t11 Subject3)	12904-137I6	9.13	6.59	0.51	0.00	0.51	0.51	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor1 (t12 Subject1)	12709-135E9	0.00	3.31	1.66	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor2 (t12 Subject2)	12807-136G8	15.49	5.98	0.82	0.54	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor3 (t12 Subject3)	12905-137I7	15.88	8.53	0.00	0.00	0.00	0.29	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor1 (t13 Subject1)	12710-135F1	5.45	4.36	1.09	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor2 (t13 Subject2)	12808-136G9	17.78	8.65	0.96	0.00	0.48	0.00	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor3 (t13 Subject3)	12906-137I8	20.81	5.20	0.00	0.00	0.00	0.00	0.40
Monocyte-derived macrophages response to LPS, 06hr, donor1 (t14 Subject1)	12711-135F2	6.86	4.11	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor2 (t14 Subject2)	12809-136H1	17.52	6.51	2.00	0.00	0.50	0.00	0.50
Monocyte-derived macrophages response to LPS, 06hr, donor3 (t14 Subject3)	12907-137I9	80.84	0.00	0.00	0.00	26.95	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor1 (t15 Subject1)	12712-135F3	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor2 (t15 Subject2)	12810-136H2	19.71	7.88	0.88	0.00	0.44	0.00	0.44
Monocyte-derived macrophages response to LPS, 07hr, donor3 (t15 Subject3)	12908-138A1	3.31	3.31	0.00	0.00	1.10	0.00	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor1 (t16 Subject1)	12713-135F4	8.97	2.56	0.00	0.00	0.00	0.64	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor2 (t16 Subject2)	12811-136H3	23.30	4.21	0.00	0.00	0.74	0.50	0.50
Monocyte-derived macrophages response to LPS, 08hr, donor3 (t16 Subject3)	12909-138A2	11.83	3.48	0.70	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor1 (t17 Subject1)	12714-135F5	2.21	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor2 (t17 Subject2)	12812-136H4	22.22	3.08	0.00	0.00	1.03	0.00	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor3 (t17 Subject3)	12910-138A3	10.94	3.50	0.00	0.44	0.00	0.00	0.44
Monocyte-derived macrophages response to LPS, 12hr, donor1 (t18 Subject1)	12715-135F6	9.23	1.07	0.36	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor2 (t18 Subject2)	12813-136H5	24.97	5.33	0.00	0.28	0.56	0.28	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor3 (t18 Subject3)	12911-138A4	12.47	4.16	0.42	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor1 (t19 Subject1)	12716-135F7	5.83	1.17	0.58	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor2 (t19 Subject2)	12814-136H6	11.46	3.32	0.00	0.00	0.60	0.00	0.60
Monocyte-derived macrophages response to LPS, 14hr, donor3 (t19 Subject3)	12912-138A5	17.53	7.51	0.00	0.00	1.25	0.42	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor1 (t20 Subject1)	12717-135F8	7.22	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor2 (t20 Subject2)	12815-136H7	16.62	5.54	1.85	0.92	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor3 (t20 Subject3)	12913-138A6	19.35	3.98	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 18hr, donor1 (t21 Subject1)	12718-135F9	13.40	3.18	0.41	0.00	0.28	0.14	0.00
Monocyte-derived macrophages response to LPS, 18hr, donor2 (t21 Subject2)	12816-136H8	13.99	3.11	0.78	0.00	0.52	0.00	0.00
Monocyte-derived macrophages response to LPS, 18hr, donor3 (t21 Subject3)	12914-138A7	12.87	6.86	0.86	0.00	0.00	0.43	0.43
Monocyte-derived macrophages response to LPS, 20hr, donor1 (t22 Subject1)	12719-135G1	7.62	0.64	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor2 (t22 Subject2)	12817-136H9	11.48	2.67	0.27	0.27	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor3 (t22 Subject3)	12915-138A8	14.97	5.39	0.00	0.00	0.30	0.30	0.30
Monocyte-derived macrophages response to LPS, 22hr, donor1 (t23 Subject1)	12720-135G2	12.29	1.98	0.42	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 22hr, donor2 (t23 Subject2)	12818-136I1	20.70	1.59	0.32	0.00	0.00	0.00	0.32
Monocyte-derived macrophages response to LPS, 22hr, donor3 (t23 Subject3)	12916-138A9	19.46	4.20	0.66	0.22	0.88	0.00	0.00
Monocyte-derived macrophages response to LPS, 24hr, donor1 (t24 Subject1)	12721-135G3	7.96	2.28	0.00	0.00	0.38	0.00	0.00
Monocyte-derived macrophages response to LPS, 24hr, donor2 (t24 Subject2)	12819-136I2	18.75	3.69	0.85	0.00	0.00	0.00	0.85
Monocyte-derived macrophages response to LPS, 24hr, donor3 (t24 Subject3)	12917-138B1	23.35	5.41	0.98	0.25	0.49	0.00	0.49
Monocyte-derived macrophages response to LPS, 36hr, donor1 (t25 Subject1)	12722-135G4	6.52	2.61	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 36hr, donor2 (t25 Subject2)	12820-136I3	16.76	2.06	0.59	0.00	0.00	0.00	0.29
Monocyte-derived macrophages response to LPS, 36hr, donor3 (t25 Subject3)	12918-138B2	23.07	4.90	1.15	0.00	0.58	0.00	0.00
Monocyte-derived macrophages response to LPS, 48hr, donor1 (t26 Subject1)	12723-135G5	20.61	5.36	0.41	0.00	0.00	0.41	0.00
Monocyte-derived macrophages response to LPS, 48hr, donor2 (t26 Subject2)	12821-136I4	10.42	2.68	0.30	0.30	0.00	0.00	0.30
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor1 (868_121:MI_0h)	13304-142I1	26.37	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor2 (150_120:MI_0h)	13316-143A4	8.91	3.56	1.78	0.00	0.00	0.00	1.78
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor3 (536_119:MI_0h)	13322-143B1	16.10	2.96	0.99	0.00	0.00	0.99	0.33
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor4 (227_121:MI_0h)	13310-142I7	16.83	9.47	1.05	0.00	0.00	0.00	3.16
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor1 (868_121:MI_24h)	13309-142I6	12.26	3.16	0.79	0.00	0.00	0.00	0.59
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor2 (150_120:MI_24h)	13321-143A9	12.11	4.66	1.86	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor3 (536_119:MI_24h)	13327-143B6	19.15	2.63	0.75	0.00	0.00	0.00	0.75
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor4 (227_121:MI_24h)	13315-143A3	12.52	4.26	0.27	0.00	0.27	0.27	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor1 (868_121:Ud_0h)	13305-142I2	16.85	2.26	1.02	0.00	0.11	0.45	0.57
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor2 (150_120:Ud_0h)	13317-143A5	7.37	2.95	0.74	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor3 (536_119:Ud_0h)	13323-143B2	10.99	2.56	1.10	0.00	0.00	0.00	0.37
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor4 (227_121:Ud_0h)	13311-142I8	14.00	3.11	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor1 (868_121:Ud_2h)	13306-142I3	26.72	4.28	0.00	0.00	0.00	0.00	0.53
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor2 (150_120:Ud_2h)	13318-143A6	19.32	3.86	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor3 (536_119:Ud_2h)	13324-143B3	12.12	0.00	0.00	0.00	0.00	1.01	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor4 (227_121:Ud_2h)	13312-142I9	12.65	6.32	0.42	0.00	0.00	0.00	0.42
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor1 (868_121:Ud_7h)	13307-142I4	25.88	4.09	1.36	0.00	0.00	0.00	1.36
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor2 (150_120:Ud_7h)	13319-143A7	19.07	3.18	0.64	0.00	0.00	0.64	0.64
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor3 (536_119:Ud_7h)	13325-143B4	18.63	3.24	0.00	0.00	0.00	0.81	0.81
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor4 (227_121:Ud_7h)	13313-143A1	24.17	6.04	1.51	1.51	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor1 (868_121:Ud_24h)	13308-142I5	62.81	5.71	5.71	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor2 (150_120:Ud_24h)	13320-143A8	65.25	13.05	6.52	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor3 (536_119:Ud_24h)	13326-143B5	28.51	4.75	4.75	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor4 (227_121:Ud_24h)	13314-143A2	37.65	0.00	50.20	0.00	0.00	0.00	0.00
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor1	11549-120C1	95.87	1.72	0.86	0.22	0.00	0.43	0.65
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor2	11629-122B9	28.22	1.05	0.00	0.00	0.52	0.00	0.52
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor1	13496-145C4	40.72	2.00	0.67	0.00	0.67	0.00	0.67
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor2	13505-145D4	15.44	0.00	2.50	0.42	0.00	0.42	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor3	13514-145E4	72.25	2.09	0.00	0.19	0.38	0.19	0.19
Myoblast differentiation to myotubes, day00, control donor1	13469-144I4	65.43	6.38	0.00	1.60	0.00	0.00	0.00
Myoblast differentiation to myotubes, day00, control donor2	13478-145A4	9.52	0.00	1.36	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day00, control donor3	13487-145B4	180.09	1.84	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor1	13497-145C5	18.42	0.42	0.84	0.00	0.00	0.00	0.84
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor2	13506-145D5	29.29	0.46	2.32	0.46	0.23	0.00	0.00
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor3	13515-145E5	14.86	0.81	1.08	0.00	0.00	0.54	0.54
Myoblast differentiation to myotubes, day01, control donor1	13470-144I5	33.64	0.63	0.21	0.00	0.00	0.00	0.21
Myoblast differentiation to myotubes, day01, control donor2	13479-145A5	345.18	0.00	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day01, control donor3	13488-145B5	21.84	0.00	1.99	0.00	0.00	0.00	0.50
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor1	13498-145C6	26.25	1.62	0.00	0.00	0.00	0.27	0.81
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor2	13507-145D6	15.87	0.91	1.36	0.23	0.00	0.23	0.00
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor3	13516-145E6	9.63	0.82	0.49	0.00	0.33	0.33	0.49
Myoblast differentiation to myotubes, day02, control donor1	13471-144I6	35.54	1.28	0.36	0.18	0.00	0.18	1.82
Myoblast differentiation to myotubes, day02, control donor2	13480-145A6	20.69	3.18	1.59	0.53	0.53	0.00	0.00
Myoblast differentiation to myotubes, day02, control donor3	13489-145B6	14.41	0.60	1.20	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor1	13499-145C7	44.30	1.64	0.00	0.00	0.33	0.33	2.63
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor2	13508-145D7	10.08	0.65	1.30	0.00	0.16	0.16	0.33
Myoblast differentiation to myotubes, day03, control donor1	13472-144I7	35.63	1.23	0.88	0.00	0.00	0.18	0.88
Myoblast differentiation to myotubes, day03, control donor2	13481-145A7	14.77	0.70	1.41	0.00	0.70	0.00	0.70
Myoblast differentiation to myotubes, day03, control donor3	13490-145B7	7.82	0.46	0.46	0.00	0.00	0.00	0.46
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor1	13500-145C8	22.17	1.29	0.96	0.32	0.00	0.00	0.64
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor2	13509-145D8	46.22	2.41	1.03	0.34	0.34	0.34	1.03
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor3	13518-145E8	161.82	5.06	0.00	0.00	0.00	0.00	2.53
Myoblast differentiation to myotubes, day04, control donor1	13473-144I8	29.18	1.11	0.67	0.00	0.45	0.00	0.89
Myoblast differentiation to myotubes, day04, control donor2	13482-145A8	15.67	0.00	0.00	0.00	0.42	0.00	0.00
Myoblast differentiation to myotubes, day04, control donor3	13491-145B8	18.75	0.71	0.71	0.00	0.00	0.00	0.71
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor1	13501-145C9	17.60	0.43	0.86	0.00	0.00	0.43	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor2	13510-145D9	288.89	0.00	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor3	13519-145E9	10.33	0.33	0.67	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day06, control donor1	13474-144I9	27.50	1.35	0.45	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day06, control donor2	13483-145A9	24.20	0.40	0.00	0.00	0.40	0.00	0.40
Myoblast differentiation to myotubes, day06, control donor3	13492-145B9	13.93	0.93	0.00	0.00	0.00	0.00	0.93
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor1	13502-145D1	18.16	1.14	1.14	0.00	0.00	0.00	1.51
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor2	13511-145E1	14.99	0.98	0.98	0.00	0.00	0.00	0.33
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor3	13520-145F1	5.67	0.00	0.00	0.00	0.00	0.44	0.00
Myoblast differentiation to myotubes, day08, control donor1	13475-145A1	35.73	0.90	0.45	0.00	0.00	0.00	0.45
Myoblast differentiation to myotubes, day08, control donor2	13484-145B1	24.69	1.76	0.88	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day08, control donor3	13493-145C1	9.31	0.00	0.66	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor1	13503-145D2	11.91	1.49	0.00	0.00	0.50	0.00	0.00
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor2	13512-145E2	9.95	0.38	1.91	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor3	13521-145F2	20.57	0.30	1.21	0.00	0.00	0.00	0.60
Myoblast differentiation to myotubes, day10, control donor1	13476-145A2	29.18	0.88	0.22	0.22	0.00	0.22	0.00
Myoblast differentiation to myotubes, day10, control donor2	13485-145B2	9.49	0.68	0.68	0.00	0.00	0.00	0.68
Myoblast differentiation to myotubes, day10, control donor3	13494-145C2	127.74	0.00	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor1	13504-145D3	12.19	0.00	2.44	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor2	13513-145E3	11.65	0.94	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor3	13522-145F3	5.45	0.00	1.21	0.00	0.00	0.00	0.30
Myoblast differentiation to myotubes, day12, control donor1	13477-145A3	12.66	2.37	0.00	0.00	0.79	0.00	0.00
Myoblast differentiation to myotubes, day12, control donor2	13486-145B3	46.48	0.00	0.00	0.00	0.00	0.00	1.13
Myoblast differentiation to myotubes, day12, control donor3	13495-145C3	126.45	15.17	0.00	0.00	0.00	0.00	0.00
Myoblast, donor1	11241-116D8	96.90	1.61	0.50	1.74	0.50	0.25	0.50
Myoblast, donor2	11322-117D8	68.28	0.38	0.77	0.38	0.19	0.19	2.11
Myoblast, donor3	11398-118D3	90.81	2.19	0.34	1.51	0.67	0.17	0.17
NK T cell leukemia cell line:KHYG-1	10777-110G3	38.23	1.61	1.02	1.31	0.15	0.15	0.29
Natural Killer Cells, donor1	11230-116C6	26.45	0.62	8.30	0.00	0.00	0.00	0.31
Natural Killer Cells, donor2	11311-117C6	27.14	2.11	13.27	0.00	0.30	0.00	1.51
Natural Killer Cells, donor3	11387-118C1	23.93	1.29	10.49	0.18	0.00	0.00	1.10
Neural stem cells, donor1	11275-116H6	93.28	2.18	0.00	0.36	0.36	0.36	0.36
Neural stem cells, donor2	11352-117H2	102.06	1.93	3.85	0.00	0.00	0.00	0.00
Neurons, donor1	11494-119E9	93.31	2.28	3.41	0.00	0.00	0.00	0.00
Neurons, donor2	11574-120E8	84.10	1.98	1.10	0.22	0.22	0.22	0.22
Neurons, donor3	11655-122E8	94.55	0.82	3.29	0.00	0.82	0.00	2.47
Neutrophils, donor1	11233-116C9	12.99	0.00	0.93	0.00	0.00	0.00	0.00
Neutrophils, donor2	11314-117C9	11.60	0.00	0.00	0.00	0.00	0.00	0.00
Neutrophils, donor3	11390-118C4	6.72	0.00	1.83	0.00	0.00	0.00	0.00
Nucleus Pulposus Cell, donor1	11252-116F1	36.69	3.80	0.24	0.00	0.59	0.12	0.47
Nucleus Pulposus Cell, donor2	11409-118E5	14.98	3.26	0.65	0.00	0.00	0.33	0.00
Nucleus Pulposus Cell, donor3	11462-119B4	50.14	1.40	0.20	0.00	0.20	0.20	3.21
Olfactory epithelial cells, donor1	11933-125I7	24.64	0.96	0.28	0.14	0.00	0.14	0.41
Olfactory epithelial cells, donor2	11934-125I8	58.04	2.03	0.14	0.43	0.14	0.14	2.89
Olfactory epithelial cells, donor3	11935-125I9	37.57	1.48	0.34	0.23	0.11	0.11	0.68
Olfactory epithelial cells, donor4	11936-126A1	28.25	1.27	0.00	0.00	0.29	0.19	0.19
Oligodendrocyte - precursors, donor1	11496-119F2	89.67	7.22	0.60	0.60	0.00	0.00	0.60
Osteoblast - differentiated, donor1	11276-116H7	35.09	1.06	0.21	0.00	0.00	0.00	0.00
Osteoblast - differentiated, donor2	11353-117H3	19.43	2.29	0.00	0.00	1.14	0.00	2.29
Osteoblast - differentiated, donor3	11425-118G3	14.90	0.00	0.62	0.62	0.00	0.00	0.62
Osteoblast, donor1	11277-116H8	60.19	2.93	0.00	1.17	0.78	0.20	0.00
Osteoblast, donor2	11354-117H4	113.78	2.11	0.00	1.40	0.00	0.00	0.70
Osteoblast, donor3	11426-118G4	51.90	0.53	0.53	0.53	0.53	0.36	0.00
Pancreatic stromal cells, donor1	11249-116E7	74.63	2.19	0.25	0.34	0.67	0.08	0.76
Pericytes, donor1	11491-119E6	7.45	0.33	0.33	0.00	0.11	0.00	0.11
Pericytes, donor2	11571-120E5	7.47	0.23	0.23	0.00	0.00	0.00	0.23
Pericytes, donor3	11652-122E5	26.04	0.61	0.61	0.20	0.00	0.00	0.20
Perineurial Cells, donor1	11499-119F5	98.55	2.03	0.23	0.34	0.45	0.34	0.11
Perineurial Cells, donor2	11579-120F4	85.11	2.94	0.09	0.64	0.37	0.18	0.00
Peripheral Blood Mononuclear Cells, donor1	11231-116C7	27.41	1.27	2.23	0.32	0.00	0.64	0.64
Peripheral Blood Mononuclear Cells, donor2	11312-117C7	16.90	0.49	1.96	0.00	0.00	0.00	1.96
Peripheral Blood Mononuclear Cells, donor3	11388-118C2	16.95	0.65	1.68	0.00	0.00	0.26	0.39
Placental Epithelial Cells, donor1	11278-116H9	41.14	1.43	1.67	0.24	0.24	0.24	0.24
Placental Epithelial Cells, donor2	11355-117H5	45.46	0.00	0.00	0.00	0.00	0.00	2.22
Placental Epithelial Cells, donor3	11427-118G5	22.77	0.39	0.59	0.00	0.20	0.39	0.39
Preadipocyte - breast donor2 (cytoplasmic fraction)	14319-155D8	26.90	2.85	0.00	0.00	0.32	0.00	1.90
Preadipocyte - breast, donor1	11467-119B9	47.65	2.63	0.56	0.19	0.56	0.19	0.19
Preadipocyte - breast, donor2 (nuclear fraction)	14320-155D9	54.95	2.87	1.04	0.13	0.26	0.26	0.00
Preadipocyte - breast, donor2	11328-117E5	30.62	2.25	0.68	0.23	0.23	0.23	0.45
Preadipocyte - omental, donor1	11468-119C1	46.03	2.34	0.43	0.32	0.32	0.21	0.43
Preadipocyte - omental, donor2	11329-117E6	39.28	4.36	1.31	0.00	0.00	0.00	0.44
Preadipocyte - omental, donor3	11403-118D8	56.44	1.29	0.57	0.43	0.57	0.14	0.29
Preadipocyte - perirenal, donor1	11469-119C2	37.40	0.00	0.98	0.00	0.00	0.00	1.97
Preadipocyte - subcutaneous, donor1	11279-116I1	54.05	2.46	0.61	0.00	0.61	0.31	0.00
Preadipocyte - subcutaneous, donor2	11356-117H6	139.36	2.30	0.53	1.06	0.71	0.53	1.59
Preadipocyte - subcutaneous, donor3	11428-118G6	89.91	2.55	0.17	1.19	0.00	0.34	0.85
Preadipocyte - visceral, donor1	11280-116I2	155.09	3.82	0.09	1.30	0.56	0.19	0.47
Preadipocyte - visceral, donor2	11357-117H7	88.81	2.30	0.46	0.92	0.00	0.00	0.92
Preadipocyte - visceral, donor3	11429-118G7	108.67	2.61	0.73	1.36	0.52	0.00	2.19
Prostate Epithelial Cells (polarized), donor1	11253-116F2	112.84	0.75	2.11	1.21	0.30	0.00	1.21
Prostate Epithelial Cells, donor2	11331-117E8	56.33	1.08	0.54	1.62	0.27	0.00	1.22
Prostate Epithelial Cells, donor3	11404-118D9	58.54	0.12	0.31	0.43	0.00	0.06	1.22
Prostate Stromal Cells, donor1	11254-116F3	132.58	1.14	0.80	0.80	0.46	0.11	0.68
Prostate Stromal Cells, donor2	11332-117E9	96.46	0.90	1.26	0.54	0.54	0.18	0.90
Prostate Stromal Cells, donor3	11405-118E1	36.50	0.31	0.31	0.10	0.21	0.21	1.67
Renal Cortical Epithelial Cells, donor1	11516-119H4	14.96	0.36	0.36	0.00	0.00	0.00	0.00
Renal Cortical Epithelial Cells, donor2	11596-120H3	73.68	1.39	0.07	0.28	0.28	0.14	0.21
Renal Epithelial Cells, donor1	11517-119H5	15.72	0.00	0.51	0.00	0.00	0.00	0.00
Renal Epithelial Cells, donor2	11597-120H4	15.65	0.00	0.71	0.00	0.00	0.00	0.00
Renal Epithelial Cells, donor3	11678-122H4	68.49	1.59	0.21	0.32	0.42	0.11	0.42
Renal Glomerular Endothelial Cells, donor1	11514-119H2	8.85	0.00	2.04	0.00	0.00	0.00	0.00
Renal Glomerular Endothelial Cells, donor2	11594-120H1	32.07	0.94	0.40	0.67	0.00	0.00	0.00
Renal Glomerular Endothelial Cells, donor3	11675-122H1	98.57	2.89	0.22	1.55	0.00	0.22	2.00
Renal Glomerular Endothelial Cells, donor4	11783-124B1	9.98	0.00	0.67	1.33	0.00	0.00	0.00
Renal Mesangial Cells, donor1	11518-119H6	27.29	0.88	0.00	0.00	0.22	0.00	0.00
Renal Mesangial Cells, donor2	11598-120H5	13.17	0.00	0.00	0.00	0.00	0.00	0.00
Renal Mesangial Cells, donor3	11679-122H5	7.49	0.28	0.55	0.00	0.00	0.00	0.00
Renal Proximal Tubular Epithelial Cell, donor1	11515-119H3	49.66	1.61	0.00	0.54	0.00	0.00	0.00
Renal Proximal Tubular Epithelial Cell, donor2	11595-120H2	24.46	0.42	0.42	0.42	0.00	0.00	0.42
Renal Proximal Tubular Epithelial Cell, donor3	11676-122H2	28.54	0.19	0.39	0.00	0.00	0.00	0.19
Retinal Pigment Epithelial Cells, donor0	11215-116A9	124.46	1.30	0.26	1.04	0.26	0.26	0.26
Retinal Pigment Epithelial Cells, donor1	11528-119I7	37.80	0.57	0.00	0.28	0.00	0.00	0.00
Retinal Pigment Epithelial Cells, donor2	11608-120I6	22.64	0.00	1.03	0.00	0.00	0.00	0.00
Retinal Pigment Epithelial Cells, donor3	11689-122I6	88.57	2.51	0.00	0.50	0.75	0.50	0.25
SABiosciences XpressRef Human Universal Total RNA, pool1	10002-101A5	24.86	1.34	0.40	0.00	0.00	0.13	0.13
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep1 (B1 T17)	12697-135D6	41.99	1.79	0.89	0.89	0.00	0.89	0.00
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep2 (B2 T17)	12795-136F5	75.95	3.85	0.00	0.00	1.10	0.00	1.10
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep3 (B3 T17)	12893-137H4	49.30	5.22	0.58	0.58	1.74	0.00	0.58
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep1 (A1 T0)	12662-134I7	92.58	3.38	0.39	1.30	0.52	0.13	0.39
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep2 (A2 T0)	12760-136B6	70.80	2.38	1.19	0.70	0.79	0.00	0.60
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep3 (A3 T0)	12858-137D5	105.07	2.79	0.78	0.45	1.45	0.11	0.11
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep1 (A1 T1)	12663-134I8	124.91	2.85	0.87	1.74	1.49	0.25	0.74
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep2 (A2 T1)	12761-136B7	74.71	3.15	0.93	0.58	0.70	0.12	0.70
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep3 (A3 T1)	12859-137D6	86.21	2.31	2.08	0.46	0.92	0.23	1.62
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep1 (A1 T2)	12664-134I9	69.14	1.92	0.41	0.55	0.68	0.27	0.55
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep2 (A2 T2)	12762-136B8	77.30	2.72	0.76	0.45	0.30	0.00	1.06
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep3 (A3 T2)	12860-137D7	85.65	1.79	0.36	0.54	0.36	0.18	0.18
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep1 (A1 T3)	12665-135A1	68.00	0.72	0.86	0.14	0.14	0.00	0.72
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep2 (A2 T3)	12763-136B9	78.34	2.15	1.82	0.32	0.43	0.11	0.64
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep3 (A3 T3)	12861-137D8	72.80	1.33	0.44	0.44	0.44	0.00	0.22
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep1 (A1 T4)	12666-135A2	64.24	1.15	0.38	1.15	0.76	0.19	0.57
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep2 (A2 T4)	12764-136C1	72.48	2.52	1.12	0.84	0.84	0.09	0.28
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep3 (A3 T4)	12862-137D9	90.20	2.25	0.75	0.75	0.56	0.00	0.19
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep1 (A1 T5)	12667-135A3	61.97	0.80	2.39	0.53	0.66	0.00	0.40
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep2 (A2 T5)	12765-136C2	73.01	2.63	0.78	0.58	0.78	0.29	0.68
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep3 (A3 T5)	12863-137E1	80.20	1.72	1.34	0.38	1.15	0.00	0.57
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep1 (A1 T6)	12668-135A4	61.62	0.85	0.32	0.75	0.43	0.32	0.53
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep2 (A2 T6)	12766-136C3	70.64	1.68	2.24	0.56	1.12	0.28	0.28
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep3 (A3 T6)	12864-137E2	79.98	1.71	0.85	0.34	0.68	0.00	0.51
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep1 (A1 T7)	12669-135A5	62.17	1.46	1.82	0.36	0.36	0.00	0.36
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep2 (A2 T7)	12767-136C4	67.57	1.72	1.10	0.61	0.74	0.00	0.25
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep3 (A3 T7)	12865-137E3	80.86	2.42	2.15	0.67	0.67	0.13	0.67
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep1 (A1 T8)	12670-135A6	91.75	2.36	1.18	0.71	0.24	0.00	0.71
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep2 (A2 T8)	12768-136C5	74.41	0.60	1.59	0.40	0.40	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep3 (A3 T8)	12866-137E4	80.44	2.57	0.70	1.17	1.64	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep1 (A1 T9)	12671-135A7	83.15	1.66	0.62	0.62	1.04	0.00	0.21
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep2 (A2 T9)	12769-136C6	86.94	3.76	1.33	1.77	0.44	0.22	1.11
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep3 (A3 T9)	12867-137E5	77.91	1.67	1.88	0.21	0.42	0.00	0.63
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep1 (A1 T10)	12672-135A8	81.83	2.29	1.21	0.94	0.67	0.13	0.27
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep2 (A2 T10)	12770-136C7	68.80	2.55	1.70	0.51	0.85	0.00	0.34
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep3 (A3 T10)	12868-137E6	76.35	1.16	0.96	0.77	0.58	0.00	0.39
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep1 (A1 T11)	12673-135A9	85.97	2.58	0.52	0.86	0.00	0.17	1.20
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep2 (A2 T11)	12771-136C8	63.65	1.65	0.82	0.55	1.23	0.27	0.14
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep3 (A3 T11)	12869-137E7	86.02	2.96	1.48	0.82	0.99	0.00	0.99
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep1 (A1 T12)	12674-135B1	49.08	2.05	1.19	0.51	0.34	0.17	0.51
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep2 (A2 T12)	12772-136C9	67.76	4.14	0.74	0.59	1.92	0.00	0.30
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep3 (A3 T12)	12870-137E8	54.91	1.33	1.07	0.53	0.27	0.00	0.27
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep1 (A1 T13)	12675-135B2	45.21	2.07	0.97	0.28	1.11	0.14	1.11
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep2 (A2 T13)	12773-136D1	55.72	2.62	0.48	0.24	0.95	0.00	0.24
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep3 (A3 T13)	12871-137E9	51.39	2.02	1.21	0.40	0.60	0.20	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep1 (A1 T14)	12676-135B3	45.58	2.26	1.22	0.09	0.94	0.00	0.28
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep2 (A2 T14)	12774-136D2	50.31	3.14	1.05	0.00	0.70	0.35	1.40
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep3 (A3 T14)	12872-137F1	43.52	2.42	0.30	0.30	0.60	0.00	0.60
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep1 (A1 T15)	12677-135B4	52.01	2.57	2.69	0.24	0.37	0.00	0.61
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep2 (A2 T15)	12775-136D3	93.59	5.09	0.73	0.29	3.64	0.00	0.44
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep3 (A3 T15)	12873-137F2	60.23	7.30	1.22	0.00	1.22	0.00	0.61
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep1 (A1 T16)	12678-135B5	56.96	3.62	1.21	0.90	0.60	0.60	0.60
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep2 (A2 T16)	12776-136D4	45.24	2.71	1.36	0.23	1.13	0.00	0.45
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep3 (A3 T16)	12874-137F3	46.73	2.70	0.30	0.00	0.30	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep1 (A1 T17)	12679-135B6	61.75	3.78	1.77	0.47	0.83	0.35	0.71
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep2 (A2 T17)	12777-136D5	41.62	2.13	0.21	0.00	0.64	0.00	0.43
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep3 (A3 T17)	12875-137F4	40.87	3.61	0.00	1.20	1.20	0.00	0.60
Schwann Cells, donor1	11498-119F4	21.82	0.00	0.56	0.19	0.00	0.00	0.38
Schwann Cells, donor2	11578-120F3	91.87	0.00	3.40	0.00	0.00	0.00	0.00
Schwann Cells, donor3	11659-122F3	52.36	2.85	0.00	0.66	0.00	0.22	0.44
Sebocyte, donor1	11220-116B5	119.41	1.10	0.00	2.19	0.00	0.00	0.55
Sebocyte, donor2	11301-117B5	99.72	0.46	0.92	2.30	0.00	0.00	0.00
Sebocyte, donor3	11378-118B1	62.04	0.62	0.41	0.21	0.00	0.00	0.82
Sertoli Cells, donor1	11255-116F4	59.64	3.31	0.00	0.00	1.66	0.00	0.00
Sertoli Cells, donor2	11333-117F1	50.84	2.82	0.00	0.00	0.00	0.00	0.00
Skeletal Muscle Cells, donor1	11281-116I3	89.03	1.58	0.26	0.26	0.18	0.09	0.62
Skeletal Muscle Cells, donor2	11358-117H8	13.01	0.72	0.00	0.00	0.00	0.72	0.00
Skeletal Muscle Cells, donor3	11430-118G8	65.21	2.51	4.18	0.00	0.00	0.84	0.84
Skeletal Muscle Cells, donor4	11451-119A2	165.89	3.14	0.79	2.20	0.79	0.00	1.89
Skeletal Muscle Cells, donor5	11455-119A6	142.10	1.78	1.19	1.34	0.00	0.15	2.23
Skeletal Muscle Cells, donor6	11459-119B1	178.53	2.15	1.08	1.69	0.31	0.15	3.08
Skeletal Muscle Satellite Cells, donor1	11240-116D7	106.22	2.65	0.50	0.50	0.76	0.50	1.01
Skeletal Muscle Satellite Cells, donor2	11321-117D7	69.20	1.28	0.57	0.29	0.43	0.00	1.28
Skeletal Muscle Satellite Cells, donor3	11397-118D2	151.30	2.78	0.69	0.99	0.20	0.10	0.99
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor1	11282-116I4	74.14	1.69	0.17	0.93	0.25	0.17	0.34
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor2	11359-117H9	45.60	4.34	2.90	0.72	0.00	0.00	0.00
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor3	11431-118G9	33.16	1.10	0.83	0.41	0.00	0.00	0.83
Skin - palm, donor1	10286-104F7	21.49	2.69	0.00	0.00	2.69	0.00	0.00
Small Airway Epithelial Cells donor2 (cytoplasmic fraction)	14334-155F5	51.61	0.29	0.72	0.86	0.00	0.00	1.73
Small Airway Epithelial Cells donor2 (nuclear fraction)	14335-155F6	61.34	0.82	4.91	0.82	0.00	0.00	1.64
Small Airway Epithelial Cells donor3 (cytoplasmic fraction)	14316-155D5	54.53	1.43	0.13	0.39	0.00	0.13	1.43
Small Airway Epithelial Cells, donor1	11256-116F5	106.06	1.11	0.00	1.11	0.00	0.14	0.70
Small Airway Epithelial Cells, donor2	11334-117F2	63.58	0.70	0.28	0.70	0.42	0.00	0.42
Small Airway Epithelial Cells, donor3 (nuclear fraction)	14317-155D6	109.32	0.21	0.85	0.63	0.21	0.00	0.00
Small Airway Epithelial Cells, donor3	11406-118E2	43.32	0.60	0.30	0.45	0.15	0.15	0.52
Smooth Muscle Cells - Aortic, donor0 (cytoplasmic fraction)	14313-155D2	66.04	0.31	0.00	0.93	0.00	0.31	2.16
Smooth Muscle Cells - Aortic, donor0 (nuclear fraction)	14314-155D3	51.80	0.89	0.22	0.89	0.22	0.00	0.22
Smooth Muscle Cells - Aortic, donor0	11210-116A4	51.73	2.35	0.59	0.59	0.00	0.00	0.00
Smooth Muscle Cells - Aortic, donor1	11283-116I5	42.87	1.10	0.66	0.44	0.22	0.00	0.00
Smooth Muscle Cells - Aortic, donor2	11360-117I1	64.19	1.58	0.39	0.39	0.00	0.39	0.39
Smooth Muscle Cells - Aortic, donor3	11432-118H1	52.53	1.55	0.00	0.00	0.77	0.77	0.00
Smooth Muscle Cells - Bladder, donor1	11519-119H7	34.03	1.00	0.00	0.00	0.00	0.00	1.00
Smooth Muscle Cells - Brachiocephalic, donor1	11284-116I6	57.22	1.60	0.53	0.67	0.13	0.00	0.13
Smooth Muscle Cells - Brachiocephalic, donor2	11361-117I2	82.90	1.77	0.22	0.66	0.00	0.22	1.33
Smooth Muscle Cells - Brachiocephalic, donor3	11433-118H2	109.59	1.79	0.90	2.18	0.38	0.38	0.64
Smooth Muscle Cells - Brain Vascular, donor1	11234-116D1	71.96	2.93	0.33	0.98	0.33	0.65	0.00
Smooth Muscle Cells - Brain Vascular, donor2	11315-117D1	69.70	2.66	0.59	0.30	0.59	0.00	0.30
Smooth Muscle Cells - Brain Vascular, donor3	11391-118C5	48.97	1.00	0.28	0.00	0.28	0.00	0.85
Smooth Muscle Cells - Bronchial, donor1	11512-119G9	12.69	0.00	0.00	0.00	0.00	0.00	0.16
Smooth Muscle Cells - Bronchial, donor2	11592-120G8	30.14	0.91	0.00	0.00	0.61	0.00	0.61
Smooth Muscle Cells - Carotid, donor1	11285-116I7	40.16	2.27	0.51	0.25	0.00	0.00	0.00
Smooth Muscle Cells - Carotid, donor2	11362-117I3	171.38	6.12	0.00	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Carotid, donor3	11434-118H3	44.35	0.48	0.48	0.95	0.00	0.00	0.48
Smooth Muscle Cells - Colonic, donor1	11239-116D6	76.24	3.24	0.74	0.59	0.44	0.15	0.29
Smooth Muscle Cells - Colonic, donor2	11320-117D6	66.72	1.29	1.29	0.65	0.22	0.22	0.86
Smooth Muscle Cells - Colonic, donor3	11396-118D1	91.84	2.20	0.52	0.73	0.42	0.52	1.26
Smooth Muscle Cells - Coronary Artery, donor1	11286-116I8	78.42	1.24	0.46	2.17	0.31	0.00	0.15
Smooth Muscle Cells - Coronary Artery, donor2	11363-117I4	71.14	1.08	1.08	1.08	0.00	0.00	1.08
Smooth Muscle Cells - Coronary Artery, donor3	11435-118H4	63.06	1.20	0.30	1.49	0.30	0.00	0.90
Smooth Muscle Cells - Esophageal, donor1	11508-119G5	21.51	0.34	0.00	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Esophageal, donor2	11588-120G4	45.47	2.12	0.16	0.00	0.31	0.08	0.24
Smooth Muscle Cells - Internal Thoracic Artery, donor1	11287-116I9	99.33	0.10	0.10	1.31	0.30	0.10	1.01
Smooth Muscle Cells - Internal Thoracic Artery, donor2	11364-117I5	56.43	2.05	0.23	1.37	0.46	0.23	0.00
Smooth Muscle Cells - Internal Thoracic Artery, donor3	11436-118H5	45.29	0.00	1.21	0.60	0.00	0.00	2.42
Smooth Muscle Cells - Intestinal, donor1	11509-119G6	289.30	2.38	0.53	4.50	0.53	0.79	0.79
Smooth Muscle Cells - Prostate, donor1	11257-116F6	80.96	2.66	0.53	0.67	0.13	0.13	0.40
Smooth Muscle Cells - Prostate, donor2	11335-117F3	64.36	0.38	0.50	0.38	0.25	0.00	1.75
Smooth Muscle Cells - Prostate, donor3	11465-119B7	26.63	0.25	0.00	0.00	0.76	0.25	0.76
Smooth Muscle Cells - Pulmonary Artery, donor1	11288-117A1	86.85	2.86	1.06	0.90	0.45	0.15	0.30
Smooth Muscle Cells - Pulmonary Artery, donor2	11365-117I6	25.51	0.00	0.00	0.00	0.00	0.00	0.75
Smooth Muscle Cells - Pulmonary Artery, donor3	11437-118H6	59.44	1.29	1.29	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Subclavian Artery, donor1	11289-117A2	39.07	1.86	0.93	0.93	0.00	0.00	0.47
Smooth Muscle Cells - Subclavian Artery, donor2	11366-117I7	59.58	1.01	0.50	1.51	0.00	0.00	0.00
Smooth Muscle Cells - Subclavian Artery, donor3	11438-118H7	47.64	1.88	0.00	0.94	0.00	0.31	0.63
Smooth Muscle Cells - Tracheal, donor1	11513-119H1	17.11	0.00	0.00	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Tracheal, donor2	11593-120G9	153.78	2.92	0.08	0.92	0.25	0.25	0.00
Smooth Muscle Cells - Tracheal, donor3	11674-122G9	20.09	0.93	0.00	0.00	0.00	0.47	0.47
Smooth Muscle Cells - Umbilical Artery, donor1	11290-117A3	58.57	1.58	0.43	0.29	0.29	0.00	0.14
Smooth Muscle Cells - Umbilical Artery, donor2	11367-117I8	57.11	1.53	1.02	0.51	0.00	0.25	0.76
Smooth Muscle Cells - Umbilical Artery, donor3	11439-118H8	52.09	1.69	0.56	0.19	0.19	0.00	0.56
Smooth Muscle Cells - Umbilical Vein, donor1	11541-120B2	125.49	2.38	0.14	0.28	0.28	0.42	0.00
Smooth Muscle Cells - Umbilical Vein, donor2	11621-122B1	82.70	1.59	0.08	0.34	0.59	0.00	0.25
Smooth Muscle Cells - Umbilical Vein, donor3	11702-123B1	8.57	0.00	0.00	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Umbilical artery, donor0	11212-116A6	64.10	0.98	0.49	0.98	0.24	0.00	0.00
Smooth Muscle Cells - Uterine, donor1	11258-116F7	77.33	2.21	0.66	0.88	0.00	0.00	0.88
Smooth Muscle Cells - Uterine, donor3	11466-119B8	86.31	2.34	0.29	0.00	0.29	0.59	0.88
Smooth muscle cells - airway, asthmatic, donor1	11960-126C7	16.13	0.97	0.19	0.00	0.00	0.00	0.78
Smooth muscle cells - airway, asthmatic, donor2	11961-126C8	34.91	2.38	0.53	0.00	0.00	0.00	1.06
Smooth muscle cells - airway, asthmatic, donor3	11962-126C9	45.75	1.49	0.74	0.74	0.00	0.00	3.72
Smooth muscle cells - airway, asthmatic, donor4	11963-126D1	37.73	1.80	0.36	1.08	0.36	0.00	1.80
Smooth muscle cells - airway, asthmatic, donor5	11964-126D2	57.63	1.42	0.28	0.28	0.00	0.00	1.42
Smooth muscle cells - airway, asthmatic, donor6	11965-126D3	85.08	3.15	0.79	0.00	0.00	0.00	1.18
Smooth muscle cells - airway, control, donor1	11966-126D4	35.55	0.51	0.25	0.25	0.51	0.00	2.54
Smooth muscle cells - airway, control, donor2	11967-126D5	13.98	0.80	1.20	0.00	0.40	0.00	0.40
Smooth muscle cells - airway, control, donor3	11968-126D6	28.42	1.67	0.00	0.00	0.00	0.00	1.67
Smooth muscle cells - airway, control, donor4	11969-126D7	23.38	1.38	0.92	0.00	0.00	0.00	0.92
Synoviocyte, donor1	11291-117A4	48.48	1.51	0.17	0.17	0.50	0.17	0.17
Synoviocyte, donor2	11368-117I9	25.65	2.85	0.00	0.00	0.00	0.67	0.67
Synoviocyte, donor3	11440-118H9	23.01	0.22	0.00	0.00	0.00	0.22	1.79
Trabecular Meshwork Cells, donor1	11532-120A2	32.52	0.71	1.07	0.00	0.00	0.00	0.00
Trabecular Meshwork Cells, donor2	11612-122A1	7.93	0.00	0.00	0.00	0.00	0.00	0.00
Trabecular Meshwork Cells, donor3	11693-123A1	16.67	0.00	0.23	0.23	0.00	0.00	0.00
Tracheal Epithelial Cells, donor1	11292-117A5	89.46	2.08	0.72	0.93	0.07	0.22	0.00
Tracheal Epithelial Cells, donor2	11369-118A1	40.98	1.93	1.93	0.77	0.00	0.00	0.00
Tracheal Epithelial Cells, donor3	11441-118I1	45.24	1.72	3.44	0.00	0.00	0.00	1.72
Universal RNA - Human Normal Tissues Biochain, pool1	10007-101B4	28.05	0.98	0.49	0.00	0.00	0.25	0.00
Urethra, donor2	10319-105A4	17.98	0.00	0.00	0.00	0.00	0.00	0.00
Urothelial Cells, donor1	11520-119H8	16.47	0.00	0.00	0.00	0.00	0.00	0.00
Urothelial Cells, donor2	11600-120H7	16.42	0.00	0.00	0.00	0.00	0.00	0.00
Urothelial Cells, donor3	11681-122H7	9.17	0.46	1.15	0.00	0.00	0.00	0.00
Urothelial cells, donor0	11216-116B1	47.25	0.89	0.22	0.00	0.00	0.00	0.00
Whole blood (ribopure), donor090309, donation1	12179-129A1	23.13	0.89	3.56	0.00	0.00	0.00	1.78
Whole blood (ribopure), donor090309, donation2	12180-129A2	32.88	0.00	2.86	1.43	0.00	0.00	0.00
Whole blood (ribopure), donor090309, donation3	12181-129A3	17.80	0.00	1.37	0.00	0.00	0.00	0.00
Whole blood (ribopure), donor090325, donation1	12176-128I7	18.25	0.34	0.69	0.00	0.00	0.00	0.34
Whole blood (ribopure), donor090325, donation2	12177-128I8	22.66	0.00	0.00	0.00	0.00	0.00	0.00
Whole blood (ribopure), donor090612, donation1	12182-129A4	17.70	0.00	1.04	0.00	0.00	0.00	0.00
Whole blood (ribopure), donor090612, donation2	12183-129A5	27.53	0.92	0.00	0.00	0.00	0.00	1.84
Whole blood (ribopure), donor090612, donation3	12184-129A6	13.69	0.91	0.91	0.91	0.00	0.00	1.83
Wilms' tumor cell line:G-401	10809-111A8	124.84	1.85	0.99	3.08	0.37	0.00	0.12
Wilms' tumor cell line:HFWT	10597-108E3	82.72	0.00	0.00	0.88	0.00	0.00	0.88
acantholytic squamous carcinoma cell line:HCC1806	10717-109I6	105.58	0.56	0.56	1.68	0.28	0.28	0.56
achilles tendon, donor2	10292-104G4	16.53	0.00	0.00	0.00	0.00	0.00	0.00
acute lymphoblastic leukemia (B-ALL) cell line:BALL-1	10455-106G5	145.07	18.10	1.78	1.53	2.04	0.51	0.25
acute lymphoblastic leukemia (B-ALL) cell line:NALM-6	10534-107G3	184.35	8.36	1.63	3.25	0.00	0.70	0.46
acute lymphoblastic leukemia (T-ALL) cell line:HPB-ALL	10429-106D6	64.34	2.49	1.42	1.31	0.36	0.24	0.12
acute lymphoblastic leukemia (T-ALL) cell line:Jurkat	10464-106H5	271.30	22.04	0.54	5.99	0.54	1.36	0.54
acute myeloid leukemia (FAB M0) cell line:KG-1	10827-111C8	128.46	3.94	1.69	0.28	0.00	0.00	0.84
acute myeloid leukemia (FAB M0) cell line:Kasumi-3	10789-110H6	67.67	6.56	2.11	0.42	0.63	0.42	0.42
acute myeloid leukemia (FAB M1) cell line:HYT-1	10828-111C9	51.45	4.90	2.45	1.09	0.27	0.00	2.18
acute myeloid leukemia (FAB M2) cell line:Kasumi-1	10788-110H5	153.34	1.76	0.88	3.97	0.00	0.00	0.88
acute myeloid leukemia (FAB M2) cell line:Kasumi-6	10792-110H9	70.24	2.86	1.63	0.82	0.41	0.00	0.82
acute myeloid leukemia (FAB M2) cell line:NKM-1	10765-110E9	69.51	8.54	2.72	3.11	0.00	1.16	0.39
acute myeloid leukemia (FAB M3) cell line:HL60	10829-111D1	236.62	14.72	0.92	4.97	0.00	0.92	2.21
acute myeloid leukemia (FAB M4) cell line:FKH-1	10830-111D2	105.31	7.80	7.80	0.00	0.00	3.90	0.00
acute myeloid leukemia (FAB M4) cell line:HNT-34	10831-111D3	132.46	10.92	0.70	1.63	1.86	0.23	1.63
acute myeloid leukemia (FAB M4eo) cell line:EoL-1	10832-111D4	242.07	6.47	0.52	2.85	1.55	0.26	1.29
acute myeloid leukemia (FAB M4eo) cell line:EoL-3	10833-111D5	158.10	3.51	1.46	0.29	0.00	0.58	1.17
acute myeloid leukemia (FAB M5) cell line:NOMO-1	10764-110E8	47.87	3.72	1.39	1.39	0.00	0.93	0.46
acute myeloid leukemia (FAB M5) cell line:P31/FUJ	10770-110F5	74.03	2.88	1.23	1.65	0.00	0.00	0.82
acute myeloid leukemia (FAB M5) cell line:THP-1 (cytoplasmic fraction)	14298-155B5	15.65	5.83	1.84	0.31	0.00	0.00	1.23
acute myeloid leukemia (FAB M5) cell line:THP-1 (fresh)	10399-106A3	118.63	4.27	0.00	0.43	0.85	0.43	0.85
acute myeloid leukemia (FAB M5) cell line:THP-1 (revived)	10400-106A4	104.03	8.19	0.91	0.30	1.21	1.21	0.30
acute myeloid leukemia (FAB M5) cell line:THP-1 (thawed)	10405-106A9	126.37	8.42	0.48	4.09	0.72	0.24	0.48
acute myeloid leukemia (FAB M5) cell line:U-937 DE-4	10834-111D6	159.04	6.01	0.00	2.00	0.89	0.00	0.67
acute myeloid leukemia (FAB M6) cell line:EEB	10835-111D7	151.76	5.34	1.67	2.00	1.00	0.33	0.33
acute myeloid leukemia (FAB M6) cell line:F-36E	10836-111D8	117.07	3.72	0.00	0.00	0.00	0.00	0.00
acute myeloid leukemia (FAB M6) cell line:F-36P	10837-111D9	162.72	3.77	0.00	0.38	0.75	0.75	0.75
acute myeloid leukemia (FAB M7) cell line:M-MOK	10699-109G6	72.83	5.67	1.74	0.44	0.87	0.00	0.00
acute myeloid leukemia (FAB M7) cell line:MKPL-1	10802-111A1	89.97	0.00	3.75	0.00	0.00	0.00	0.00
adenocarcinoma cell line:IM95m	10796-110I4	58.17	1.65	0.94	1.18	0.24	0.47	0.24
adipose tissue, adult, pool1	10010-101C1	17.84	3.26	0.47	0.00	0.00	0.00	0.31
adipose, donor1	10184-103D4	143.08	2.93	2.93	0.00	4.10	0.00	4.10
adipose, donor2	10185-103D5	22.71	0.00	3.65	0.00	0.41	0.00	1.22
adipose, donor3	10186-103D6	72.97	2.72	5.45	0.82	0.54	0.00	1.63
adipose, donor4	10187-103D7	196.75	6.07	1.73	6.07	2.60	0.87	0.87
adrenal cortex adenocarcinoma cell line:SW-13	10810-111A9	93.59	0.47	0.32	0.79	0.00	0.16	0.16
adrenal gland, adult, pool1	10081-102A9	32.74	0.00	0.00	0.00	0.00	0.00	0.00
adult T-cell leukemia cell line:ATN-1	10421-106C7	52.83	3.87	2.13	0.53	0.53	0.40	0.13
alveolar cell carcinoma cell line:SW 1573	10708-109H6	136.49	1.07	0.71	0.71	0.00	0.00	0.71
amniotic membrane cells, donor1	12235-129G3	25.97	0.46	0.46	0.93	0.23	0.00	0.00
amniotic membrane cells, donor2	12236-129G4	29.41	2.03	0.68	0.00	0.34	0.34	0.34
amniotic membrane cells, donor3	12237-129G5	23.86	0.29	0.29	0.29	0.00	0.00	0.59
amygdala - adult, donor10196	10167-103B5	45.06	8.30	0.00	0.00	0.00	3.56	1.19
amygdala, adult, donor10252	10151-102I7	29.00	4.06	3.45	0.20	0.00	2.43	0.41
amygdala, newborn, donor10223	10360-105E9	27.76	1.29	2.58	0.00	0.00	0.00	0.32
anaplastic carcinoma cell line:8305C	10428-106D5	34.12	1.27	0.00	0.51	0.00	0.00	0.38
anaplastic large cell lymphoma cell line:Ki-JK	10795-110I3	183.34	5.52	2.21	6.40	1.32	0.66	1.10
anaplastic squamous cell carcinoma cell line:RPMI 2650	10805-111A4	52.11	3.34	2.34	2.34	0.00	0.33	0.33
aorta, adult, pool1	10052-101G7	10.00	0.59	0.20	0.00	0.00	0.20	0.20
appendix, adult	10189-103D9	32.21	3.49	0.78	0.00	0.39	0.00	0.00
argyrophil small cell carcinoma cell line:TC-YIK	10589-108D4	141.70	6.19	0.00	2.06	0.34	0.34	0.69
artery, adult	10190-103E1	16.30	1.36	1.36	0.00	0.00	0.00	0.00
astrocytoma cell line:TM-31	10425-106D2	80.69	8.11	0.43	0.43	0.29	0.72	0.43
b cell line:RPMI1788	10427-106D4	70.48	8.77	1.04	1.19	1.49	0.00	0.15
basal cell carcinoma cell line:TE 354.T	10702-109G9	45.22	0.28	0.28	0.28	0.28	0.00	0.55
bile duct carcinoma cell line:HuCCT1	10432-106D9	124.44	0.40	0.10	2.08	0.10	0.30	0.30
bile duct carcinoma cell line:TFK-1	10496-107C1	60.93	0.50	0.17	0.50	0.00	0.33	0.17
biphenotypic B myelomonocytic leukemia cell line:MV-4-11	10718-109I7	49.21	1.12	0.56	0.00	0.56	0.00	0.00
bladder, adult, pool1	10011-101C2	18.14	1.63	0.22	0.00	0.00	0.22	0.33
blood, adult, pool1	10053-101G8	4.43	0.00	0.00	0.00	0.00	0.00	0.00
bone marrow stromal cell line:StromaNKtert	10686-109F2	43.67	4.28	0.00	0.00	0.86	0.00	0.00
bone marrow, adult	10192-103E3	41.16	2.02	0.00	0.00	0.00	0.00	0.00
brain, adult, donor1	10084-102B3	16.40	9.23	2.05	0.00	0.00	0.00	0.00
brain, adult, pool1	10012-101C3	29.40	13.03	0.78	0.11	0.22	2.45	0.00
brain, fetal, pool1	10085-102B4	21.37	5.34	0.00	0.00	0.00	0.00	2.67
breast carcinoma cell line:MCF7	10482-107A5	59.80	0.99	0.66	0.66	0.00	0.66	2.97
breast carcinoma cell line:MDA-MB-453	10419-106C5	49.06	1.62	0.87	0.25	0.75	0.25	0.00
breast, adult, donor1	10080-102A8	12.63	0.00	1.26	0.00	0.00	0.00	0.63
bronchial squamous cell carcinoma cell line:KNS-62	10760-110E4	203.90	1.02	0.25	0.51	1.14	0.13	0.89
bronchioalveolar carcinoma cell line:NCI-H358	10709-109H7	74.52	0.31	1.24	0.62	0.00	0.31	0.00
bronchioalveolar carcinoma cell line:NCI-H650	10715-109I4	103.60	0.69	0.23	1.38	0.46	0.00	0.92
bronchogenic carcinoma cell line:ChaGo-K-1	10710-109H8	40.43	1.45	1.21	0.73	0.48	0.24	0.24
carcinoid cell line:NCI-H1770	10703-109H1	68.64	4.70	0.47	0.00	1.88	0.00	0.00
carcinoid cell line:NCI-H727	10735-110B6	88.38	1.20	0.66	0.66	0.77	0.00	0.22
carcinoid cell line:SK-PN-DW	10719-109I8	102.99	3.49	0.63	0.32	1.58	0.00	0.63
carcinosarcoma cell line:JHUCS-1	10642-109A3	75.59	0.00	0.53	0.53	0.00	0.00	2.93
caudate nucleus - adult, donor10196	10177-103C6	28.78	4.61	0.00	0.00	0.00	2.30	0.00
caudate nucleus, adult, donor10252	10164-103B2	26.77	6.02	3.01	0.00	0.00	2.34	0.33
caudate nucleus, adult, donor10258	10379-105H1	13.75	9.17	1.53	0.00	0.00	0.00	0.76
caudate nucleus, newborn, donor10223	10354-105E3	27.47	3.30	2.56	0.00	0.00	0.00	0.37
cerebellum - adult, donor10196	10173-103C2	26.22	0.00	0.00	0.00	0.00	0.00	2.91
cerebellum, adult, donor10252	10166-103B4	27.97	1.49	3.42	0.00	0.00	1.07	0.21
cerebellum, adult, pool1	10083-102B2	13.80	1.72	2.07	0.00	0.34	1.38	1.03
cerebellum, newborn, donor10223	10357-105E6	30.72	0.00	5.81	0.00	0.00	0.00	0.00
cerebral meninges, adult	10188-103D8	25.21	11.60	0.76	0.50	0.25	1.76	0.00
cerebrospinal fluid, donor2	10294-104G6	12.43	0.00	1.46	0.00	0.00	0.00	0.00
cervical cancer cell line:D98-AH2	10552-107I3	83.68	0.72	0.29	0.29	0.43	0.00	0.29
cervical cancer cell line:ME-180	10553-107I4	57.01	1.49	0.33	0.83	0.00	0.00	0.33
cervix, adult, pool1	10013-101C4	23.73	1.26	0.31	0.10	0.10	0.31	0.31
cholangiocellular carcinoma cell line:HuH-28	10536-107G5	60.89	1.81	0.70	0.98	0.00	0.42	0.42
chondrosarcoma cell line:SW 1353	10700-109G7	23.51	1.31	0.00	0.00	1.31	1.31	0.00
choriocarcinoma cell line:BeWo	10423-106C9	197.47	1.74	0.37	1.99	1.37	0.00	1.12
choriocarcinoma cell line:SCH	10785-110H2	56.43	1.36	0.86	0.74	0.62	0.00	0.49
choriocarcinoma cell line:T3M-3	10618-108G6	87.52	0.95	0.95	1.90	0.24	0.47	1.19
chorionic membrane cells, donor1	12238-129G6	39.32	1.99	0.00	0.28	0.28	0.28	0.00
chorionic membrane cells, donor2	12239-129G7	60.16	3.18	0.40	0.20	0.80	0.20	0.70
chorionic membrane cells, donor3	12240-129G8	38.46	1.65	1.65	0.00	0.00	0.55	1.10
chronic lymphocytic leukemia (T-CLL) cell line:SKW-3	10416-106C2	135.31	13.13	0.00	7.07	2.02	0.00	2.02
chronic myeloblastic leukemia (CML) cell line:KCL-22	10801-110I9	89.13	2.50	1.15	1.15	0.38	0.00	0.38
chronic myelogenous leukemia (CML) cell line:MEG-A2	10766-110F1	72.01	5.28	1.27	0.63	0.42	0.21	0.21
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep1	10824-111C5	181.56	2.57	1.03	0.26	0.26	0.00	0.77
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep2	10825-111C6	194.95	2.42	1.94	1.69	0.48	0.24	0.73
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep3	10826-111C7	179.58	2.85	1.83	1.43	0.81	0.20	1.22
chronic myelogenous leukemia cell line:K562	10454-106G4	351.58	9.13	0.00	4.42	0.29	0.29	0.29
chronic myelogenous leukemia cell line:KU812	10409-106B4	141.00	6.78	0.52	1.30	1.30	0.52	0.00
clear cell carcinoma cell line:JHOC-5	10638-108I8	82.75	2.74	0.91	0.46	0.00	0.00	1.14
clear cell carcinoma cell line:TEN	10636-108I6	104.80	0.35	0.52	1.21	0.17	0.00	1.21
colon carcinoma cell line:CACO-2	10513-107D9	120.44	1.28	0.18	2.56	0.37	0.55	0.18
colon carcinoma cell line:COLO-320	10420-106C6	183.58	2.28	3.42	1.52	1.14	0.00	0.38
colon, adult, donor1	10082-102B1	11.90	2.38	0.00	0.00	1.19	1.19	1.19
colon, adult, pool1	10014-101C5	21.86	1.76	0.24	0.12	0.12	0.24	0.35
colon, fetal, donor1	10070-101I7	8.65	1.24	0.00	0.00	0.00	0.00	0.62
common myeloid progenitor CMP, donor1	12130-128D6	9.17	0.00	0.00	0.00	0.00	0.00	0.00
common myeloid progenitor CMP, donor2	12134-128E1	50.07	0.00	0.00	0.00	0.00	0.00	25.04
cord blood derived cell line:COBL-a 24h infection(-C)	10452-106G2	142.35	4.67	3.40	2.55	0.85	0.85	0.00
cord blood derived cell line:COBL-a 24h infection	10453-106G3	183.99	7.09	0.75	2.72	0.30	0.30	0.15
cord blood derived cell line:COBL-a untreated	10449-106F8	215.61	8.18	0.71	2.40	0.71	0.42	0.14
corpus callosum, adult, pool1	10042-101F6	22.44	1.99	2.65	0.00	0.00	0.33	0.00
cruciate ligament, donor2	10295-104G7	20.26	0.81	1.62	0.00	0.00	0.00	0.00
diaphragm, fetal, donor1	10069-101I6	8.83	0.00	0.00	0.00	0.00	0.00	0.80
diencephalon, adult	10193-103E4	28.80	4.08	1.44	0.24	0.00	0.96	0.24
diffuse large B-cell lymphoma cell line:CTB-1	10631-108I1	178.87	16.07	3.90	0.46	0.69	0.92	5.97
ductal cell carcinoma cell line:KLM-1	10438-106E6	123.09	2.31	0.00	2.56	0.00	0.00	0.51
ductal cell carcinoma cell line:MIA Paca2	10488-107B2	98.21	4.57	0.48	0.48	0.00	0.72	0.72
ductus deferens, adult	10196-103E7	25.91	0.00	0.50	0.00	0.00	1.00	1.50
duodenum, fetal, donor1, tech_rep1	10071-101I8	20.16	1.44	0.00	0.00	0.00	0.00	1.44
duodenum, fetal, donor1, tech_rep2	10071-101I8	33.84	0.74	0.74	0.00	0.00	0.00	0.74
dura mater, adult, donor1	10041-101F5	30.89	4.05	0.33	0.17	0.08	0.74	0.17
embryonic kidney cell line: HEK293/SLAM infection, 24hr	10451-106G1	275.81	1.33	7.33	12.44	0.00	0.44	0.67
embryonic kidney cell line: HEK293/SLAM untreated	10450-106F9	423.72	1.72	1.00	11.03	0.43	0.00	0.86
embryonic pancreas cell line:1B2C6	10604-108F1	104.21	4.32	0.00	0.00	0.00	0.62	0.00
embryonic pancreas cell line:1C3D3	10605-108F2	91.42	2.42	0.00	0.91	0.00	0.30	1.51
embryonic pancreas cell line:1C3IKEI	10606-108F3	121.65	2.78	0.00	0.62	0.31	0.31	0.31
embryonic pancreas cell line:2C6	10603-108E9	151.05	3.94	2.63	0.00	0.00	1.31	1.31
endometrial carcinoma cell line:OMC-2	10497-107C2	218.21	7.04	0.67	4.36	4.69	0.34	0.34
endometrial stromal sarcoma cell line:OMC-9	10448-106F7	97.14	1.99	0.54	1.81	0.36	0.36	0.36
endometrioid adenocarcinoma cell line:JHUEM-1	10643-109A4	142.96	1.77	0.64	3.70	0.16	0.32	1.77
epidermoid carcinoma cell line:A431	10426-106D3	78.92	2.89	0.44	1.00	0.11	0.33	0.22
epidermoid carcinoma cell line:Ca Ski	10431-106D8	142.98	0.55	0.55	1.10	0.11	0.11	0.11
epididymis, adult	10197-103E8	18.84	1.26	0.42	0.00	0.21	0.21	0.21
epithelioid sarcoma cell line:HS-ES-1	10443-106F2	59.25	0.89	0.89	0.18	0.00	0.00	0.00
epithelioid sarcoma cell line:HS-ES-2R	10495-107B9	66.46	0.79	0.00	0.79	0.00	0.00	1.18
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep1	10815-111B5	215.84	1.05	1.83	3.54	0.39	0.13	0.92
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep2	10816-111B6	162.89	1.18	0.59	4.53	0.39	0.10	0.98
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep3	10817-111B7	216.44	1.46	0.78	3.47	0.34	0.00	0.90
esophagus, adult, pool1	10015-101C6	30.79	1.38	0.00	0.11	0.00	0.00	0.32
extraskeletal myxoid chondrosarcoma cell line:H-EMC-SS	10410-106B5	71.63	0.50	0.75	0.75	0.38	0.13	0.38
eye - muscle inferior rectus, donor1	10272-104E2	12.07	2.41	0.00	0.00	0.00	0.00	0.00
eye - muscle lateral, donor2	10298-104H1	12.63	0.00	2.10	0.00	0.00	0.00	0.00
eye - muscle medial, donor2	10299-104H2	7.44	0.00	1.49	0.00	0.00	0.00	0.00
eye - muscle superior, donor2	10297-104G9	14.90	0.00	1.15	0.00	0.00	0.00	1.15
eye - vitreous humor, donor1	10268-104D7	14.57	0.00	0.00	0.00	0.00	0.00	0.00
eye, fetal, donor1	10054-101G9	15.76	0.51	1.02	0.00	0.00	0.00	0.00
fibrosarcoma cell line:HT-1080	10758-110E2	140.66	9.87	0.64	2.18	1.54	0.77	0.51
fibrous histiocytoma cell line:GCT TIB-223	10711-109H9	285.38	8.78	1.66	9.02	2.14	1.66	0.00
frontal lobe, adult, pool1	10040-101F4	33.21	16.89	2.25	0.00	0.38	2.63	0.00
gall bladder carcinoma cell line:TGBC14TKB	10470-106I2	98.48	1.80	0.90	0.60	0.90	0.00	0.30
gall bladder carcinoma cell line:TGBC2TKB	10415-106C1	66.93	0.37	0.37	0.37	0.09	0.00	0.09
gall bladder, adult	10198-103E9	18.11	0.48	0.48	0.00	0.24	0.00	0.72
gamma delta positive T cells, donor1	11937-126A2	40.80	0.54	3.76	0.00	0.00	0.00	2.15
gamma delta positive T cells, donor2	11938-126A3	35.86	0.75	4.86	0.00	0.00	0.00	0.37
gastric adenocarcinoma cell line:MKN1	10614-108G2	162.43	1.27	0.42	4.44	0.00	0.00	2.75
gastric adenocarcinoma cell line:MKN45	10612-108F9	44.87	0.19	0.97	0.19	0.00	0.19	1.16
gastric cancer cell line:AZ521	10549-107H9	177.07	1.15	1.15	2.46	0.82	0.00	0.00
gastric cancer cell line:GSS	10560-108A2	68.64	2.75	2.75	0.92	0.00	0.00	0.00
gastrointestinal carcinoma cell line:ECC12	10615-108G3	75.85	1.83	0.91	1.60	0.23	0.00	3.43
giant cell carcinoma cell line:LU65	10487-107B1	182.55	0.80	0.34	1.61	0.00	0.11	0.00
giant cell carcinoma cell line:Lu99B	10433-106E1	57.52	0.42	0.14	0.56	0.00	0.00	0.00
glassy cell carcinoma cell line:HOKUG	10688-109F4	94.28	0.00	0.50	0.50	0.00	0.25	0.50
glioblastoma cell line:A172, tech_rep1	10444-106F3	54.04	0.95	0.32	0.32	0.11	0.00	0.11
glioblastoma cell line:A172, tech_rep2	10444-106F3	57.72	1.26	0.14	0.14	0.14	0.00	0.14
glioblastoma cell line:T98G	10485-107A8	67.99	3.20	0.11	0.11	0.00	0.99	0.22
glioma cell line:GI-1	10413-106B8	50.08	0.29	0.29	0.88	1.17	0.00	0.29
globus pallidus - adult, donor10196	10175-103C4	24.05	2.92	2.19	0.00	0.00	0.00	0.73
globus pallidus, adult, donor10252	10161-103A8	22.21	1.95	4.64	0.00	0.00	0.00	0.49
globus pallidus, adult, donor10258	10367-105F7	17.80	2.74	5.48	0.00	1.37	0.00	1.37
globus pallidus, newborn, donor10223	10364-105F4	34.11	2.13	1.60	0.00	0.00	0.00	0.00
granulocyte macrophage progenitor, donor1	12131-128D7	9.79	2.45	7.34	0.00	2.45	0.00	0.00
granulocyte macrophage progenitor, donor2	12135-128E2	43.71	0.00	0.00	0.00	0.00	0.00	0.00
granulocyte macrophage progenitor, donor3	12139-128E6	36.59	5.23	0.00	0.00	0.00	0.00	0.00
granulosa cell tumor cell line:KGN	10624-108H3	43.84	0.96	0.32	0.00	0.32	0.32	0.64
hIPS +CCl2, biol_rep1	14383-156B9	196.50	3.21	0.46	3.21	3.21	0.92	2.75
hIPS +CCl2, biol_rep2	14384-156C1	164.61	1.83	0.91	3.20	3.66	0.46	2.29
hIPS +CCl2, biol_rep3	14385-156C2	180.35	5.80	1.29	2.58	1.29	0.00	1.93
hIPS, biol_rep1	14380-156B6	152.35	1.44	1.44	0.00	2.87	0.00	1.44
hIPS, biol_rep2	14381-156B7	187.93	1.37	3.43	2.06	4.12	2.06	4.80
hIPS, biol_rep3	14382-156B8	39.72	3.31	3.31	0.00	0.00	1.10	0.00
hairy cell leukemia cell line:Mo	10712-109I1	87.64	8.33	0.86	0.86	0.29	0.00	0.57
heart - mitral valve, adult	10205-103F7	17.64	0.00	0.00	0.00	0.00	0.00	0.00
heart - pulmonic valve, adult	10206-103F8	14.12	1.05	0.26	0.00	0.00	0.00	0.00
heart - tricuspid valve, adult	10207-103F9	47.46	2.50	0.83	0.00	0.00	0.00	0.83
heart, adult, diseased post-infarction, donor1	10050-101G5	26.32	1.02	0.00	0.61	0.00	0.00	0.00
heart, adult, diseased, donor1	10051-101G6	5.54	0.43	0.43	0.00	0.00	0.00	0.00
heart, adult, pool1	10016-101C7	10.58	1.15	0.00	0.00	0.00	0.46	0.00
heart, fetal, pool1	10046-101G1	23.82	0.82	0.10	0.21	0.10	0.21	0.00
hepatic mesenchymal tumor cell line:LI90	10778-110G4	28.38	1.85	0.00	0.00	0.00	0.00	0.31
hepatoblastoma cell line:HuH-6	10633-108I3	92.76	0.00	1.19	0.00	0.00	0.00	0.00
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep1	10818-111B8	163.87	3.98	1.22	3.76	1.88	0.22	0.55
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep2	10819-111B9	177.69	5.22	0.73	4.85	1.21	0.24	0.61
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep3	10820-111C1	173.41	4.85	0.71	3.64	1.62	0.20	0.40
hepatoma cell line:Li-7	10484-107A7	137.91	3.56	0.44	1.11	0.22	1.22	0.00
hereditary spherocytic anemia cell line:WIL2-NS	10808-111A7	175.27	9.45	2.11	4.02	1.11	0.00	0.20
hippocampus - adult, donor10196	10169-103B7	28.39	5.68	1.89	0.00	0.95	0.95	0.95
hippocampus, adult, donor10252	10153-102I9	22.86	4.08	2.25	0.00	0.00	0.82	0.00
hippocampus, adult, donor10258	10374-105G5	27.89	8.47	1.49	0.00	0.00	1.00	0.00
hippocampus, newborn, donor10223	10363-105F3	25.03	4.23	1.76	1.06	0.00	0.35	0.35
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep1	13421-144D1	397.94	7.93	1.83	7.93	10.38	0.61	9.16
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep2	13425-144D5	220.70	4.52	2.36	4.52	7.07	0.39	1.96
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep3	13429-144D9	250.85	4.32	0.00	5.59	7.87	0.00	2.54
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep1	13422-144D2	65.41	0.00	2.82	0.56	1.69	0.00	1.69
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep2	13426-144D6	77.46	0.77	3.61	0.26	1.29	0.26	8.26
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep3	13430-144E1	108.19	1.90	0.76	0.38	1.52	0.00	2.66
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep1	13423-144D3	64.81	1.46	5.26	0.58	0.88	0.00	4.38
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep2	13427-144D7	56.01	2.15	6.89	0.00	0.86	0.22	1.94
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep3	13431-144E2	77.58	0.83	3.75	0.00	0.83	0.00	2.92
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep1	13424-144D4	133.31	2.37	3.08	0.47	1.42	0.24	0.47
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep2	13428-144D8	112.50	2.89	2.73	0.80	1.93	0.32	1.45
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep3	13432-144E3	129.95	3.37	2.02	0.00	1.35	0.00	1.35
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep1	13433-144E4	229.25	7.67	1.41	5.48	10.80	0.31	1.56
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep2	13437-144E8	282.49	5.40	1.47	10.32	9.33	0.49	12.77
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep3	13441-144F3	437.25	12.22	1.75	9.60	13.96	0.00	4.36
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep1	13434-144E5	76.94	1.15	3.25	0.38	1.15	0.19	4.01
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep2	13438-144E9	67.16	1.74	4.36	0.00	0.44	0.44	3.05
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep3	13442-144F4	81.46	1.00	1.00	0.00	2.00	0.00	8.50
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep1	13435-144E6	50.30	1.13	3.20	0.00	0.38	0.00	1.32
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep2	13439-144F1	62.75	0.91	4.55	0.00	0.91	0.91	2.73
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep3	13443-144F5	48.24	0.63	3.13	0.00	0.31	0.00	2.19
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep1	13436-144E7	79.53	1.31	2.94	0.82	0.65	0.16	2.12
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep2	13440-144F2	71.13	1.16	2.90	0.29	0.58	0.29	2.32
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep3	13444-144F6	66.06	0.90	1.79	0.00	0.30	0.00	1.20
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep1	13445-144F7	259.38	6.10	2.03	5.17	6.47	0.18	2.59
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep2	13449-144G2	251.05	4.28	2.00	4.85	5.14	0.00	2.28
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep3	13453-144G6	364.62	6.94	0.41	7.76	6.53	0.41	6.12
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep1	13446-144F8	89.08	1.41	2.11	0.70	2.46	0.00	7.39
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep2	13450-144G3	80.77	1.58	2.22	0.00	0.95	0.00	3.48
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep3	13454-144G7	83.52	1.82	1.51	0.61	1.51	0.00	3.03
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep1	13447-144F9	57.40	0.00	2.59	0.00	0.00	0.00	2.59
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep2	13451-144G4	59.11	3.32	8.63	0.66	0.00	0.00	3.98
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep3	13455-144G8	69.26	1.80	3.59	0.26	1.03	0.00	2.57
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep1	13448-144G1	112.23	2.30	3.58	0.51	0.26	0.26	5.37
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep2	13452-144G5	87.84	3.79	2.27	0.76	0.76	0.00	3.03
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep3	13456-144G9	95.44	1.68	2.69	0.67	1.34	0.00	0.67
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep1	13457-144H1	246.09	5.55	4.11	4.11	5.55	0.48	4.35
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep2	13461-144H5	290.12	4.01	2.67	8.47	5.79	0.45	4.01
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep3	13465-144H9	231.22	6.34	4.39	6.34	5.85	0.00	2.93
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep1	13458-144H2	81.91	0.92	1.83	0.00	1.53	0.00	1.83
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep2	13462-144H6	751.50	3.25	0.00	0.00	9.76	0.00	65.06
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep3	13466-144I1	120.46	0.66	1.65	0.00	0.99	0.00	3.97
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep1	13459-144H3	61.30	1.09	3.83	0.00	1.09	0.00	4.93
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep2	13463-144H7	55.73	1.45	5.43	0.00	1.81	0.36	2.17
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep3	13467-144I2	70.82	1.42	5.34	0.00	0.36	0.00	3.91
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep1	13460-144H4	91.89	0.00	4.77	0.00	0.00	0.00	1.19
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep2	13464-144H8	134.07	1.35	2.03	0.54	0.81	0.00	2.17
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep3	13468-144I3	94.29	0.81	1.62	0.81	0.27	0.27	1.08
immature langerhans cells, donor1	11904-125F5	26.15	2.91	2.18	0.00	0.00	0.24	0.24
immature langerhans cells, donor2	11905-125F6	22.18	1.58	5.54	0.00	0.00	0.00	0.00
insula, adult, pool1	10039-101F3	37.19	12.59	1.23	0.09	0.09	1.89	0.00
keratoacanthoma cell line:HKA-1	10791-110H8	37.07	2.60	0.65	0.00	0.00	0.00	0.33
kidney, adult, pool1	10017-101C8	37.45	3.30	0.60	0.20	0.00	0.30	0.20
kidney, fetal, pool1	10045-101F9	19.17	0.50	0.07	0.00	0.00	0.28	0.14
large cell lung carcinoma cell line:IA-LM	10509-107D5	256.21	4.69	0.28	4.40	0.85	0.14	0.28
large cell lung carcinoma cell line:NCI-H460	10839-111E2	49.91	1.38	0.28	0.28	0.28	0.28	1.94
large cell non-keratinizing squamous carcinoma cell line:SKG-II-SF	10692-109F8	68.26	0.92	0.37	1.47	0.00	0.18	0.18
left atrium, adult, donor1	10079-102A7	14.71	0.54	0.00	0.00	0.00	0.00	0.00
left ventricle, adult, donor1	10078-102A6	5.56	0.51	0.00	0.00	0.00	0.00	0.00
leiomyoblastoma cell line:G-402	10721-110A1	129.14	0.55	0.82	2.19	0.82	0.00	0.82
leiomyoma cell line:10964C	10569-108B2	49.22	2.16	0.72	0.72	1.08	0.36	1.80
leiomyoma cell line:15242A	10570-108B3	64.13	3.26	0.00	1.09	0.54	0.00	0.54
leiomyoma cell line:15425	10571-108B4	70.17	1.21	0.49	0.97	0.00	0.24	1.70
leiomyosarcoma cell line:Hs 5.T	10722-110A2	38.10	6.35	0.00	0.00	0.00	6.35	0.00
lens epithelial cell line:SRA 01/04	10647-109A8	62.73	0.00	0.00	0.00	0.00	0.00	1.05
leukemia, chronic megakaryoblastic cell line:MEG-01	10752-110D5	138.25	4.01	0.83	2.95	0.35	0.35	0.71
liposarcoma cell line:KMLS-1	10782-110G8	40.46	0.16	0.47	0.16	0.31	0.16	0.16
liposarcoma cell line:SW 872	10726-110A6	58.97	2.92	1.34	1.22	0.24	0.73	0.24
liver, adult, pool1	10018-101C9	42.14	1.30	0.97	0.97	0.16	0.16	0.00
liver, fetal, pool1	10086-102B5	17.87	0.94	0.00	0.00	0.00	0.00	0.00
locus coeruleus - adult, donor10196	10182-103D2	33.10	3.79	2.92	0.15	0.15	1.02	0.00
locus coeruleus, adult, donor10252	10165-103B3	32.67	3.51	3.51	0.37	0.00	1.11	0.37
locus coeruleus, adult, donor10258	10375-105G6	24.26	4.23	4.23	0.00	0.00	0.85	1.13
locus coeruleus, newborn, donor10223	10362-105F2	55.94	4.63	1.68	0.00	0.00	0.00	1.26
lung adenocarcinoma cell line:A549	10499-107C4	66.15	1.80	0.00	0.55	0.42	0.00	0.28
lung adenocarcinoma cell line:PC-14	10408-106B3	56.53	1.38	0.00	0.69	0.69	0.69	0.00
lung adenocarcinoma, papillary cell line:NCI-H441	10742-110C4	72.89	1.71	0.92	1.58	0.92	0.13	0.13
lung, adult, pool1	10019-101D1	15.59	0.95	0.24	0.00	0.24	0.00	0.12
lung, fetal, donor1	10068-101I5	38.82	0.57	0.29	0.00	0.00	0.00	0.86
lung, right lower lobe, adult, donor1	10075-102A3	15.58	1.37	2.29	0.00	0.00	0.00	1.37
lymph node, adult, donor1	10077-102A5	22.72	3.31	0.47	0.00	0.00	0.00	0.00
lymphangiectasia cell line:DS-1	10727-110A7	34.85	1.97	0.66	0.00	0.00	0.00	0.22
lymphoma, malignant, hairy B-cell cell line:MLMA	10775-110G1	118.78	2.72	1.21	0.45	0.60	0.30	0.91
malignant trichilemmal cyst cell line:DJM-1	10412-106B7	121.48	1.70	0.00	2.55	0.00	0.00	0.00
mature adipocyte, donor1	12231-129F8	18.20	0.89	2.66	0.00	0.00	0.89	0.00
mature adipocyte, donor2	12232-129F9	19.30	2.91	1.66	0.00	0.00	0.62	0.00
mature adipocyte, donor3	12233-129G1	20.62	3.08	0.95	0.00	0.47	0.24	0.24
mature adipocyte, donor4	12234-129G2	25.01	2.37	1.32	0.00	0.00	1.84	0.53
maxillary sinus tumor cell line:HSQ-89	10414-106B9	172.02	0.95	0.95	1.19	0.48	0.00	0.71
medial frontal gyrus - adult, donor10196	10170-103B8	42.87	14.66	1.13	0.00	0.00	0.00	0.00
medial frontal gyrus, adult, donor10252	10150-102I6	28.51	6.44	4.05	0.18	0.00	1.10	0.18
medial frontal gyrus, adult, donor10258	10368-105F8	31.45	13.66	1.59	0.00	0.00	0.95	0.32
medial frontal gyrus, newborn, donor10223	10352-105E1	73.36	8.10	0.00	0.85	0.00	0.43	0.85
medial temporal gyrus - adult, donor10196	10183-103D3	45.39	19.74	2.53	0.00	0.34	1.86	0.34
medial temporal gyrus, adult, donor10252	10156-103A3	29.29	5.09	5.31	0.00	0.00	1.70	0.64
medial temporal gyrus, adult, donor10258, tech_rep1	10376-105G7	26.97	7.71	1.93	0.00	0.00	0.00	0.00
medial temporal gyrus, adult, donor10258, tech_rep2	10376-105G7	186.60	71.77	14.35	0.00	0.00	57.41	0.00
medial temporal gyrus, newborn, donor10223	10353-105E2	30.51	4.67	4.67	0.00	0.36	0.36	0.00
medulla oblongata - adult, donor10196	10174-103C3	29.20	0.65	3.24	0.00	0.00	0.00	0.00
medulla oblongata, adult, donor10252	10155-103A2	24.15	2.32	1.39	0.15	0.00	0.93	0.31
medulla oblongata, adult, pool1	10038-101F2	27.43	3.67	1.63	0.16	0.08	0.82	0.00
medulla oblongata, newborn, donor10223	10361-105F1	19.09	2.43	1.39	0.00	0.00	0.69	0.00
medulloblastoma cell line:D283 Med	10838-111E1	176.24	1.55	1.55	4.65	1.33	0.44	1.55
medulloblastoma cell line:ONS-76	10759-110E3	106.62	3.79	1.47	0.98	0.37	0.24	0.12
melanoma cell line:COLO 679	10514-107E1	95.74	8.91	0.43	1.01	0.43	1.15	0.29
melanoma cell line:G-361	10465-106H6	98.27	5.70	0.54	0.81	0.81	0.27	0.00
meningioma cell line:HKBMM	10691-109F7	47.58	2.53	0.54	0.36	0.00	0.18	1.63
merkel cell carcinoma cell line:MKL-1	10843-111E6	99.57	6.17	0.88	2.64	1.76	0.00	0.88
merkel cell carcinoma cell line:MS-1	10844-111E7	137.65	4.41	2.07	2.33	0.26	0.00	0.00
mesenchymal precursor cell - adipose, donor1	11747-123G1	131.19	2.15	0.15	2.45	0.77	0.15	1.23
mesenchymal precursor cell - adipose, donor2	11748-123G2	64.35	2.18	0.18	0.36	0.55	0.73	0.55
mesenchymal precursor cell - adipose, donor3	11749-123G3	78.68	0.83	0.41	1.24	0.00	0.41	0.41
mesenchymal precursor cell - bone marrow, donor1	11750-123G4	41.16	1.97	0.00	0.00	0.14	0.42	1.12
mesenchymal precursor cell - bone marrow, donor2	11751-123G5	47.37	2.50	0.77	0.00	0.77	0.19	0.39
mesenchymal precursor cell - bone marrow, donor3	11840-124H4	38.17	3.47	0.00	0.00	0.00	0.00	0.69
mesenchymal precursor cell - cardiac, donor1	11752-123G6	48.57	0.86	0.17	0.00	0.34	0.17	0.17
mesenchymal precursor cell - cardiac, donor2	11753-123G7	59.23	1.84	0.58	0.23	0.23	0.00	0.81
mesenchymal precursor cell - cardiac, donor3	11754-123G8	98.95	2.12	0.27	1.46	0.53	0.40	0.66
mesenchymal precursor cell - cardiac, donor4	11755-123G9	106.14	1.76	0.27	1.08	0.00	0.41	0.41
mesenchymal precursor cell - ovarian cancer left ovary, donor1	11756-123H1	85.64	3.27	0.28	1.00	0.14	0.28	0.28
mesenchymal precursor cell - ovarian cancer left ovary, donor2	11833-124G6	34.91	0.66	0.00	0.66	0.00	0.00	0.66
mesenchymal precursor cell - ovarian cancer left ovary, donor3	11760-123H5	76.38	2.91	0.28	0.42	0.69	0.14	0.69
mesenchymal precursor cell - ovarian cancer left ovary, donor4	11836-124G9	52.71	4.54	0.00	0.00	0.70	1.05	1.05
mesenchymal precursor cell - ovarian cancer metastasis, donor1	11758-123H3	56.15	1.63	0.20	0.00	0.61	0.00	1.02
mesenchymal precursor cell - ovarian cancer metastasis, donor2	11835-124G8	36.66	1.80	0.36	1.44	0.00	0.00	0.00
mesenchymal precursor cell - ovarian cancer metastasis, donor3	11762-123H7	32.38	1.34	0.10	0.31	0.10	0.10	0.52
mesenchymal precursor cell - ovarian cancer metastasis, donor4	11838-124H2	43.55	0.23	0.00	1.14	0.23	0.00	0.00
mesenchymal precursor cell - ovarian cancer right ovary, donor1	11757-123H2	174.12	7.55	0.00	1.68	0.42	1.26	0.00
mesenchymal precursor cell - ovarian cancer right ovary, donor2	11759-123H4	66.05	2.69	0.30	0.75	0.30	0.30	0.60
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02)	11761-123H6	55.84	1.31	0.26	0.09	0.00	0.53	0.44
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02-G)	11842-124H6	24.67	2.21	0.00	0.00	0.37	0.00	1.84
mesenchymal precursor cell - ovarian cancer right ovary, donor4	11837-124H1	40.92	1.72	0.00	0.29	0.29	0.29	0.29
mesenchymal stem cell line:Hu5/E18	10568-108B1	116.20	1.68	0.84	0.84	0.42	0.42	2.95
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep1	13229-141I7	46.58	1.83	0.46	0.00	0.00	0.00	1.37
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep2	13230-141I8	44.25	1.79	0.51	0.00	0.00	0.26	1.02
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep3	13231-141I9	40.57	2.09	0.00	0.00	0.26	0.26	0.52
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep1	13232-142A1	36.35	1.85	0.00	0.00	0.31	0.31	0.92
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep2	13233-142A2	48.95	1.65	0.24	0.24	0.00	0.24	2.12
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep3	13234-142A3	39.94	1.02	0.68	0.00	0.00	0.00	0.68
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep1	13235-142A4	43.62	1.96	0.79	0.00	0.39	0.00	0.39
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep2	13236-142A5	31.97	1.39	0.93	0.00	0.00	0.46	0.93
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep3	13237-142A6	96.61	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep1	13238-142A7	56.82	2.02	0.29	0.29	0.00	0.00	0.29
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep2	13239-142A8	44.17	0.89	0.89	0.00	0.45	0.00	0.22
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep3	13240-142A9	48.07	1.68	0.48	0.24	0.72	0.00	0.48
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep1	13241-142B1	62.33	3.67	0.73	0.00	1.47	0.00	0.73
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep2	13242-142B2	36.25	2.35	0.00	0.34	0.34	0.00	0.34
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep3	13243-142B3	37.66	1.23	0.82	0.00	0.00	0.00	1.64
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep1	13244-142B4	49.40	1.29	0.86	0.00	0.43	0.00	0.86
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep2	13245-142B5	51.95	0.00	0.00	0.00	0.00	0.00	2.73
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep3	13246-142B6	5.16	10.33	0.00	0.00	5.16	0.00	5.16
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep1	13247-142B7	42.87	2.27	0.32	0.00	0.00	0.00	1.30
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep2	13248-142B8	43.65	0.00	0.00	0.00	0.00	0.00	4.36
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep3	13249-142B9	37.32	1.07	0.00	0.00	0.53	0.00	1.60
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep1	13250-142C1	29.44	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep2	13251-142C2	43.54	0.78	0.78	0.00	0.78	0.00	2.72
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep3	13252-142C3	39.88	4.20	0.00	0.00	0.00	0.00	4.20
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep1	13253-142C4	33.78	0.00	0.99	0.00	0.00	0.00	3.97
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep2	13254-142C5	52.44	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep3	13255-142C6	36.76	0.59	1.19	0.00	0.00	0.00	1.78
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep1	13256-142C7	35.34	1.22	0.00	0.00	1.22	0.00	3.66
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep2	13257-142C8	54.10	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep3	13258-142C9	42.44	2.53	0.63	0.63	0.63	0.00	0.63
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep1	13259-142D1	30.35	1.38	0.34	0.00	0.34	0.00	1.38
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep2	13260-142D2	25.79	2.15	2.15	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep3	13261-142D3	35.93	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep1	13262-142D4	30.99	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep2	13263-142D5	35.04	1.22	0.41	0.00	0.41	0.00	2.44
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep3	13264-142D6	44.49	0.00	1.59	0.00	0.00	0.00	2.38
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep1	13265-142D7	30.66	0.00	0.59	0.00	0.00	0.00	2.95
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep2	13266-142D8	35.53	0.94	0.31	0.00	0.00	0.00	1.87
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep3	13267-142D9	28.07	0.00	0.00	0.00	0.00	0.00	2.67
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep1	13268-142E1	54.40	1.18	0.00	0.00	0.00	0.00	3.55
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep2	13269-142E2	59.06	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep3	13270-142E3	61.27	0.00	2.07	1.38	0.00	0.00	3.44
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep1	13271-142E4	56.41	0.00	0.49	0.99	0.00	0.00	3.46
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep2	13272-142E5	32.52	2.24	0.00	0.00	0.00	0.00	1.12
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep3	13273-142E6	59.79	2.54	1.27	0.00	0.00	0.00	1.27
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep1	13274-142E7	40.30	0.00	0.81	0.00	0.40	0.00	0.81
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep2	13275-142E8	61.06	0.00	2.18	0.00	0.00	0.00	4.36
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep3	13276-142E9	38.01	0.00	0.00	0.00	0.00	0.00	1.27
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep1	13277-142F1	29.13	1.21	0.00	0.00	0.00	0.00	1.21
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep2	13278-142F2	40.67	0.00	0.00	0.00	0.00	0.00	4.52
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep3	13279-142F3	28.83	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep1	13280-142F4	28.37	0.99	0.40	0.40	0.00	0.20	0.79
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep2	13281-142F5	26.61	0.65	0.00	0.00	0.00	0.00	1.30
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep3	13282-142F6	34.63	0.00	1.02	0.00	0.00	0.00	5.09
mesodermal tumor cell line:HIRS-BM	10696-109G3	25.53	0.77	0.00	0.77	0.00	0.00	0.00
mesothelioma cell line:ACC-MESO-1	10493-107B7	72.29	1.18	0.24	0.00	0.00	0.00	0.00
mesothelioma cell line:ACC-MESO-4	10494-107B8	61.39	9.04	0.00	1.39	0.23	0.46	0.00
mesothelioma cell line:Mero-14, tech_rep1	10849-111F3	72.65	0.00	0.00	0.00	0.00	0.00	0.00
mesothelioma cell line:Mero-14, tech_rep2	10849-111F3	108.30	4.52	0.41	1.85	0.10	0.51	0.10
mesothelioma cell line:Mero-25	10850-111F4	78.30	1.13	0.00	1.36	0.00	0.23	0.23
mesothelioma cell line:Mero-41	10851-111F5	95.35	1.47	0.98	0.24	0.00	0.24	0.00
mesothelioma cell line:Mero-48a	10852-111F6	79.27	2.66	0.66	1.11	0.22	0.22	0.22
mesothelioma cell line:Mero-82	10853-111F7	98.81	3.42	0.79	1.31	0.53	1.05	0.26
mesothelioma cell line:Mero-83	10854-111F8	81.88	1.53	1.02	1.36	0.34	0.00	0.34
mesothelioma cell line:Mero-84	10855-111F9	70.27	3.54	0.51	0.25	0.00	0.25	0.51
mesothelioma cell line:Mero-95	10856-111G1	81.37	6.00	0.41	1.04	0.21	0.62	1.45
mesothelioma cell line:NCI-H2052	10847-111F1	108.00	0.99	0.50	1.33	0.00	0.66	0.50
mesothelioma cell line:NCI-H226	10846-111E9	146.24	6.15	0.54	6.33	0.36	0.54	0.90
mesothelioma cell line:NCI-H2452	10848-111F2	90.36	1.71	0.85	1.02	0.00	0.00	0.51
mesothelioma cell line:NCI-H28	10845-111E8	77.36	1.78	1.27	1.27	0.76	0.51	0.76
mesothelioma cell line:No36	10857-111G2	99.49	0.98	0.98	1.30	0.00	0.33	0.98
mesothelioma cell line:ONE58	10858-111G3	67.20	0.54	0.81	1.08	0.00	0.00	0.27
migratory langerhans cells, donor1	11901-125F2	16.89	0.38	1.54	0.00	0.00	0.00	0.38
migratory langerhans cells, donor2	11902-125F3	10.01	0.61	0.37	0.00	0.00	0.00	0.12
migratory langerhans cells, donor3	11903-125F4	17.59	1.79	1.08	0.00	0.00	0.00	0.36
mixed mullerian tumor cell line:HTMMT	10689-109F5	79.99	1.31	0.65	0.00	0.00	0.00	0.98
mucinous adenocarcinoma cell line:JHOM-1	10648-109A9	127.59	9.54	1.48	1.91	2.33	0.85	1.06
mucinous cystadenocarcinoma cell line:MCAS	10784-110H1	64.50	0.23	0.00	1.61	0.00	0.00	0.00
mycosis fungoides, T cell lymphoma cell line:HuT 102 TIB-162	10744-110C6	59.18	2.66	0.76	0.38	0.19	0.38	0.76
myelodysplastic syndrome cell line:SKM-1	10772-110F7	87.78	3.33	2.03	0.55	0.00	0.37	0.74
myeloma cell line:PCM6	10474-106I6	42.10	7.12	1.19	0.20	0.20	0.59	0.40
myxofibrosarcoma cell line:MFH-ino	10600-108E6	51.74	4.06	0.51	1.52	0.00	0.00	0.00
myxofibrosarcoma cell line:NMFH-1	10684-109E9	64.92	3.14	1.37	0.59	0.39	0.20	0.39
nasal epithelial cells, donor1, tech_rep1	12226-129F3	82.90	0.56	0.56	0.56	0.00	0.11	0.11
nasal epithelial cells, donor1, tech_rep2	12226-129F3	97.88	0.59	0.07	0.37	0.07	0.00	0.44
nasal epithelial cells, donor2	12227-129F4	59.61	2.21	0.00	0.00	0.00	0.00	0.00
neuroblastoma cell line:CHP-134	10508-107D4	147.24	5.75	1.38	0.23	4.37	0.23	0.46
neuroblastoma cell line:NB-1	10539-107G8	142.75	3.93	0.56	0.75	0.37	0.37	0.37
neuroblastoma cell line:NBsusSR	10607-108F4	97.64	2.53	0.84	0.84	0.42	0.42	0.21
neuroblastoma cell line:NH-12	10555-107I6	104.92	3.73	2.24	0.75	1.12	0.19	1.12
neuroectodermal tumor cell line:FU-RPNT-1	10637-108I7	40.09	3.56	1.90	0.24	0.00	0.47	2.61
neuroectodermal tumor cell line:FU-RPNT-2	10663-109C6	68.58	2.53	1.43	0.63	0.32	0.48	1.11
neuroectodermal tumor cell line:TASK1	10774-110F9	74.87	1.41	0.60	0.40	0.20	0.00	1.01
neuroepithelioma cell line:SK-N-MC	10728-110A8	138.60	1.91	0.64	3.81	0.00	0.64	0.64
neurofibroma cell line:Hs 53.T	10729-110A9	47.64	1.33	0.27	0.53	0.00	0.27	0.27
neutrophil PMN, donor1	12133-128D9	14.87	0.00	0.00	0.00	0.00	0.00	0.00
neutrophil PMN, donor2	12137-128E4	0.00	0.00	0.00	0.00	0.00	0.00	0.00
neutrophil PMN, donor3	12141-128E8	9.47	0.00	0.00	0.00	0.00	0.00	0.00
non T non B acute lymphoblastic leukemia (ALL) cell line:P30/OHK	10430-106D7	85.57	14.04	3.72	0.85	0.00	0.51	0.68
non-small cell lung cancer cell line:NCI-H1385	10730-110B1	135.29	44.83	1.60	0.80	4.00	3.20	0.80
normal embryonic palatal mesenchymal cell line:HEPM	10813-111B3	33.34	0.00	0.32	0.00	0.00	0.64	1.92
normal intestinal epithelial cell line:FHs 74 Int	10812-111B2	40.73	4.47	0.53	0.26	0.26	0.53	1.58
nucleus accumbens, adult, pool1	10037-101F1	32.71	10.22	1.69	0.19	0.19	2.25	0.00
occipital cortex - adult, donor10196	10172-103C1	43.27	12.36	2.06	0.00	0.00	2.06	2.06
occipital cortex, adult, donor10252	10163-103B1	22.81	2.42	4.56	0.00	0.00	1.34	0.00
occipital cortex, newborn, donor10223	10355-105E4	34.94	5.82	1.46	0.00	0.00	0.00	0.00
occipital lobe, adult, donor1	10076-102A4	29.13	11.28	1.05	0.00	0.00	2.62	0.00
occipital lobe, fetal, donor1	10073-102A1	22.74	1.72	0.86	0.00	0.43	0.00	1.72
occipital pole, adult, pool1	10036-101E9	18.92	7.88	1.18	0.00	0.08	1.34	0.00
olfactory region, adult	10195-103E6	26.17	8.22	1.72	0.00	0.57	2.10	0.19
optic nerve, donor1	10277-104E7	14.01	0.00	8.00	0.00	0.00	0.00	0.00
oral squamous cell carcinoma cell line:Ca9-22	10434-106E2	136.12	1.25	0.57	4.10	0.68	0.11	0.68
oral squamous cell carcinoma cell line:HO-1-u-1	10550-107I1	134.64	1.51	1.10	2.61	0.41	0.00	0.00
oral squamous cell carcinoma cell line:HSC-3	10545-107H5	89.40	1.69	0.51	1.52	0.00	0.17	2.20
oral squamous cell carcinoma cell line:SAS	10544-107H4	99.68	0.35	1.04	0.92	0.23	0.12	0.35
osteoclastoma cell line:Hs 706.T	10704-109H2	29.10	0.88	0.00	0.00	0.00	0.00	0.29
osteosarcoma cell line:143B/TK^(-)neo^(R)	10510-107D6	147.62	3.74	0.00	3.74	0.00	0.00	0.00
osteosarcoma cell line:HS-Os-1	10558-107I9	79.31	1.48	0.21	1.27	0.85	0.21	0.85
ovary, adult, pool1	10020-101D2	19.74	1.66	0.17	0.00	0.00	0.52	0.00
pagetoid sarcoma cell line:Hs 925.T	10732-110B3	111.09	3.48	0.92	1.10	0.18	0.00	0.18
pancreas, adult, donor1	10049-101G4	32.92	0.00	0.00	0.00	0.00	0.94	0.94
pancreatic carcinoma cell line:NOR-P1	10698-109G5	62.90	0.00	0.28	1.40	0.28	0.00	0.28
papillary adenocarcinoma cell line:8505C	10437-106E5	82.79	0.51	0.00	0.68	0.00	0.00	1.36
papillotubular adenocarcinoma cell line:TGBC18TKB	10417-106C3	33.12	0.99	0.17	0.66	0.17	0.33	0.33
paracentral gyrus, adult, pool1	10035-101E8	32.67	12.81	1.10	0.00	0.00	1.92	0.00
parietal cortex, adult, donor10258	10373-105G4	30.09	6.61	2.94	0.00	0.00	0.73	0.00
parietal lobe - adult, donor10196	10171-103B9	29.15	13.17	1.88	0.00	0.00	2.82	0.00
parietal lobe, adult, donor10252	10157-103A4	30.78	5.42	2.57	0.00	0.29	1.43	0.00
parietal lobe, adult, pool1	10034-101E7	31.81	11.54	1.06	0.00	0.26	1.94	0.00
parietal lobe, fetal, donor1	10072-101I9	35.88	3.88	1.94	0.00	0.00	0.00	0.97
parietal lobe, newborn, donor10223	10356-105E5	38.13	3.74	2.99	0.37	0.75	0.37	0.00
parotid gland, adult	10199-103F1	36.38	0.62	0.00	0.00	0.00	1.23	1.85
penis, adult	10200-103F2	19.34	2.15	0.00	0.00	0.00	0.00	0.54
peripheral neuroectodermal tumor cell line:KU-SN	10697-109G4	53.18	0.74	1.12	0.19	0.00	0.37	1.12
pharyngeal carcinoma cell line:Detroit 562	10723-110A3	63.38	3.06	0.29	0.73	0.44	0.15	0.29
pineal gland - adult, donor10196	10179-103C8	23.87	0.65	1.94	0.00	0.00	0.65	0.00
pineal gland, adult, donor10252	10160-103A7	46.19	0.59	1.78	0.00	0.00	0.59	0.00
pineal gland, adult, donor10258	10377-105G8	30.10	0.00	1.88	0.63	0.00	0.00	1.25
pituitary gland - adult, donor10196	10180-103C9	60.71	4.05	2.02	0.00	1.01	0.00	0.00
pituitary gland, adult, donor10252	10162-103A9	76.09	2.08	1.56	1.56	0.52	0.52	0.00
pituitary gland, adult, donor10258	10378-105G9	44.26	0.00	1.70	0.85	0.00	0.85	0.85
placenta, adult, pool1	10021-101D3	31.39	1.08	0.32	0.11	0.22	0.00	0.00
plasma cell leukemia cell line:ARH-77	10840-111E3	97.07	2.65	0.79	2.25	0.40	0.13	0.79
pleomorphic hepatocellular carcinoma cell line:SNU-387	10706-109H4	22.72	2.18	0.00	0.16	0.00	0.31	0.47
pons, adult, pool1	10033-101E6	42.09	7.14	1.46	0.17	0.26	1.20	0.09
postcentral gyrus, adult, pool1	10032-101E5	25.02	10.98	0.70	0.09	0.17	3.14	0.17
promyelocytes/myelocytes PMC, donor1	12132-128D8	4.18	2.09	8.37	0.00	0.00	0.00	0.00
promyelocytes/myelocytes PMC, donor2	12136-128E3	27.54	22.03	5.51	0.00	0.00	0.00	5.51
promyelocytes/myelocytes PMC, donor3	12140-128E7	46.94	11.74	0.00	0.00	0.00	0.00	0.00
prostate cancer cell line:DU145	10490-107B4	164.60	0.15	0.44	3.64	0.00	0.15	0.44
prostate cancer cell line:PC-3	10439-106E7	151.74	3.45	0.54	0.00	0.00	0.36	0.00
prostate, adult, pool1	10022-101D4	20.13	0.45	0.27	0.09	0.00	0.27	0.18
putamen, adult, donor10196	10176-103C5	27.62	13.46	2.83	0.00	0.00	3.30	0.71
putamen, adult, donor10252	10152-102I8	21.57	3.92	1.96	0.00	0.00	1.96	0.00
putamen, adult, donor10258, tech_rep1	10372-105G3	68.85	2.19	1.09	1.09	1.09	2.19	5.46
putamen, adult, donor10258, tech_rep2	10372-105G3	28.03	6.28	1.69	0.00	0.24	0.48	0.24
putamen, newborn, donor10223	10365-105F5	49.48	5.25	0.00	0.75	0.00	0.00	0.00
rectal cancer cell line:TT1TKB	10469-106I1	50.91	1.16	0.58	0.87	0.00	0.00	0.00
rectum, fetal, donor1	10067-101I4	27.82	0.00	0.00	0.00	0.00	0.00	0.00
renal cell carcinoma cell line:OS-RC-2	10411-106B6	45.16	0.21	0.85	0.21	0.00	0.21	0.00
renal cell carcinoma cell line:TUHR10TKB	10471-106I3	16.98	1.24	0.41	0.41	0.00	0.00	0.83
retina, adult, pool1	10030-101E3	18.59	0.89	0.50	0.00	0.00	0.50	0.00
retinoblastoma cell line:Y79	10475-106I7	171.21	3.38	0.52	0.52	1.30	0.26	0.26
rhabdomyosarcoma cell line:KYM-1	10787-110H4	111.27	2.70	0.49	2.09	0.37	0.00	0.49
rhabdomyosarcoma cell line:RMS-YM	10477-106I9	140.04	0.56	0.28	0.56	0.00	0.00	0.00
sacrococcigeal teratoma cell line:HTST	10695-109G2	28.80	1.52	0.00	0.00	0.76	0.00	0.00
salivary acinar cells, donor1	11771-123I7	52.93	1.94	0.16	0.65	0.49	0.00	0.81
salivary acinar cells, donor2	11772-123I8	28.78	2.20	0.28	0.00	0.96	0.28	0.69
salivary acinar cells, donor3	11773-123I9	13.90	0.00	0.00	0.00	0.00	0.66	0.00
salivary gland, adult, pool1	10093-102C3	27.45	1.14	0.00	0.00	0.00	0.00	0.00
schwannoma cell line:HS-PSS, tech_rep1	10442-106F1	67.03	3.46	0.25	0.34	0.17	0.25	0.17
schwannoma cell line:HS-PSS, tech_rep2	10442-106F1	71.00	4.11	0.24	0.71	0.12	0.24	0.35
seminal vesicle, adult	10201-103F3	26.45	0.53	0.53	0.00	0.53	0.00	2.12
serous adenocarcinoma cell line:JHOS-2	10639-108I9	102.76	0.49	0.73	2.19	0.00	0.24	2.43
serous adenocarcinoma cell line:SK-OV-3-R after co-culture with SOC-57-02-G, biol_rep1	11843-124H7	36.24	1.01	0.50	0.00	0.25	0.25	1.76
serous adenocarcinoma cell line:SK-OV-3-R, biol_rep1	11841-124H5	130.46	6.02	2.01	0.00	0.00	1.00	0.00
serous cystadenocarcinoma cell line:HTOA	10693-109F9	44.73	0.67	0.94	0.94	0.00	0.00	0.40
signet ring carcinoma cell line:Kato III	10436-106E4	96.60	1.99	0.77	0.77	0.22	0.33	0.22
signet ring carcinoma cell line:NUGC-4	10483-107A6	113.41	4.26	0.13	1.81	0.52	0.52	0.65
skeletal muscle - soleus muscle, donor1	10282-104F3	19.15	0.71	0.71	0.00	0.00	0.00	0.71
skeletal muscle, adult, pool1	10023-101D5	25.67	0.72	0.24	0.12	0.12	0.00	0.12
skeletal muscle, fetal, donor1	10066-101I3	6.03	0.00	0.00	0.00	0.00	0.00	1.01
skin, adult, donor1	10074-102A2	40.71	0.00	0.00	0.00	0.00	0.00	0.00
skin, fetal, donor1	10065-101I2	25.25	0.00	0.00	0.00	0.00	0.00	0.63
small cell cervical cancer cell line:HCSC-1	10800-110I8	171.76	1.33	2.33	1.33	1.00	0.33	1.67
small cell gastrointestinal carcinoma cell line:ECC10	10610-108F7	56.74	1.89	0.95	1.89	0.95	0.00	2.21
small cell lung carcinoma cell line:DMS 144	10841-111E4	111.41	1.54	0.58	1.16	0.39	0.19	1.73
small cell lung carcinoma cell line:LK-2	10541-107H1	162.35	1.98	0.99	1.32	0.33	0.16	0.49
small cell lung carcinoma cell line:NCI-H82	10842-111E5	143.00	0.80	1.29	0.64	0.00	0.00	1.29
small cell lung carcinoma cell line:WA-hT	10562-108A4	75.40	8.93	0.87	0.44	0.44	0.87	0.22
small intestine, adult, pool1	10024-101D6	28.67	0.96	0.36	0.12	0.12	0.12	0.12
small intestine, fetal, donor1	10064-101I1	30.22	0.98	0.00	0.00	0.25	0.25	0.98
small-cell gastrointestinal carcinoma cell line:ECC4	10609-108F6	45.65	1.54	0.51	1.03	0.51	0.00	1.03
smooth muscle, adult, pool1	10048-101G3	13.96	0.52	0.00	0.00	0.00	0.00	0.26
somatostatinoma cell line:QGP-1	10781-110G7	31.09	2.14	0.27	0.00	0.80	0.00	0.27
spinal cord - adult, donor10196	10181-103D1	23.63	1.61	2.06	0.00	0.23	0.69	1.15
spinal cord, adult, donor10252	10159-103A6	21.68	2.76	1.18	0.00	0.00	0.79	0.00
spinal cord, adult, donor10258	10369-105F9	24.90	1.38	1.38	0.00	0.00	0.00	0.69
spinal cord, fetal, donor1	10056-101H2	23.17	1.22	1.22	0.00	0.00	0.00	0.61
spinal cord, newborn, donor10223	10359-105E8	39.03	3.21	0.92	0.00	0.00	0.00	0.46
spindle cell sarcoma cell line:Hs 132.T	10737-110B8	41.37	1.05	0.00	0.00	0.30	0.15	0.30
spleen, adult, pool1	10025-101D7	28.63	3.63	0.44	0.33	0.11	0.55	0.22
spleen, fetal, pool1	10044-101F8	18.51	1.35	0.48	0.00	0.00	0.08	0.00
splenic lymphoma with villous lymphocytes cell line:SLVL	10424-106D1	71.53	4.45	0.21	0.10	0.41	0.10	0.21
squamous cell carcinoma cell line:EC-GI-10	10463-106H4	115.82	1.90	0.95	0.57	0.38	0.00	0.00
squamous cell carcinoma cell line:JHUS-nk1	10646-109A7	55.56	0.70	0.00	1.05	0.00	0.00	0.00
squamous cell carcinoma cell line:T3M-5	10616-108G4	105.16	0.39	1.17	3.13	0.39	0.39	1.95
squamous cell lung carcinoma cell line:EBC-1	10486-107A9	234.35	8.10	1.24	1.91	0.23	2.14	0.56
squamous cell lung carcinoma cell line:LC-1F	10457-106G7	94.46	2.54	0.00	0.85	0.00	0.42	1.69
squamous cell lung carcinoma cell line:RERF-LC-AI	10501-107C6	56.27	2.54	0.42	0.42	0.42	0.42	0.42
stomach, fetal, donor1	10062-101H8	35.24	0.00	0.00	0.00	0.00	0.00	0.00
submaxillary gland, adult	10202-103F4	23.36	0.57	0.00	0.00	0.00	0.00	0.57
substantia nigra - adult, donor10196	10178-103C7	0.00	0.00	0.00	0.00	0.00	0.00	0.00
substantia nigra, adult, donor10252	10158-103A5	23.26	0.83	2.49	0.00	0.00	0.00	0.21
substantia nigra, adult, donor10258	10371-105G2	33.10	1.55	0.52	0.00	0.00	0.52	0.52
substantia nigra, newborn, donor10223	10358-105E7	33.92	1.41	2.12	0.71	0.00	0.00	0.00
synovial sarcoma cell line:HS-SY-II	10441-106E9	86.66	3.67	0.23	0.92	0.00	0.23	0.46
temporal lobe, adult, pool1	10031-101E4	24.41	8.73	1.36	0.08	0.34	1.70	0.00
temporal lobe, fetal, donor1, tech_rep1	10063-101H9	29.92	1.42	0.71	0.00	0.00	0.00	1.42
temporal lobe, fetal, donor1, tech_rep2	10063-101H9	29.45	1.32	0.88	0.00	0.00	0.00	1.32
tenocyte, donor1	11763-123H8	41.54	0.35	0.35	0.00	0.00	0.00	0.70
tenocyte, donor2	11765-123I1	25.18	3.05	0.00	0.38	0.00	0.38	1.14
tenocyte, donor3	11768-123I4	39.66	2.22	0.00	0.00	0.37	0.00	1.11
teratocarcinoma cell line:NCC-IT-A3	10790-110H7	213.64	3.57	2.38	4.59	2.21	0.17	1.02
teratocarcinoma cell line:NCR-G1	10798-110I6	177.12	4.01	2.77	2.77	1.54	0.00	1.54
teratocarcinoma cell line:PA-1	10807-111A6	139.48	1.39	0.31	1.39	0.46	0.00	0.31
testicular germ cell embryonal carcinoma cell line:ITO-II	10786-110H3	147.64	2.16	1.14	5.33	1.90	0.13	1.27
testicular germ cell embryonal carcinoma cell line:NEC14	10591-108D6	275.69	2.65	0.76	3.03	1.13	0.00	0.76
testicular germ cell embryonal carcinoma cell line:NEC15	10593-108D8	104.70	1.42	0.87	0.87	0.65	0.33	0.22
testicular germ cell embryonal carcinoma cell line:NEC8	10590-108D5	216.92	9.12	0.33	1.63	1.30	1.30	2.93
testis, adult, pool1	10026-101D8	25.88	16.43	5.15	0.21	0.97	1.83	0.11
testis, adult, pool2	10096-102C6	27.52	10.83	7.67	0.00	0.45	0.45	0.00
thalamus - adult, donor10196	10168-103B6	25.39	0.00	3.31	0.00	0.00	0.00	0.00
thalamus, adult, donor10252	10154-103A1	23.13	1.72	2.97	0.00	0.00	0.31	0.00
thalamus, adult, donor10258, tech_rep1	10370-105G1	15.40	1.54	1.54	0.00	0.00	1.54	0.00
thalamus, adult, donor10258, tech_rep2	10370-105G1	21.74	1.81	2.31	0.00	0.16	0.49	0.16
thalamus, newborn, donor10223	10366-105F6	47.75	1.73	0.58	1.15	0.00	0.00	0.00
throat, adult	10209-103G2	24.97	1.75	0.25	0.25	0.00	0.25	0.00
throat, fetal, donor1	10061-101H7	22.85	0.91	0.91	0.30	0.00	0.00	1.52
thymic carcinoma cell line:Ty-82	10803-111A2	129.97	15.70	1.19	1.39	0.00	1.19	2.19
thymus, adult, pool1	10027-101D9	35.39	2.49	1.19	0.10	0.20	0.20	0.30
thymus, fetal, pool1	10043-101F7	35.33	0.94	1.25	0.10	0.10	0.21	0.31
thyroid carcinoma cell line:KHM-5M	10776-110G2	97.59	1.99	0.40	1.46	0.27	0.13	0.80
thyroid carcinoma cell line:TCO-1	10783-110G9	109.66	2.65	0.98	1.40	0.84	0.70	0.56
thyroid, adult, pool1	10028-101E1	31.63	0.93	0.19	0.00	0.37	0.28	0.37
thyroid, fetal, donor1	10060-101H6	23.20	0.26	0.26	0.26	0.00	0.26	0.00
tongue epidermis (fungiform papillae), donor1	10288-104F9	3.08	0.00	0.00	0.00	0.00	0.00	0.00
tongue, adult	10203-103F5	53.96	1.86	0.23	0.70	0.23	0.00	1.86
tongue, fetal, donor1	10059-101H5	24.43	1.18	1.18	0.39	0.00	0.39	0.79
tonsil, adult, pool1	10047-101G2	40.27	2.30	0.30	0.30	0.20	0.10	0.10
trachea, adult, pool1	10029-101E2	40.08	1.80	0.16	0.08	0.00	0.16	0.41
trachea, fetal, donor1	10058-101H4	23.08	0.38	0.38	0.00	0.38	0.00	0.77
transitional cell carcinoma cell line:Hs 769.T	10707-109H5	70.86	0.71	0.35	0.00	0.35	0.00	0.00
transitional-cell carcinoma cell line:5637	10418-106C4	72.54	0.10	0.20	1.42	0.10	0.00	0.20
transitional-cell carcinoma cell line:JMSU1	10492-107B6	114.07	0.78	0.78	1.57	0.00	0.00	0.47
tridermal teratoma cell line:HGRT	10694-109G1	53.27	3.81	0.00	0.00	1.90	0.00	0.00
tubular adenocarcinoma cell line:SUIT-2	10797-110I5	54.77	0.42	0.25	0.85	0.08	0.00	0.51
umbilical cord, fetal, donor1	10057-101H3	18.78	0.00	0.00	0.00	0.00	0.00	0.00
uterus, adult, pool1	10100-102D1	21.16	1.37	0.00	0.17	0.00	0.34	0.17
uterus, fetal, donor1	10055-101H1	28.67	1.02	0.51	0.00	0.00	0.00	1.02
vagina, adult	10204-103F6	7.75	0.00	0.65	0.00	0.00	0.65	0.65
vein, adult	10191-103E2	17.97	1.10	0.44	0.22	0.00	0.22	0.44
xeroderma pigentosum b cell line:XPL 17	10563-108A5	55.01	4.27	0.80	0.27	0.53	0.00	0.27